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Abstract
Nuclear Factor I is a cellular transcription factor involved in the initiation of adenovirus 
type 2 replication. It exists as a family of proteins and comprises two distinct domains. 
The N-terminal domain is highly conserved between species and is involved in DNA 
binding, dimérisation, and stimulates adenovirus replication. The C terminal domain is 
responsible for the transcriptional activation.
In this work, the N terminal, DNA binding domain of Nuclear Factor I, was cloned in 
two different expression systems. Using recombinant baculovirus, the unmodified 
protein and a GST fusion product were expressed in insect cells. Although both 
proteins were expressed at high levels, it was impossible to purify the fusion protein, 
while after purification, the unmodified protein remained heterogeneous. Expression in 
E. coli using the expression vector pET22b and pGEX2T produced inclusion bodies. 
The insoluble material was extracted, solubilised using guanidine HCl, then folded in 
vitro using new additives known as non detergent sulphobetaines. In vitro folding was 
optimised and yields of up to 8% could be obtained. The affinity of the refolded 
material for a specific DNA oligonucleotide was determined in a gel electrophoresis 
DNA binding assay and was identical to the native protein purified from baculovirus 
infected insect cells.
The structure of the Nuclear Factor I DNA Binding Domain was investigated using 
limited proteolysis followed by separation on SDS PAGE, N terminal sequencing and 
mass spectrometry. Residues 1 to 165 formed a compact domain. Residues 166 - 181 
were extremely sensitive to degradation in the absence of DNA but fully protected in 
the presence of specific DNA. The C terminal region from residue 182 could be 
degraded in both conditions. Along with two other regions previously determined 
which bind DNA, the region between residues 166 and 181 is required for DNA 
binding. Differential labelling using iodoacetate showed that cysteine residues 95 and 
111 were modified in the free protein which resulted in an inactive protein but were 
protected in the presence of DNA. This demonstrates their direct involvement in DNA 
binding.
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Introduction
I. Nuclear Factor I : A family of proteins
I .l Introduction
Identification of proteins involved in the replication of adenovirus 2 and 5 DNA was 
facilitated by the development of an in vitro replication assay. The first cell free assay 
was developed by Challberg et al. in 1979 and could sustain the replication of protein 
linked adenovirus genomes. This system utilised HeLa cells infected with adenovirus 
in the presence of an inhibitor of DNA replication (hydroxyurea). When exogenous 
adenovirus genome purified from virion was added to nuclear extracts from infected 
cells, semi conservative viral DNA replication was detected. This assay was modified 
in order to fractionate the various elements required for replication (Ikeda et al, 1982, 
Lichy et al, 1982). Therefore a cytoplasmic extract from cells infected by adenovims 
was complemented with nucleai’ extract from uninfected cells. By fractionating the 
nuclear extract and testing for the stimulation of replication, several factors were 
purified and shown to be involved in the replication of adenovirus 2 and 5 DNA. These 
included Nuclear Factor I (Nagata et al, 1982), Nuclear Factor II (Nagata et al, 1983) 
and Nucleai* Factor III (Pmijn et al, 1986). Similarly the preteiminal protein-DNA 
polymerase (pTP-pol) complex required for adenovirus DNA replication was purified 
by fractionation of the cytoplasmic extract.
1.2 Identification and isolation of Nuclear Factor I and related proteins.
The first protein purified from the nuclear extract and responsible for the stimulation of 
adenovirus replication was a novel protein with a moleculai* weight estimated at 47 IcDa 
(Nagata et al, 1982). The protein was named Nuclear Factor I (NFI). Nuclear Factor I 
was purified by several ion exchange chromatography steps, followed by affinity 
chromatography on denatured DNA. The final step in the purification was the 
separation of proteins by centrifugation on a glycerol gradient. Using nitrocellulose 
filter binding assays and a DNA footprinting method, it was shown that NFI bound to 
a DNA sequence conserved among a number of adenovirus serotypes (Nagata et al, 
1983). The DNA binding site of NFI was determined by the combination of deletion 
and mutation analysis. An NFI DNA binding site lies at the end of the adenovirus type 
2 genome between nucleotides 23 and 40 (Leegwater et al, 1985).
Meanwhile, in the flanking region of the chicken lysozyme gene, four different DNA 
regions, which bound a protein possessing a similai* DNA binding specificity were 
described (Nowock and Sippel, 1982). This protein recognised a specific DNA 
sequence and was named TGGCA binding protein (Borgmeyer et al, 1984). It could 
also bind to the adenovirus origin of DNA replication and enhance initiation of 
adenovirus DNA replication to the same degree as NFI (Nowock et al, 1985, 
Leegwater et al, 1985). Isolation of cDNAs encoding the TGGCA binding protein 
revealed that it was the chicken form of the human NFI protein (Rupp et al, 1990).
The function of NFI was still undetermined at that time. One function of NFI was 
found by Jones (1985) while studying the promoter of herpes simplex virus thymidine 
kinase (HSV tk). Two distinct proteins bound to the promoter of this gene : Spl and a 
protein binding to a CCAAT DNA sequence. This DNA sequence was required for 
efficient transcription in vivo and in vitro. The protein, although not yet purified, was 
named CTF (CAAT Transcription Factor). Purification and identification of the CTF 
protein revealed that CTF and NFI were similar (Jones et al, 1987). Both proteins
shared the same DNA binding properties and the ability to stimulate replication and 
transcription. Furthermore NFI and CTF 1 contained identical polypeptides.
Using an immobilised DNA with a specific NFI binding site, Rosenfeld and Kelly 
(1986) purified NFI. SDS PAGE analysis revealed a population of proteins of apparent 
moleculai' weight ranging from 52 to 66 kDa. This suggested that NFI was in fact a 
family of proteins. This was different from the protein purified by Nagata in terms of 
molecular weight (47 kDa). However the purification described by Nagata involved 
many steps where NFI could have been degraded. It is possible that this 47 kDa. 
protein is not NFI. NFI whose activity is observed thi'ough a gel retardation assay 
might be at a level below detection in Silver stained SDS PAGE.
1.3 Cloning of cDNAs encoding Nuclear Factor I and the emergence of a family of related proteins
cDNA encoding NFI was obtained from a variety of species including: human (Santoro 
et al, 1988, et al, 1994), rat (Paonessa et al, 1988), hamster (Gil et al, 1988), 
chicken (Rupp et al, 1990), pig (Meisterernst et al, 1989), mouse (Inoue et al, 1990) 
and Xenopus (Roulet et al, 1995). Protein expressed from the cloned cDNA isolated 
from human, rat and pig bound to DNA and specifically recognised a CCAAT binding 
site.
1.3.1 Alternative splicing
From HeLa cells, three different clones were isolated : CTF 1, 2, 3 (the porcine NFI 
pCTF 1 to 3 were cloned and found almost identical to the human forms). CTF 4 and 
6 were also cloned from HeLa cells but their functions are yet unknown. The porcine 
NFI gene was mapped and revealed eleven exons. pCTF 1 was the product of the 
translation of all eleven exons, while pCTF 2 and 3 lack exon 9 (figure 1).
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Figure 1 The N uclear Factor I fam ily
Isolated cDNA encoding NFI proteins were characterised by a conserved DNA binding 
region (red boxes). The variable C terminal region is produced by alternative splicing 
of the pre mRNA (green boxes) which can produce a frame shift in the open reading 
frame (lighter blue boxes). The NFI proteins represented in this figure are those 
isolated in humans except for CTF 7 (porcine).
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The absence of exon 9 subsequently changed the reading frame of the mRNA. The 
shift in reading frame produced shorter proteins as a stop codon was present after 
encoding for 16 residues in exon 10 instead of the 33 residues in the reading frame 
used by pCTF 1. pCTF 3 also lacks exon 3. In other species such as chicken and 
Xenopus, several similar proteins were found differing only by the presence or 
absence of a number of residues at the C terminus. These variations seem to come from 
an alternative splicing of a pre mRNA. Therefore other unidentified NFI proteins 
might well exist. Recently two other forms of CTF protein were cloned : CTF 7 from a 
porcine library (Altmann et al, 1994) and CTF 5 from a cDNA libraiy of HeLa cells 
(Wenzelides et al, 1996). CTF 7 lacks exons 9 and 10 while CTF 5 lacks exon 7 to 10. 
However these splicing events did not shift the reading frame of exon 11.
1.3.2 Gene encoding for NFI
Originally, in chicken, 4 different genes were found to code for NFI type proteins. In 
human and in hamster only 2 genes were known (NFI C and X). However 
chromosomal localisation of NFI genes in human using the FISH technique revealed 
four genes (NFI A, B, C and X) on different chromosomes (Qian et al, 1995).
1.3.3 NFI is a family of proteins
From these observations, a clearer picture of the various cloned proteins can be drawn. 
Figure 1 shows some of the NFI protein which have been isolated in human. To 
produce the various NFI proteins, cells have a choice of four genes. By differentially 
splicing the pre mRNA, cells can produce a plethora of different CTF proteins. In 
HeLa cells, seven different CTF proteins were found. Other cells produce other CTFs. 
However the mechanisms choosing which gene is expressed and how it is spliced aie 
unknown. In one particular cell line (HeLa) it was observed that cells grown under 
different conditions produced different apparent molecular weight CTFs (Goyal et al.
1990) suggesting that these mechanisms are dynamic and are regulated by external 
conditions.
1.4 The domain organisation of the protein and its function.
Sequence analysis of the various NFI proteins clearly revealed the existence of two 
distinct regions : at the N terminus a domain rich in positively charged residues (20% 
in this domain compared to 11% on average), while the C terminus contains a high 
proportion of serine (16% compared to 8%), thieonine (9% compared to 5.4%) and 
proline residues (13.4% compared to 6.1%). The prolines are clustered in the last 
hundred residues in the human CTF 1 protein. The C terminal region is not as well 
conserved as the N terminus and varies in length. This is due to the alternative splicing 
which affects tliis domain.
The N terminus region spans up to residue 179 (human CTF 1). Comparison between 
the protein sequences from different species (Figure 2) shows a highly conserved 
domain with at least 85% identity between the cDNA clones obtained. Also it shows 
that about two thirds of the basic residues are clustered between the arginine in position 
28 and lysine at position 91 in the human NFI. Recently a NFI like sequence has been 
found in Caernorhabditis elegans. This protein was called Nuclear Factor I but has not 
yet been shown to specifically bind to DNA. Comparison between NFI from 
C. elegans and human shows at least 60% identity in the residues with the other NFI 
species. The comparison also revealed some highly conserved domains especially from 
an aspartic acid at position 102 to the valine in position 175 (numbering based on 
human NFI). Also the hydrophobic and hydrophilic regions are conserved (in red and 
blue in figure 2).
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32
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65
57
65
65
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T 1 T G K 98
T 1 T G  K 90
S V T G K 98
S V T G K 98
T V T G K 99
S 1 T G K 90
A 1 nIg Js 88
haNFI 132 VMj i J  L F K G 1 P L  E S  T # G  E R L Y K S P Q C S N G L C VQ 164
xNFI 124 VM P ‘L F KG M P L e s t I g e r l Y K S P Q C S  N P G L C VQ 156
pNFI 132 VM | J , L ' F K G V P L  e s t I g e r l A K A P Q C A S P G L C VQ 164
cNFI 132 VM % I L F KG V P L  E S  T # G  E R L A K A P Q C A S P G L C VQ 164
mNFI 133 VM W l  L F KG 1 P L E S T I G E R L  
P L  E S  T # G  E R L
M K S P H)C T N P A L C VQ 165
hNFI 124 VM L & K G 1 V K A A Q C GH P V L C VQ 156
ceNFI 122 VM SI 1 L F KG 1 P L  E S  T & G  E R L V K A A Q C GH P V L C VQ 154
haNFI 165 P H  H 1 G V T 1 K E L D L Y L A Y F VlH T P E S 188
xNFI 157 P H H 1 G V S 1 K E L D L Y L A F f L I h t  P D - 179
pNFI 165 P H H 1 G V T 1 K E L D L Y L A F F V Q A P D S 188
cNFI 165 P H H 1 G V T 1 K E L D L Y L A F F V 0  A P D S 188
mNFI 166 P H H  l|TJV S V K E L D L 0 L  A Y yIv Q EQ i s 189hNFI 157 P H H 1 G V A V K E L D L Y L A Y F V R E R D - 179
ceNFI 155 P H H 1 G V A V K E L D L Y L A Y F V R E R D - 177
Figure 2 Comparison of the amino acid sequence of the N term inal 
region o f human NFI with different anim al species.
The deduced amino acid sequence of the 179 N terminal residues of the human Nuclear 
Factor I was compared to other species from pig (p), hamster (ha), mouse (m), chicken 
(c), Xenopus (x) and C. elegans (ce). Conserved residues are showed in boxes. 
Hydrophobic regions are in blue while hydrophobic regions are in red.
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1.4.1 The DNA binding domain
The different regions in the protein possess different functions. From a rat clone, 
Gounari et al (1990) produced an NFI where the C terminal domain was deleted. The 
first 240 residues were expressed in a recombinant vaccinia virus. The purified protein 
was still dimeric and retained DNA binding activity.
The conserved 177 residue N temiinal region is encoded in a single exon. It was 
thought that this region only was sufficient to confer a DNA binding activity to NFI. 
However the NFI B3 protein, which is translated from an unspliced mRNA and only 
contains the 178 N terminal residues, cannot on its own bind to DNA as a homodimer 
(Liu et al, 1997). Therefore some residues which do not belong to the N temiinal 
region are also required for a proper DNA binding activity.
The specific DNA binding site for NFI was first examined by synthesising various 
oligonucleotides and by determining the DNA binding affinity for NFI for each one of 
them (Gronostajski 1988). The actual specific DNA site was discovered by sequencing 
oligonucleotides which were purified by gel retardation when bound to NFI. After 
seven rounds of purification, the oligonucleotides were cloned and sequenced. By 
comparing the various sequences, the best DNA site bound by NFI is a symmetrical 
dyad of the following sequence: 5’- TTGGCA N4 GCCAA - 3’ (Osada et al, 1996). 
NFI bound tightly to a DNA oligonucleotide containing this site and could not be 
released easily by competition using the natural site found in the adenovirus genome. 
The DNA binding equilibrium constants of NFI were determined experimentally for a 
number of NFI binding sites. Equilibrium binding constants range from 2x10* ^  M'^ for 
a palindromic site found in the a  globin gene promoter to 10  ^ M‘* for the half binding 
site in the HSV tk promoter (Meisterernst et al, 1988). The equilibrium binding 
constant for the binding site in the adenovirus genome is 8.4x10**  ^ M’* (Cleat et al, 
1989). Binding to non specific DNA has an equilibrium constant of 5x10^ M *.
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Méthylation of DNA affects the guanine and adenine nucleotides. An oligonucleotide 
containing a NFI binding site was treated by random méthylation. The methylated 
oligonucleotide was tested for its interference on the DNA binding activity of NFI. 
Therefore the various methylated oligonucleotides were incubated with NFI. Bound 
oligonucleotide and free probe were separated by filtration over a nitrocellulose 
membrane. Bound and free oligonucleotides were subsequently treated to cleave 
specifically the oligonucleotide at the point of the méthylation. By mnning each fraction 
in a sequencing gel, the position of guanines in the oligonucleotide bound by NFI were 
compaied to the unbound oligonucleotide. Unmethylated guanines in the TTGGA 
sequence were retained by NFI on the filter, hence showing that this sequence was 
bound to NFI. This also demonstrated that NFI bound to the major groove. A similar 
result was obtained by éthylation interference experiments in which éthylation affects 
the phosphate backbone of the DNA. Using méthylation protection, NFI was bound to 
the oligonucleotide while méthylation of guanine occurred. By compaiing the guanine 
protected from méthylation in the presence of NFI, the same result as the méthylation 
interference was obtained.
Computational analysis suggested that the contacts between DNA and NFI occurred 
only on one side of the DNA molecule (De Vries et al, 1987). By éthylation 
interference assay, the region of contact between the protein and the DNA was 
mapped. Furthermore some protein-DNA interaction also occurred outside the DNA 
recognition sites as revealed by hydroxyl radical footprinting (Zorbas et al, 1989).
The primaiy structure of NF I does not contain any of the common DNA binding 
motifs such as zinc finger (Klug and Rhodes 1987), leucine zipper (Vinson et al, 
1989), p sheets (Breg et al, 1990) or helix-turn-helix (Harrison and Aggai*wal 1990). 
Deletion analysis of the NFIDBD revealed two different regions involved in DNA 
binding. A region between residues 1 and 78 is involved in non specific DNA binding 
while the region between residues 71 to 236 recognised specifically the NFI DNA 
binding site as a dimer (Dekker et al, 1996).
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A new family of DNA binding proteins has been found from solving the structure of 
two unrelated proteins with no sequence homology : the Epstein-Barr virus nucleai' 
antigen 1 (EBNAl) (Bochkarev et al, 1996) and the E2 protein of bovine 
papillomavims (Hegde et al, 1992). NFI shares similar biochemical properties with the 
EBNAl since EBNAl also binds DNA as a dimer on a specific palindromic binding 
site (Ambinder et al, 1991, Frappier and O’Donnell 1991). Furthermore, EBNAl DNA 
binding domain is also split into two regions : at the N terminus a region binding non 
specifically to DNA and another region which can bind specifically to DNA as a dimer.
Interestingly Suzuki (1993) compaied the residues involved in DNA interaction of 
structurally known DNA binding proteins and showed the frequent existence of an 
helix in the protein residues recognising the DNA. In this helix, basic residues aie 
conserved in positions 2, 1 , 9 ,  11 and 12. In NFI, a putative a  helix with a similar 
motif was identified in CTF 1 between residues 24 and 36. This region may be 
involved in the non specific DNA binding activity of NFI.
Site directed mutational analysis of NFI proteins in this region generally produced an 
inactive protein (Ai'mentero et al, 1994). The DNA binding activity of NFI is also 
dependent upon its dimérisation. The role of the cysteine residues and of a possible 
red-ox regulation of the DNA binding activity has been demonstrated. NFI possesses 
four conserved cysteines at position 95, 111, 148 and 154. Treatment of NFI with 
cysteine modifying chemicals (such as diamide, N-ethylmaleinede) abolished DNA 
binding of NFI. Site directed mutagenesis of these residues produced misfolded 
protein except for the mutation of cysteine 111. The mutated NFI at position 111 from 
a cysteine to a serine or alanine was resistant to inactivation by oxidation (Novak et al, 
1992, Bandyopadhyay et al, 1994). The regulation of NFI through the red-ox states of 
cysteines was also investigated : in vitro, a cellular enzyme thioltransferase 
(glutaredoxin) was able to restore activity from NFI inactivated by oxidation. In vivo, 
investigation of the cellulai' pathway of NFI reactivation suggests that the enzyme
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thiotransferase, catalyses the reactivation in conjunction with GSH and GSH reductase 
(Bandyopadhyay etal, 1998).
1.4.2 The Transcriptional activation domain
Deletion analysis in vivo (Mermod et al, 1989), demonstrated that the C teiminal 
domain is required for transcription stimulation. Using a reporter plasmid with DNA 
binding sites for NFI expressing the Chloramphenicol Acetyl Transferase (CAT), 
various CTF and deletions were co-transfected into Drosophila Schneider line-2 cells. 
These cells do not contain any known NFI protein. Deletion of any sequence in a 
region at the C terminus rich in proline residues, reduced dramatically the expression of 
the CAT. The region between residue 399 and 499 contained the transcription 
activation domain of CTF 1.
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II. Function of Nuclear Factor I in transcription.
Il l  Promoters regulated by Nuclear Factor I.
The number of NFI binding sites in the HeLa genome was experimentally estimated at 
30 000 (Gronostajski et al, 1985). Some of these potential DNA binding sites have 
been identified, but only in a limited number of instances have promoters been shown 
to be regulated by NFL
The promoter of the mouse mammary tumour virus (MMTV) contains at least two NFI 
binding sites : one in the proximal region (Nowock et at, 1985; Buetti and Kuhnel, 
1986; Cordingley et al, 1987 and 1988) and one in the distal region of the promoter 
(Mink et al, 1992). The role of the proximal region of the promoter has been 
extensively studied. It remains at this time the best example of a promoter for which 
both the role of NFI and its regulation are known.
The promoter of the MMTV is located in the Long Terminal Repeats (LTRs) at each 
end of the viral genome. The regulation of transcription is complex and involves many 
activator and inhibitor proteins binding along the whole length of the U3 region of the 
LTR (about 1200 bp). Although the effect of all proteins on the promoter is not fully 
understood and all transcription factors involved have not yet been characterised, a 
general picture starts to appear (Reviewed by Gunzburg and Salmons 1992).
The site of transcription initiation is located at the border between the U3 and R region 
in the LTR. In the proximal promoter which extends from the stait site of transcription 
and 221 bp upstream, four different motifs were identified : a TATA box (-20 to -27), 
an NFIII or octamer binding site (-56 to -37), an NFI binding domain (-60 to -80) and 
a hormone responsive element binding domain which lies between -80 and -190.
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Gene expression of the MMTV promoter can be induced by steroid hormones such as 
androgens, glucocorticoides and progestérones (Scheidereit et al, 1983, Chalepakis et 
al, 1988). Steroid hormones bind to their receptor which migrates to the nucleus and 
binds to specific DNA binding sites in the hormone responsive element of the MMTV 
LTR. Following glucocorticoid induction, five binding site were located at position -78 
to -83, -93 to -98, -114 to -119, -144 to -156 and -170 to -175 (Bruggemeier et al, 
1991, Chavez and Beato 1997). Under glucocorticoid induction, mutations which 
abolished NFI binding to the promoter of the MMTV resulted in a reduction of gene 
expression by six to eight fold. Similarly mutation of the NFIII binding site at position 
-49 to -56 reduced activation by glucocorticoid thiee to four times. Mutation of the 
other NFIII site (-37 to -44), had no effect on gene expression even when stimulated 
by steroid hormone (Cato et al, 1988). Similar results were obtained using androgen as 
inducer instead of glucocorticoids. Therefore NFI was required to stimulate gene 
expression under glucocorticoid hormone activation.
However using progestin as an inducer, the level of gene expression remained similar 
to the wild type even after mutation of the NFI DNA binding site. NFIII was required 
and was shown to bind DNA in a cooperative manner with the loaded progestin 
receptor. These results obtained in vivo were in agreement with transfection assays 
using mutated promoters and testing the induction at various concentrations of steroid 
hormone (Kalff et al, 1990, Cato et al, 1988). NFI and NFIII did not act in synergy 
but rather competed for their binding site on the MMTV promoter (Mows et al, 1994).
Although the MMTV promoter has been extensively investigated, other promoters 
which also contain specific NFI binding sites have been studied. Their specificity can 
be shown either using a competition assay with an oligonucleotide containing an NFI 
site or by DNA footprinting. The role of NFI in the promoter was usually studied 
using transfection of various promoter constructs and by mutation of the potential NFI 
binding elements followed by testing for the gene expression of a marker protein. The
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various promoters can activate extremely diverse functions and some are even cell 
specific. In some promoters, NFI activates gene expression such as in the promoter of 
the fibronectin gene (Alonso et al, 1996), the aspaitate amino transferase gene 
promoter (Garlatti et al, 1996) which contains an NFI binding site between nucleotide - 
519 to-543, the phosphoenolpyruvate carboxykinase gene promoter (binding site at - 
100 to -115) (Crawford et al, 1998), in the production of milk protein such as a  
lactalbumin, (3 lactoglobulin and whey acidic protein (Mink et al, 1992; Li and Rosen 
1995) and the rat pyruvate kinase L gene promoter (Yamada et al, 1997). However 
NFI can also act as a silencer as found in the regulation of expression of a DNA 
binding protein, the Pit-l/GHF-1 (Rajas et al, 1998). Other NFI binding sites have 
been located in other genes such as the promoter of a  globin, IgM and a  (I) collagen 
(Zorbas et al, 1992; Hennighausen et al, 1985; Oikaiinen et al, 1987). However then 
role in the transcription process is still unclear.
A number of viruses contain recognisable NFI binding sites such as polyomaviixis BK 
virus (Chakraborty et al, 1991) and hepatitis (Ori et al, 1994). The human polyoma JC 
virus contains at least 3 NFI sites in the late and early promoters for gene expression 
(Kumar et al, 1993). These NFI binding sites are involved in regulating transcription 
and replication of the virus (Sock et al, 1993). In brain cells, NFI was characterised for 
its transcriptional role specificity for gene expression of the late and early promoter of 
the human JC virus (Kumar et al, 1996).
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II.2 Basal transcription and the formation of pre initiation complex.
A key stage in the control of gene expression is at the level of transcription and 
especially the initiation of the transcription. With recent advances in this aiea of 
research, the mechanism of basal transcription was extensively reviewed (Goodrich 
and Tjian 1994, Orphanides et al, 1996, Hampsey 1998).
In a promoter, the RNA polymerase II does not bind DNA alone but through a 
pre assembled protein complex (figure 3). Experiments isolated the various 
components required to form a preinitiation complex before the RNA polymerase is 
able to transcribe the gene. These various components are found in all species from 
yeast to human and are therefore known as general transcription factors. The different 
general transcription factors have been isolated and are composed of 6 protein 
complexes (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH). The formation of the 
preinitiation complex has been studied In vitro (usually using binding kinetics and gel 
retention assay), in an orderly manner to understand the role of each protein and how 
they affect the assembly of the preinitiation complex. Once this preinitiation complex is 
formed, other events are required such as synthesis of the first phosphodiester bond, 
strand melting, and promoter clearance before the elongation occurs and a pre mRNA 
is synthesised. The preinitiation complex is also described as the basal transcription 
machineiy since it does not require, for its formation, any activators binding to an 
upstream DNA element of the TATA box.
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Stepwise assembly model Holoenzyme model
Figure 3 M odel for the in itiation of transcription by RNA 
polym erase II: holoenzym e m odel versus the stepwise assem bly model
In the stepwise assembly model, TFllD binds first the TATA element of the promoter. 
This is achieved by the TATA Binding Protein (TBP). TFllA and TFllB are next to 
bind. TFllF escorts the RNA polymerase II to the promoter. The preinitiation complex 
is completed by the binding of TFllE and TFllH. In the holoenzyme model, TFllB, F, 
E and H preassembles with the RNA polymerase II before binding in a single step to 
the TFllD-TFllA complex (the TAFlI of the TFllD was omitted for clarity).
in
II.2.1 The structure of the TFIID complex
The first step in the formation of the preinitiation complex involves the recognition of 
the TATA box by the TFIID complex (Parker et al, 1984, Nakajima et al, 1988).
TFIID is formed of several proteins, the TATA binding protein (TBP, 27 kDa in yeast) 
and TBP associated factors (TAF) (Hernandez 1993). The binding activity of TFIID to 
the TATA box is confined to one protein in particular: the TBP. TBP alone is sufficient 
to catalyse the formation of the preinitiation complex in vitro but the whole TFIID 
complex is required for response to transcriptional activators.
TBP is made of two domains: the amino terminus is divergent between species and its 
function in the formation of the preinitiation complex is still unclear. However this 
region is known to regulate the RNA polymerase III transcription at the U6 promoter 
(Mittal et al, 1997). The carboxyl terminus region is conserved between species and 
consists of two imperfect repeats. This C terminal region is sufficient to diiect 
transcription in vitro (Hoey etal, 1990; Zhou et al, 1993). The crystal structure of the 
carboxyl terminus revealed that TBP has a saddle shape (Nikolov et al, 1992). The 
protein has a two fold symmetry with each half of the symmetry made up of each 
repeat. Each repeat is composed of 2 a  helices and 5 |3 sheets in the order of SI- H l- 
S2 - S5- H2. Crystal structure of TBP bound to the TATA box demonstrated that the 
protein recognised 8 base pair in the minor groove of the TATA box and that the DNA 
stmcture was dramatically affected by TBP binding (Kim J. et al, 1993; Kim Y. et al,
1993). The DNA binding surface in TBP is a cuiwed, antiparallel p sheet and therefore 
to facilitate DNA recognition, the minor groove moulded itself to follow the curve of 
the P sheet of TBP which causes a bend in the structure of the DNA. As a result, 
downstream and upstream DNA elements were brought into closer contact. The 
binding of TBP to the TATA box also resulted in a partial unwinding of the DNA.
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II.2.2 Regulation of the TBP binding to the TATA box.
As the recruitment of TBP to the promoter is the first step to the formation of the 
preinitiation complex, it is not surprising that TBP plays a critical role in the 
mechanism of transcriptional activation. The regulation of TBP binding to the DNA 
depends on three different factors :
1) TBP dimer formation: The recruitment of TBP to the TATA box is slow and 
potentially a rate limiting step in the formation of the preinitiation complex (Klein et al,
1994). This could be due to the fact that TBP was reported to form a homodimer 
thereby inactivating the DNA binding activity of the protein (Coleman et al, 1995). 
Dissociation of the TBP dimer is slow suggesting that dimer dissociation dictates the 
kinetics of TBP-DNA binding (Coleman et al, 1997). The TFIID also dimerises 
through the TBP protein (Taggait et al, 1996). Furthermore the yeast transcription 
factor GCN4 stimulates transcription by enhancing the kinetics of TBP recruitment 
(Klein etal, 1994).
2) Complex formation: TBP exists in a complex with at least eight other proteins 
known as TBP Associated Factors (TAFs) to form the TFIID complex (Tanese et al, 
1991; Takada et al, 1992). TAFs are composed of proteins with moleculai’ weights 
varying from 15 to 250 kDa in human. In vitro reconstitution experiments 
demonstrated that the TAFs were required for activation dependent, but not basal 
transcription (Tjian and Maniatis, 1994). Several roles have been associated with TAF 
proteins: mediation of transcription activation, DNA binding, and enzymatic activity. 
Several reports have demonstrated that TAF proteins such as the dTAFlI 40 can interact 
with activators e.g. VP 16 (Goodrich et al, 1993). However depletion or inactivation of 
several TAF did not affect transcriptional activation in vivo (Moqtaderi et al, 1996). 
The role of TAF in the transcription process remains a contentious issue.
A novel DNA sequence motif located 30 base pair downstream of the start site in 
TATA less promoter is recognised by TAF. A TAF was affinity purified with this
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DNA motif (Burke and Kanodaga, 1996). In Drosophila, TAFlI 150 was shown to 
bind DNA (Verrijzer et al, 1994).
Experimental evidence also demonstrated that TAFll 250 catalyses several enzymatic 
reactions: in human, TAFll 250 can specifically phosphorylate RAP74, a subunit of the 
TFIIF which stimulated its activity (Dikstein et al, 1996). TAFlI 250 also contains a 
histone acetyl transferase activity which may affect chromatin structure (Mizzen et al, 
1996).
A combination of biochemical and crystallographical experiments has provided strong 
evidence that a histone-like structure exists within the TFIID (Nakatani et al, 1996; 
Hoffmann etal, 1997). The amino termini of Drosophila TAFlI 40 and 60 have strong 
homology to the histone proteins H3 and H4. The crystal structure of the amino termini 
of TAFII 40 and 60 showed that they form a heterotetramer which is similar to the 
corresponding region in H3 and H4 and exhibits a histone fold (Xie et al, 1996). A 
homologue of H2B was also identified as TAFlI 20 forming a homodimer which can 
interact with TAFII 40 and 60 (Hoffmann et al, 1996). The role of the histone like 
structure may be to modify the interaction with DNA although the ai'ginine residues in 
H3 and H4 are not conserved in TAFll 40 and 60 (Luger et al, 1997). Alternatively, the 
histone fold may function solely to mediate protein - protein interaction within TFIID.
3) role of TFIIA : TFIIA also recognises the TBP - promoter complex although the 
protein can also bind soluble TBP (Buratowski et al, 1989). TFIIA consists of three 
subunits in Drosophila (a, P, y) (Yokomori et al, 1993) and two in yeast (TOAl and 
TOA2, Ranish et al, 1992). The two largest subunits of TFIIA in Drosophila are 
encoded by the same gene but have different post translational modifications. The role 
of TFIIA in transcription was controversial. The requirement of TFIIA was different 
depending on the source of TBP. Using recombinant TBP, TFIIA was not required for 
transcription in vitro (Cortes et al, 1992). However using purified TBP from cells, 
TFIIA was needed to stimulate the same assay (Ozer et al, 1994; Sun et al, 1994). It 
has since been established that TFIIA acts as an activator by blocking transcriptional
23
repression. By binding to TBP, TFIIA displaces repressors associated with TBP such 
as MOTI (Auble et al, 1994) or topoisomerase I (Ma et al, 1996) and prevents TBP 
from forming other protein - protein interactions than those required for formation of 
the preinitiation complex. TFIIA also appeared to increase the affinity of TBP for the 
TATA box. In addition it was shown that TFIIA is required for TBP to bind the TATA 
box when in a nucleosome structure (Imbalzano et al, 1994a and b).
The spatial structure of yeast TFIIA has been determined by X-ray ciystallography and 
shows that TFIIA is L shaped (Geiger et al, 1996; Tan et al, 1996). The carboxyl 
termini of both subunits forms a compact P sheet structure termed a P sandwich : thiee 
antiparrallel strands of each subunit form the hydrophobic core of a p barrel structure 
which can contact DNA. Another structural element identified is a four helix bundle 
made up of two helices from each subunit.
II.2.3 The TFIIB complex
The second step in the formation of the preinitiation complex is the recruitment of 
TFIIB which recognises the TFIID-promoter complex. TFIIB has a pivotal role in 
recruiting RNA polymerase to the TFIID-promoter complex. TFIIB can interact 
directly with TBP (Buratowski et al, 1989) and RNA polymerase II (Fang and Burton
1996), as well as with TFIIF (Ha et al, 1993), and TAF 40 of the TFIID complex 
(Goodrich et al, 1993). The binding of the TFIIB results in a more stable complex 
between TFIID or the TBP and DNA.
TFIIB is a monomeric protein of 38 kDa containing two distinct regions (Ha et al, 
1991). The N-terminal region interacts with RNA polymerase and while the stmcture 
of this region has not been determined it is predicted to contain a zinc ribbon motif 
which is important for the function of the protein (Zhu et al, 1996). This region plays 
an important yet undefined role in selecting the start site for transcription in vivo 
(Bangui* et al, 1997). The C-terminal region of TFIIB binds TBP and has been shown 
to contain two similar domains, each consisting of five a  helices (Bagby et al, 1995).
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Such a structure has also been found in cyclin A and in the retinoblastoma proteins 
(Gibson et al, 1994). The co crystal structure of the ternary complex containing the C- 
terminal region of TFIIB bound to TBP and DNA has been solved (Nikolov et al,
1995). This reveals that TFIIB binds to one side of TFIID downstream of the TATA 
box and underneath the TBP-DNA complex. In this complex, acidic residues of TBP 
interact with basic residues of TFIIB. The bend in the DNA caused by TBP allows 
TFIIB to contact promoter DNA both upstream and downstream of the TATA box 
sequence. TFIIA and TFIIB thus bind on opposite sides of TBP.
II.2.4 Recruitment of the RNA polymerase II - TFIIF complex
The TBP-TFIIB-DNA complex is finally recognised by the RNA polymerase II. 
Although in some cases RNA polymerase alone can be recruited to some promoters, in 
most cases the binding of the polymerase is escorted by TFIIF (Flores et al, 1989; 
Price et al, 1989).
TFIIF is a heterotetramer composed of two different subunits RAP30 and 74. Rap30 
resembles the a  factor in bacteria (Conaway and Conaway 1990; Killeen and 
Greenblatt 1992). Rap30 alone can accomplish some of the functions of TFIIF such as 
interacting with TFIIB (Ha et al, 1993), RNA polymerase (McCracken and Greenblatt, 
1991) and DNA (Tan et al, 1994). However for transcription activation RAP74 is 
needed. The role of RAP74 is to remove the RNA polymerase from non specific sites. 
RAP74 was found to position the RNA polymerase at the stait site and had the ability 
to interact with TFIIB (Sun and Hampsey, 1995). RAP74 is a protein of 58 kDa which 
is highly phosphorylated. The TAFII 250 mediated phosphorylation of RAP74 seems 
to stimulate the activity of TFIIF.
In yeast, the RNA polymerase II is composed of 12 different subunits encoded by 
RPB genes 1 to 12 in yeast (Woychik and Young, 1994). 9 of the proteins encoded by 
these genes are either similar or common to all RNA polymerases (type I, II and III). 
Proteins Rpb 4, 7 and 9 are unique to the RNA polymerase II, and genes RPB 4 and 9
25
are dispensable for yeast growth. The role of each subunit is not yet fully understood. 
Some similaiities exist between the subunit in yeast and the bacterial RNA polymerase. 
Therefore Rpb 1 and 2 are homologous to the p and P’ subunits, while Rpb 3 is related 
to the a  subunit (Young, 1991). Using yeast genetics and mutational analysis, it was 
demonstrated that, like the bacterial p’ subunit, Rpb 1, the largest subunit (200 kDa) is 
also involved in DNA binding. Rpb 2 is known to bind nucleotide substrates. Rpb 4 
and 7 aie weakly bound to the polymerase and were found to easily dissociate and 
associate to other RNA polymerase II. These proteins could shuttle between RNA 
polymerase II molecules (Edwards et al, 1991). Yeast with a null RPB 4 gene could 
not grow in nutritionally deprived medium or at elevated temperatures. Furthermore 
these yeast are inactive in promoter directed transcriptional initiation. These proteins are 
implicated in recognition of promoters which regulate genes responsible for the stress 
response (Choder and Young, 1993).
II.2.5 The RNA polymerase, the Carboxyl Terminal Domain (CTD) and associated factors: The role of CTD in RNA polymerase II
The CTD is only found in RNA polymerase II and is composed of heptapeptide repeats 
of YSPTSPS. The number of repeats varies depending on the species. This varies 
from 26 to 27 in yeast to 34 in Drosophila and up to 52 repeats in the mouse and 
human RNA polymerase. The role of the CTD in RNA polymerase II mediated 
transcription is not well understood and was thought to be involved in phosphorylation 
dependent switching from the recmited RNA polymerase in the initiation complex to 
the actively elongating enzyme (Reviewed by Dahmus 1995). However other functions 
have been attributed to the CTD such as interaction with some basal transcription 
factors (Kang and Dahmus 1995) and interaction with DNA (Suzuki 1990). However a 
lai'ge number of proteins have been associated with the CTD and ai*e known as 
Suppressors of RNA polymerase B (SRBs).
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II.2.6 Proteins associated with the CTD of RNA polymerase II.
Using yeast genetics, a group of proteins have been identified which associate with the 
RNA polymerase II (review by Calson 1997). A yeast strain containing only 10 to 12 
heptapeptide repeats in the CTD (instead of 26 to 27 in the wild type) was found to be 
cold temperature sensitive. Yeasts were selected which could suppress this defect by 
growing at a low temperature and were termed Suppressors of RNA polymerase B 
(SRB) (Nonet and Young, 1989). Nine different genes (SRB 2 and 4 to 11) were 
isolated, of which Srb 2, 4 and 7 are associated with purified RNA polymerase. A 
number of other proteins have been isolated by yeast genetics which are also thought to 
be components of an RNA polymerase II holoenzyme (Gall 1, SIN4, RgiT and Rox3) 
and play similar roles to the Srbs.
These gene products have been linked to the mediation of gene expression. Srbs have 
been shown to affect repression and activation of gene expression. The repression of 
particular genes (HO, SUC2) are targeted by the Tupl and Ssn6 (Cyc8) proteins which 
interact with site specific DNA binding protein (Migl, a l)  (Roth, 1995). Mutations in 
some of the SRBs (SIN4, G a lll, Srb 8 to 11) partly prevented the repression. 
Activation of genes under the Gal4 promoter control also required the activity of SRBs. 
In vitro experiments evidence demonstrate that Srbs aie involved in the recruitment of 
the RNA polymerase to the promoter. This was shown by fusing Srb 2 to the DNA 
binding domain of LexA and demonstrating that the fusion protein activated 
transcription from a reporter containing a LexA DNA binding site in the promoter 
(Pareil etal, 1996). Srbs 10 and 11 were shown to contain a kinase activity which 
could phosphorylate the CTD (Liao et al, 1995).
II.2.7 TFIIE and TFIIH
The complex formed at this stage is stable but in order to initiate transcription, two 
further general transcription factors need to be recruited ; TFIIE and TFIIH.
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TFIIE is a heterotetramer composed of two different subunits of molecular weight 34 
and 56 kDa (Ohkuma et al, 1990; Inotroza et al, 1991). Both subunits are highly 
charged (with a pi of 4.5 and 9.5 respectively in the human form of TFIIE). The role 
of TFIIE is still unclear but TFIIE might act in the melting of DNA. Initiation of 
transcription could be achieved in the absence of TFIIE using a premelted DNA 
template. Furthermore, cross linking experiments showed that TFIIE lies on the DNA 
between the TATA box and the start site of transcription (Robert et al, 1996). A zinc 
ribbon motif, identified in an elongating factor TFIIS, is able to bind single stranded 
and double stranded DNA (Qian et al, 1993). Such a motif is also proposed in TFIIE 
(Maxon and Tijan 1994). As TFIIE is required for the binding of the TFIIH complex to 
the preinitiation complex, TFIIE might act as a checkpoint for the formation of the 
preinitiation complex via its control of TFIIH recruitment. This was elegantly 
demonstrated in a complementation assay : TFIIE from S. cerevisia could not replace 
the TFIIE in a preinitiation complex of S. pombe, except if exchanged as a complex 
TFIIE-TFIIH (Li et al, 1994).
T F IIH  is a complex factor in which nine different subunits have been identified 
(Drapkin and Reinberg, 1994). The various subunits possess diverse enzymatic 
activities such as kinase, DNA helicase, DNA repair and might act during cell cycle 
regulation. Through its CTD kinase, TFIIH regulates the transition from transcription 
initiation to elongation. This was suggested by the observation that RNA polymerase II 
enters the complex in a unphosphorylated Ila form and is converted to the 
phosphorylated IIo form by CTD kinase (Dahmus, 1995). The kinase enzyme is 
located in the 40 kDa subunit which is also known as cdk7. This kinase associates with 
cyclin H (the 37 kDa subunit) and MAT 1 (the 32 kDa subunit of TFIIH) to form the 
cdk activating kinase factor. The cdk activating kinase is thought to have a key role in 
the regulation of cell cycle (Morgan, 1995). Although cdk7 was shown to be solely 
responsible for the phosphoiylation of the CTD, its activity was not essential in a
28
promoter containing a TATA box (Maleka et al, 1995). As the cdk activating kinase 
complex is weakly bound to the TFIIH, it has been proposed that this may be another 
general transcription factor called TFIIK. In cells only a fifth of the existing cdk 
activating kinase is associated with TFIIH (Drapkin et al, 1996). In yeast, the subunit 
phosphorylating the CTD is known as Kin 28. This protein is not involved in 
regulating cell cycle. It is however unknown whether the cdk activating kinase does 
indeed regulate the cell cycle in mammalian cells.
Another biochemical activity of the TFIIH complex is the nucleotide excision repair 
(NER) mechanism. Five subunits of TFIIH are involved in DNA repair: ERCC2 and 
3, the p62 subunit, the hSSLI (44 kDa) subunit and the p34 (Drapkin et al, 1994, 
Wang et al, 1995). This multienzyme complex repairs lesions in the DNA especially in 
transcribed genes (Mellon and Hanawalt, 1989). Furtheimore, ERCC2 and 3 also have 
a DNA helicase activity.
H.2,8 The polymerase holoenzyme
In vitro, the general transcription factors and the RNA polymerase can be assembled 
onto a promoter in an ordered and stepwise manner. However the assembly, in vivo, 
of the preinitiation complex probably does not occur in such a way. Purification of the 
RNA polymerase from various cellular sources showed that the RNA polymerase is 
already preassembled with other general transcription factors (reviewed Greenblatt
1997). Purification of the RNA polymerase revealed that general transcription factors 
such as TFIIE, TFIIF, TFIIH co purified. However the general transcription factors 
which copurified with the RNA polymerase varied depending the source of material 
and the purification procedure. Some of these interactions seem to be very weak and 
therefore could easily be disturbed during the purification. Consistent with this idea, 
purification of the holoenzyme by affinity chromatography led to the isolation of 
holoenzyme with all five TFII (B, D, F, E and H) in near stochiometric amounts.
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II.3 Effect of CTF 1 (NFI) on the formation of the preinitiation complex of transcription.
11.3.1 A CTD motif is present in CTF 1
The mechanism by which NFI stimulates transcription is poorly understood. CTF 1 
was found to be the strongest activator in the NFI family of proteins and was therefore 
used to investigate the role of CTF 1 in transcription stimulation. The residues 
involved in the stimulation of transcription were mapped to a proline rich region which 
was sufficient to stimulate transcription when fused to the DNA binding domain of 
Gal 4 (Kim et al, 1993). NFI deleted of the proline rich region was unable to stimulate 
transcription suggesting that this region alone was responsible for transcription 
activation. Further mapping of the residues involved in transcription stimulation was 
achieved by deletion and point mutational analysis of the proline rich domain (Kim et 
al, 1994, Wendler et al, 1994). In the proline rich domain, a region spanning from 
position 460 to 480 was the main factor influencing transcription. This sequence has 
strong homology to the Cai'boxyl Terminal Domain (CTD) motif found in the RNA 
polymerase II and hence was called CTD motif.
11.3.2 Role of the CTD motif in CTF 1.
In yeast, the expression of only the CTD motif of CTF 1 (that is residue 460 to 480 
found in the proline rich domain) as a fusion protein with the DNA binding domain of 
Gal 4 enhances the transcription of a Gal 4 dependent p galactosidase reporter vector. 
If this CTD motif was removed or replaced by a unrelated sequence, there was a sharp 
decrease in ti'anscription stimulation. However transcriptional activity could be 
recovered by adding a single CTD repeat from the RNA polymerase. If several CTD 
repeats were added, the transcription stimulation was increased (Xiao et al, 1994). 
These workers demonstrated an interaction between the yeast TATA binding protein 
and the proline rich region. It is supposed that the Proline rich region stabilised the
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interaction between TBP and the DNA. However by doing reconstitution experiments, 
Kim (1994) could not find any interaction between TBP and the proline rich sequence 
in vitro. Instead CTF 1 interacted with the TFIIB complex. Thus the role of the proline 
region in formation of the preinitiation complex is to facilitate the recmitment of TFIIB 
on to the TBP-DNA complex in vitro in humans and in yeast.
11.3.3 Transcription activation from other CTF proteins.
Recent work on the transcription activation of other CTF proteins have slightly altered 
the model described above. Vectors expressing either CTF 1, CTF 2, CTF 5 or CTF 7 
were co transfected with an NFI dependent p galactosidase reporter. Although they 
lack elements of the proline region and the CTD motif, CTF 5 and CTF 7 were the 
strongest activators in the NFI family (Wenzelides et al, 1996). Similar results were 
obtained in Drosophila cells transfected by NFI XI and X2. NFI X2 which lacks pait 
of the proline region, was the most potent transcriptional activator (Apt et al, 1994). 
These experiments suggest that other regions in the proline region of NFI apart from 
the CTD motif are involved in stimulation of transcription.
11.3.4 Role of upstream binding factors in transcription
Other transcription factors act in a similar way to NFI. For example, Spl which has a 
glutamine region involved in the transcription also interacts with the TFIIB. TFIIB can 
associate with the TBP-TATA complex in the absence of activators although stable 
binding does require activators (Choy and Green 1993). The role of the transcription 
factor could be to stabilise the TFIIB-TBP interaction(s), and subsequently to alter the 
recmitment of the other factors in the following steps. The proline rich region also 
affected another factor in the TFIID complex: TAFli 55, a factor discovered in the 
human TFIID complex but not in Drosophila. TAFll 55 interacts with various 
transcription factors such as Spl, adenoviral E l A and CTF (Chiang et al, 1995). Other 
transcription factors interact with other TAF subunits. For example, VP 16 is known to
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interact with TAFII 40. It is worth noting that many transcription factors function as 
dimers and hence it would not be surprising if these dimers had several taigets.
Other transcription factors which bind to upstream elements of promoters have been 
cloned and placed, in three classes, following the existence in their sequence of specific 
regions: the proline rich region, the acidic rich domain (as found in VP 16 activation 
domain) and the glutamine rich domain (found in Spl).
These transcription factors could also be classified by their effect in activating 
transcription. The role of these different types in affecting the transcription has been 
studied by the “nuclear run on” method and through RNase protection analysis. Both 
sets of experiments showed that there aie thi*ee type of transcription modulation 
domains depending upon their role in stimulating transcription : type I (such as Spl 
and NFI) stimulates initiation, type 2 stimulates only the elongation reaction (Tat) while 
type 3 stimulates both elongation and initiation (VP 16). Mutation of VP 16 could 
convert the transcription factor from a type 3 to type 2 (Blau et al, 1996).
II.4 Regulation of NFI activity
II.4.1 The regulation of NFI DNA binding through the structure o f  chromatin.
In eukaiyotic cells, the DNA is structurally organised in chromatin. The DNA is 
compacted by a complex of proteins known as the histone. The histone is composed of 
9 proteins: a core of 4 dimers of proteins H2A, H2B, H3 and H4 locked in place by 
H I. The DNA wraps around the core proteins and forms almost a double loop of 
160 bp.
Early research on the promoter region of the c-myc gene showed that the structure of 
DNA is important for gene expression. The DNA stmcture in the promoter region was 
very different in transformed or quiescent Burkitts cells. The study of DNase I
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hypersensitive sites showed a difference between the translocated allele and the non 
translocated allele. DNase sensitive sites were reported to be located next to NFI DNA 
binding sites. When these hypersensitive sites were lost, transcription decreased 
(Sienbenlist et al, 1982).
Many reseaichers used the promoter region of MMTV to study the role of chromatin in 
transcription. The long terminal repeat of the MMTV is tightly organised into six 
nucleosomes which prevent any transcription (Reviewed by Wolffe 1994). In the 
presence of glucocorticoids, the nucleosome was reorganised to stimulate transcription. 
The glucocorticoid receptors could bind the DNA even when the DNA was organised 
into a chromatin structure and stimulate recmitment of the SWI/SNF complex. The 
SWI/SNF complex then induced a restructuring of the chromatin (Farrants et al, 1997). 
This was demonstrated in vitro using DNA footprinting on an LTR promoter. The 
glucocorticoid receptor after induction of glucocorticoid, was able to bind to the LTR 
and recruited the SWFSNF complex. The chromatin structure was altered and became 
more sensitive to nuclease. On the other hand the nucleosome structure inhibited NFI 
binding to the DNA. In the LTR of MMTV, the NFI site faces toward the inside of the 
nucleosome core and could not be bound by NFI. In fact Blomquist (1996) showed 
that as soon as an NFI binding site is found in a nucleosome, NFI was unable to bind 
the specific site irrespective of its localisation in the nucleosome. However NFI can 
bind DNA depending on which nucleosomal components were present. By 
reconstituting nucleosomes in vitro with the MMTV LTR, a tetramer nucleosome 
composed only of the proteins H3 and H4 could bind to NFI and Octl but these 
transcription factors could not bind to the octamer particle made up of the proteins 
H2A, H2B, H3 and H4 (Spangenberg et al, 1998).
Despite the fact that the compaction of the DNA into the nucleosome is detrimental to 
the transcription activation properties of promoters, surprisingly, the existence of a 
specific nucleosome organisation does enhance transcription. In the promoter of
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Xenopus vitellogenin B 1, a nucleosome organises itself between the two regulatory 
elements (Schild et al, 1993). The nucleosome forms itself between the oestrogen 
responsive unit located at a site of -300 to-330 with a NFI binding site in position -119 
to -95. The reconstituted nucleosome stimulates the transcription by bringing into close 
proximity the various elements regulating transcription. Furthermore, the estrogen 
receptor and the proline rich region of CTF 1 act in synergy to promote transcription 
(Martinez etal, 1991).
In vivo, Chavez et al (1997), prepared a yeast strain producing the H4 protein under 
the control of an inducible galactose promoter. It was thus possible to modulate the 
degree of compaction in chromatin structures by growing the yeasts in media 
containing either glucose or galactose. Growing yeast in glucose media depleted 
histones from DNA, while using galactose media allowed nucleosome formation. 
Using an MMT virus LTR reporter plasmid, they measured the activation of the 
promoter by NFI. In the absence of histones, the promoter was activated while in the 
presence of histones it was repressed. This is in line with the results obtained 
previously. Surprisingly, the activation effect of glucocorticoids in the presence of NFI 
was diminished in the absence of histones suggesting that histones help NFI and 
glucocorticoids to act in synergy. This was in line with results obtained in-vitro on the 
promoter of vitellogenin B 1. Therefore the role of chromatin is dual : it acts as a 
repressor but also as an activator depending on the concentration of nucleosome and its 
position in DNA.
II.4.2 Regulation of NFI activity by post translational modification
Glycosylation: Some transcription factors are glycosylated by linkage of an N-acetyl 
glucosamine to the protein via a OH group (serine, threonine or tyrosine group). NFI 
proteins possess sugars residues (Jackson et al, 1988). These glycosylated NFI forms 
were purified using a wheat germ agglutinin column. Using this method two CTF 
proteins were purified with appai*ent molecular weight of 62 and 64 kDa (non
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glycosylated NFI range from 52 to 66 kDa) (Jackson et al, 1989). The function of NFI 
glycosylation has yet to be detennined but the DNA binding activity is not affected by 
glycosylation. Experiments on the effect of glycosylation on transcriptional activation 
were mainly performed on Spl. Wheat germ agglutinin inhibited the transcriptional 
activation of Spl, however a further purification of Spl by wheat germ did not 
enhance transcription activation. Comparison of the transcription activation of Spl 
purified by affinity chromatography with Spl purified on a wheat geim agglutinin 
resin, did not show any significant differences. Thus the role of glycosylation is still 
unclear.
Phosphorylation: Little is known about the phophoiylation of NFL The DNA 
activated protein kinase is the only kinase to date known to phosphorylate NFI 
(Reviewed Anderson, 1993). This kinase recognises also a number of transcription 
factors such as Spl and cJun.
Dimérisation: NFI proteins only bind DNA as a dimer. Residues involved in 
dimérisation of the protein are located in the N terminal domain which is very well 
conserved. NFI forms homodimers and even heterodimers between a full length NFI 
and a C terminal truncated fragment of the protein (Ki*use and Sippel 1994). These 
homo and heterodimers are stable and could only be obtained by co-translation. The 
transcription activation potential of these heterodimers has not been properly 
investigated yet. Chaudhiy (1998) studied the effect on transcription of homo- and 
heterodimers. Transcription activation of the heterodimer is intermediate to those of the 
homodimers. Similarly, in vivo, NFI B3 regulates transcription by forming a 
heterodimer with transcriptionally active NFI proteins. The transcription activity of the 
heterodimer NFI B3 with other CTF (CTF 1, NFI-Bl and NFI-B2) proteins is 
decreased (2 to 6 times) compared to the homodimers of these same CTF proteins (Liu 
et al, 1997).
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11.4.3 NFI regulation by Interaction with other nuclear proteins
A few proteins interact with NFL Pirin was isolated by a yeast two hybrid system 
screen as an interactor with CTF 1 (Wendler et al, 1997). Pirin may be a cofactor of 
NFI. Also, the transcription of some promoters is affected by binding of NFI to other 
proteins. In the human papillomaviais type 16, a regulatory element in the promoter 
contains an Octamer binding element and a NFI binding site. A synergistic interaction 
between the two protein binding to these sites, promotes transcription (O'Connor and 
Bernard, 1995).
11.4.4 Regulation of the activity of NFI through its synthesis.
The synthesis of NFI in the cells has mainly been studied in embiyonic cells. In 
primitive chicken eiythrocytes, the NFI DNA binding site acts as a silencer in the 
synthesis of the a" globin. In these cells, little NFI is present while in the adult 
synthesis of NFI led to the inhibition of the synthesis of the globin (Knezetic and 
Felsenfeld, 1993), The same observation has been seen in rats which had a partial 
ablation of their liver. NFI was showed to activate transcription of the promoter coding 
for a lb  adrenergic receptors. The regenerating liver maikedly decreased the levels of 
the adrenergic receptor due to a decrease in the quantity of NFI protein (Gao et al,
1996). The role of NFI in transcription seems to affect growing tissue and embryonic 
cells. Therefore the amount of NFI protein synthesised during embryonic and post 
embryonic development has been studied (Puzianowska-Kuznicka and Shi, 1996) in 
Xenopus. The mRNA level and DNA binding activity was studied of NFI-C and NFI- 
B. NFI-B was not synthesised before stage 54 of the development while synthesis of 
NFI-C started at stage 33/34. This showed that different NFI proteins are synthesised 
at various times (sometimes for a short period of time) and in a tissue specific fashion.
36
II.5 Oncogeneity of NFL
Overexpression of any NFI protein in chicken embryo fibroblast did not induce 
oncogenic transformation. Superinfection by an oncogenic retrovirus expressing jun or 
fos or junD of fibroblasts overexpressing NFI did not lead to transformation. However 
superinfection by an oncogenic retrovirus expressing ras (Schuur et al, 1995) resulted 
in transformation. However the reduced susceptibility of transformation with jun was 
not observed when using the C terminal taincated NFI. The effect of Ha-ras 
transformation on the action of NFI was investigated in murine cells. Transformation 
of these cells correlated with the down regulation of the expression of NFI protein. The 
mRNA encoding for NFI was less stable resulting in a low level of protein being 
encoded and affecting the gene expression of promoters relaying on NFI protein (Nebl 
et al, 1994). Since four genes aie available and since alternative splicing occurs, a 
whole range of NFI protein can be synthesised. In recent years, the purification of NFI 
specific to some tissues was reported. NFI in the cerebellum is part of the NFI A 
family in human and NFI B in mouse. The response in gene expression in the presence 
of NFI A, is more pronounced than using co transfected NFI C protein (Krebs et al, 
1996, Inoue et al, 1990). Studies of various tissues and cells have shown both that the 
mRNA synthesised and the protein obtained were tissue specific (Goyal et al, 1990, 
McQuillan et al, 1991, Paonessa et al, 1988). Furthermore other NFI proteins have 
been purified from other tissues such as in the mammaiy gland (Furlong et al, 1996) 
and in bone cells (Candeliere et al, 1996).
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III. Role of Nuclear Factor I in the replication o f
Adenovirus DNA.
The mechanism of adenovirus replication and the role of NFI has been extensively 
studied and is now fairly well understood. Replication of small viral genomes was 
thought to give an insight into the replication mechanism of larger genomes. In this 
section, I will first briefly discuss adenovirus 2 and its genome and later, the 
mechanism of DNA replication and the role of NFI in this process.
III.l Adenovirus: introduction.
Adenoviruses were first isolated while attempting to culture cells from tonsils and 
adenoidal tissue of children (Rowe 1953). Hilleman and Werner (1954) also found a 
variety of respiratory illnesses in military personnel due to this virus. Adenoviruses are 
a family of viruses with two different genera : the mastadenovirus which infects 
mammals and the aviadenoviais which infects birds (Hortwitz 1990). Over a hundred 
different serotypes of adenovirus have now been identified, among them 47 serotypes 
infect humans, causing illnesses such as respiratory, gastrointestinal, ocular and 
urinary diseases. In 1962, Trentin e ta l found that injection of adenovirus type 12 into 
new born hamsters induced malignant tumours. However, so far, no epidemiological 
evidence has been reported linking adenoviruses with malignant disease in human.
As adenoviruses ai’e easily manipulated and obtained, they have been extensively used 
to study replication, gene expression, gene regulation and cell cycle control. There is 
now a renewed interest in these viruses since they may be used as a vector for gene 
therapy.
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111,2 Structure of the adenovirus
Adenovirus are non enveloped, régulai* icosahedrons viruses (20 triangular surfaces 
and 12 vertices) of 70 to 100 nm in diameter. The virus is composed of an outer shell 
(the capsid) which surrounds an inner core containing the viral genome (Figure 4). The 
capsid is composed of 240 hexons and 12 pentons. Each penton makes up the base of 
a projecting fibre whose length varies among different serotypes (Shenk 1996). The 
capsid is made of a variety of different proteins (11 proteins identified to date). The 
hexon is formed of a tiimer of protein II and associated with three other proteins VI, 
VIII and IX. Protein Ilia is also associated with the hexon units. Each penton is made 
up of five copies of the polypeptide III and is located at the vertex of the icosahedral 
particle. Three units of polypeptide IV forms the fibre which projects from the penton 
base. The fibre in most adenovirus species is encoded by one gene whereas 2 genes 
encode for the fibre in the adenovirus 40 and 41.
The core is composed of the viral DNA and four known proteins : V, VII, Mu and TP. 
V, V n and mu are highly basic proteins, rich in arginine residues (20 % of residues). 
Each core protein is in contact with the viral DNA. Polypeptide VII is the major core 
protein and probably functions as a histone-like protein on which the viral genome is 
wrapped. Polypeptide V can bind to the penton base and might bridge the core to the 
capsid. The fourth protein is a terminal protein which is covalently linked to the 
genome and will be discussed later.
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Figure 4 Model of the adenovirus particle with its polypeptide
components and DNA.
Virion constituents are designated by their protein numbers with the exception of the 
terminal protein (TP).
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III.3 The viral genome.
The genome is a linear, double stranded DNA of 35 to 36 kbp. Human adenovirus 12 
DNA has 34 125 bp (Sprengel et al, 1984) while adenovirus 2 has 35 937 bp (Robert 
et al, 1986). The genome has the unusual feature of possessing a protein covalently 
linked to each 5’ end of the DNA.
The temiinal protein in adenovirus 2 makes a phosphodiester link between the serine 
residue in position 580 to a dCMP. Another paiticulai’ feature is that an identical 
nucleotide sequence is present at each end of the viral genome. These sequences are 
known as Inverted Terminal Repeats (ITRs) (Wolfson et al, 1972, Garon et ai, 1972). 
The length of these ITRs are specific of adenovirus serotypes and ranges from 63 bp in 
the chicken embryo lethal oiphan virus (CELO) to 165 bp in human adenovirus 18 
(Garon et al, 1982). Adenovirus types 2 and 5 have identical inverted terminal repeats 
in nucleotide sequence and in length (103 bp).
III.4 Adenovirus replication.
Adenovirus replication is estimated to begin 6 to 8 hours after infection and to reach a 
maximum 19 hrs after infection coinciding with a 90 % reduction in host DNA 
synthesis. After 24 hrs, 10^ to 10^ copies are synthesised from the original genome. 
However only 20% ai*e packaged into mature virions.
The first attempts to obtain a cell free system for the replication of DNA were 
performed by isolating the adenovivus 2 replication complex with its DNA from 
infected cells (Frenkel 1978). However the isolated DNA was fragmented. The first 
replication assay in vitro was obtained after fractionation of nuclei using ammonium 
sulphate. The isolated complexes could synthesise DNA but these could only proceed 
from complexes that had already initiated the replication (Kaplan et al, 1977).
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Chalberg and Kelly (1979) were the first to set up a fully functional in vitro system to 
study adenovirus replication. A nuclear protein exti'act from infected cells was isolated 
and used to obtain the replication of a DNA template purified from the virus. This in 
vitro system lead to the identification of the relevant nucleotide sequences in the viral 
genome and to the characterisation of three viral and three cellular proteins required for ?
adenovirus 2 DNA replication. Cloning and overexpression of these proteins meant 4I
that replication could be accomplished in vitro using only purified proteins and DNA. |
III.5 Origin of replication in adenovirus in vivo and in vitro.
Replication of adenovirus DNA was studied, in vivo, in infected cells using electron 
microscopy and pulse labelling techniques.
The first experiments used pulse labelling methods to identify the replicative 
intermediates in the presence of tritiated thymidine. A significant amount of DNA had a |
greater sedimentation rate than the virus DNA (Pearson et al, 1971). This band was 
composed of a single stranded DNA molecule as it disappeai'ed after treatment with S 1 
nuclease (Pearson 1975). Studies from Lechner and Kelly (1977) isolated two different %
type of replicating DNA molecules which were seen under election microscope named 
type I and II. Type I intermediates were described as adenovirus DNA molecules with 
one or more single stranded branches whereas type II intermediates were adenovirus 
DNA molecules consisting of a lineai' double stranded DNA molecule with a single 
stranded region extending from the other end of the genome.
Further observations led to the following model for the replication of adenovirus DNA 
in vivo. Replication initiates stochastically at either end of the viral DNA and proceeds 
in a semi conservative way in the 5’ to 3’ direction with concomitant strand 
displacement. Type I molecule was therefore a double stranded DNA molecule being 
replicated with a single strand being displaced. Other rounds of replication were started
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on the same molecule before the first round was over therefore creating the existence of 
several branches of single stranded DNA molecules. DNA replication could also start 
from a single stranded molecule creating a hybrid molecule partly single stranded and 
partly double stranded as seen in type II molecules. The inverted terminal repeats 
region could anneal to one another (Daniell 1976), creating a local region of double 
stranded DNA. This inverted terminal repeats region could be used to initiate 
replication from a single stranded DNA molecule. Further evidence supporting this idea 
of a panhandle structure was given by experiment from Stow (1982) and Hay et al 
(1984). Stow showed that transfection of genomes with deletions of the left inverted 
terminal repeats generate virions containing the complete inverted terminal repeats at 
each end of the genome.
Further mapping, in vitro, of the origin of DNA replication was realised by in vitro 
DNA replication assay. As shown by the experiment of Lechner and Kelly (1977), 
DNA replication proceeded from one end of the genome to the other. Therefore the 
origin of replication was most likely to be in the inverted terminal repeats. The terminus 
of the viral genome was cloned. By assaying for replication on various deleted inverted 
terminal repeats and point mutations, the precise nucleotides required for initiation of 
DNA replication were delimited. To initiate DNA replication, only the first 18 
nucleotides were needed. A region between nucleotide 9 and 18 was sensitive to a 
single nucleotide mutation. In the region upstream, only the first cytosine nucleotide 
was sensitive to mutation. Point mutation at any other nucleotide between 2 and 8 did 
not affect the initiation of replication (Tamanoi and Stillman 1983, Challberg and 
Rawlins 1984, Rawlins et al, 1984). Two further regions were delimited in the origin 
of replication. Both regions correspond to the DNA binding site of a cellular protein. 
None of these sites was necessaiy for in vitro replication but both stimulated the 
replication considerably : these were a NFI DNA binding site in the region between 23 
and 40 nucleotides which stimulated the initiation of replication by 50 fold (Nagata et
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al, 1983, Leegwater et al, 1985) and a NFIII DNA binding site between nucleotides 39 
and 51 which stimulated the initiation of replication by 7 fold (Pruijn et al, 1986).
In vivo the requirement of each domain was tested by cotransfecting a wild type 
adenovirus DNA and various plasmid constmcts containing 3’ end deletion in the 
origin. The helper virus brought all the machinery required for replication in these 
transfected cells. These plasmids replicated efficiently as long as they contained the 
first 45 bp of the inverted tenuinal repeats. The plasmid containing only 36 bp 
replicated very poorly (Hay et al, 1984, 1985a 1985b). In vivo, adenovirus seems to 
require only the core origin and the NFI DNA binding site for efficient replication. 
Further studies using viral genome showed that inverted terminal repeats containing 
only the 45 bp of the 5’ end inverted teiminal repeats were as infectious as the virus 
containing the full inverted terminal repeats. However adenovirus 2 having just the first 
18 bp of the inverted terminal repeats were not infectious (Hay and McDougall 1986).
111,6 Positioning and orientation of the DNA binding sites of the auxiliary region
The effect of the positioning and the orientation of these transcription factor binding 
sites was determined by comparing the relative enhancement obtained on the wild type 
origin of replication from adenovims type 2 in vitro. Adhya et al (1986) reported that a 
NFI DNA binding site isolated from the human genome was as active in replication as 
the wild type adenovirus. This site was active in both orientations as long it remained 
centred between 30 to 36 nucleotides from the 5’ end. Positioning of the NFI site from 
the core origin showed that there was little flexibility. The deletion of 2 nucleotides or 
the addition of 3 nucleotides between the core origin and the NFI DNA binding site 
reduces significantly the enhancement effect of replication obtained in the presence of 
NFI. Virtually no activation by NFI was found if six or more nucleotides were added 
between the core origin and the NFI binding site. Furthermore the nucleotide
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composition in this spacer region was found to affect the stimulation of replication by 
NFI (Coenjaerts et al, 1991, Adhya etal, 1986). Similar results were obtained when a 
spacer region was added between the NFI and NFIII binding site. However the 
addition of at least 2 nucleotides or the deletion of 7 nucleotides (into the NFI DNA 
binding site) abolished the stimulation of replication by NFIII. All these results indicate 
that NFI and NFIII have direct interaction with the viral protein involved in the 
initiation of replication. In vivo, only the positioning requirements of NFI were 
studied: vaiious plasmid construct with the insertion of 5, 10, 16 and 22 nucleotides 
between the core origin and the NFI binding site. These constructs and the wild type 
adenovirus genome were cotransfected and the synthesis of the plasmid DNA was 
measured. The level of replication of these various constructs was similar to the 
plasmid containing only the core origin. Therefore NFI lost the ability to stimulate 
replication in these constructs (Bosher et al, 1990).
Sequence comparison between the different serotypes of adenovirus in the inverted 
terminal repeats demonstrated a highly conserved region between nucleotide 9 and 18 
and of the following sequence : 5' - AT A AT AT ACC - 3' (Tolun et al, 1979). Also the 
first nucleotide in the adenovirus genome (a cytosine) is highly conserved among 
adenovirus serotypes. Furthermore the region between nucleotide 2 and 8 is also very 
well conserved but variation exists in adenovirus types 4, 7 and 9. However it is 
important to note that the first 3 or 4 nucleotides are always repeated in position 4 to 6 
(for a trimer repeat) or 5 to 8 (for a the 4 nucleotide repeat). Overall this region is 
extremely rich in nucleotide A and T, probably being a reflection of the fact that this 
region must open to allow replication initiation. The NFI and NFIII binding sites are 
conserved between most adenovirus serotypes.
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III.7 Viral proteins required for adenovirus replication.
Thi'ee viral proteins are needed for adenovirus replication in vitro : the DNA binding 
protein (DBF), the preterminal protein (pTP) and the viral DNA polymerase (Ad poi). 
All three are transcribed from the same promoter in the viral genome. Two types of 
mRNA ai'e transcribed depending on their polyadenylation site : E2a and E2b. E2a 
encodes for the DBF while E2b was for Ad pol and pTF. The mRNA E2a and E2b are 
detectable 2 hours after infection and reach a maximum after 3 to 4 hrs.
III.7.1 The DNA binding Protein (DBF).
DBF is expressed in high abundance during the infectious cycle and therefore was 
easily purified and identified (Van der Vliet and Levine 1973). Initially, two proteins 
were purified (apparent Mi' of 48 and 72 kDa) but the smaller protein was in fact a 
proteolytic product of the larger one (Van der Vliet and Levine 1977). The adenovims 
5 DBF is a protein of 529 residues with a calculated molecular weight of 59 049 Da but 
migrated oddly in a SDS FAGE at Mr = 72 kDa. Other serotypes of adenovims 
encode a similar size DBF (Kruijer et al, 1981).
Temperature sensitive mutants (H5tsl25, H5ts07) of adenovirus have shown the role 
of this protein during infection : These temperature sensitive viruses are defective in 
DNA replication at the restrictive temperature. DNA replication could be restored by 
adding wild type DBF in vitro (Friefeld et al, 1983). A subsequent extensive 
investigation of the phenotype of H5tsl25 revealed that DBF is in fact a multifunctional 
protein involved in a variety of functions such as transcriptional control, transformation 
and virus assembly (Chase and William 1986, Van der Vliet 1988).
Faitial chymotrypsin digest of purified DBF produced two distinguishable protein 
fragments (apparent Mr = 40 kDa and 27 kDa, Klein et al, 1979; Cleghon et al, 
1993). The 27 l<Da fragment is the N terminal region of the protein (residues from 1 to 
173). This fragment is highly phosphorylated, not very conserved between the
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different adenovirus serotypes and contains two nuclear localisation signals (Morin et 
al, 1989). This protein fragment is involved in the hostrange determination which 
interfere with the splicing of the late mRNAs (Anderson et al, 1983). The C terminal 
region (from residue 174 to 529) is conserved among the various adenovirus serotypes 
especially in thi'ee regions named CRl to 3 (Kichingman 1985). The DNA binding 
activity of DBF is located in this region and this region is sufficient to stimulate 
replication in vitro (Tsernoglou etal, 1985).
Two crystal structures of the C terminal fragment of DBF were solved (Tucker et al, 
1994, Kanellopoulos etal, 1996). DBF contains seven a  helices (A to G) and three P 
sheets. Two atoms of zinc are coordinated by the loops that connect the strands of the 
P sheets. The structural role of the zinc finger was confirmed on temperature sensitive 
mutants H 5 ts lll and Ad2NDts23. These viruses have a mutation in the region of the 
cysteines from the zinc finger. DBF produced by these mutant virus at the restrictive 
temperature has a different proteolytic digestion pattern. Furthermore all cysteine 
residues involved in the coordination of the zinc are conserved between the different 
serotypes of adenovirus. A C-terminal extension of the final 17 residues hooks into 
residues in a pocket formed of the helix E and G via hydrophobic interactions to an 
adjacent DBF molecule. This enables DBF to form long chain of protein of 20 to 30 
molecules. The role of this long chain of protein is to help cooperative binding of DBF 
to the DNA. Deletion of this C terminal extension decreases the ability of DBF to forai 
these multimeric proteins in solution but did not abolish it (Dekker et al, 1997). Further 
protein-protein interactions between DBF have been reported involving residues 262, 
406, 408, 506 and 511 (Kanellopoulos et al, 1996). Unfortunately although co­
crystals of DNA-DBF were obtained, their structure has yet to be solved 
(Kanellopoulos et al, 1995). Therefore other methods were used to map the region 
involved in the DNA binding of DBF (Cleghon et al, 1992). By trypsin digestion, the 
DNA binding region was identified between residues 174 and 470. By crosslinking the 
protein to a polythymidine template, two peptides were found to be cross-linked to the
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DNA at a region between 294 to 308 and 415 to 434. The methionine in position 299 
and the phenylalanine in position 418 were directly crosslinked to the DNA. This gave 
an indication of the regions which may be involved in DNA binding. However the 
precise nature of all the residues involved in DNA binding is still to be determined.
To fully understand the role of DBF, one must investigate its DNA binding properties. 
DBF has different DNA binding depending on the structure of DNA. On ssDNA and 
RNA, DBF binds with higher affinity and in cooperative manner. A model indicates 
that the ssDNA winds around the DBF creating an extended staicture with bases 
unstacked as predicted by circular dichi'oism measurements (Van Amerongen et al, 
1987). These findings are also in agreement with electi'on microscope observations of 
DBF-ssDNA (Van der Vliet a/, 1978). In vivo, only DBF bound to single stranded 
DNA was isolated from infected cells (Kedinger et al, 1978). DBF was also found to 
bind dsDNA but with a lower affinity compaied to ssDNA (Fowlkes et al, 1979, 
Schechter et al, 1980). The binding of DBF to dsDNA is not cooperative and 
dissociates more rapidly.
The role of DBF in replication affects both the initiation as well as in the elongation 
step. DBF stimulates at the level of initiation although initiation could occur without 
DBF (Kenny et al, 1988, Cleat et al, 1989). Kinetics studies showed that DBF lowered 
the Km of the initiation reaction for dCTF (Mul et al, 1993) while at the same time 
increasing the DNA binding affinity of NFI at the origin of adenovirus 2 replication. It 
is unclear how DBF affects the initiation of replication, this may be achieved either by 
affecting DNA structural changes in the origin of replication or via a direct interaction 
between the DBF and the complex pol-pTF. This latter possibility is more likely 
although no specific protein - protein contact(s) have yet been established. However 
pTF-pol binding to the origin is stimulated by DBF (Deklcer et al, 1997) and the 
processivity of the polymerase was enhanced by DBF during the elongation stage 
especially on ssDNA (Lindenbaum et al, 1986). Furtliermore the sensitivity of the Ad
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pol changed to inhibitors such as S-HPMPA in the presence of DBF (Mul et al, 1989) 
suggesting that DBF interacts with the Ad pol.
Another role of DBF is to act in DNA unwinding to dissociate double stranded DNA 
into single stranded (Monagan et al, 1994, Zijderveld et al, 1994). Unlike ssDNA 
replication which does not require DBF, elongation of double stranded DNA is 
absolutely dependent on DBF. Furthermore adenovirus does not require a helicase. 
DBF act as the helicase but is ATF independent. The mechanism has been studied by 
Dekker et al and Monaghan et al (1994, 1997, 1998). Two deletion forms of DBF 
were produced : a C-terminal deleted form which lacks the last 17 residues and 
therefore could not produce multimerised protein chains, and a deleted DBF which 
lacks a flexible loop (between residue 297 and 331). The C-teraiinal deleted DBF could 
still stimulate initiation but could not support elongation probably due to a reduced 
helix destabilising activity. The DBF deleted of the flexible loop could not unwind 
DNA and stimulate the elongation process of adenovirus replication. However a 
mixture of each deleted form of DBF restored the activity of the protein in replication 
and could unwind the dsDNA. Therefore the results indicate that the C-temiinal aim 
and the flexible loop aie required for DNA unwinding and elongation but have distinct 
functions.
III.7.2 The preTerminal Protein (pTP) and the complex pTP-poL
Early studies on the replication resulted in the purification of a protein complex of 
220 kDa which was required for replication. The pTF and the polymerase form a 
stable complex in infected cells (Stillman et al, 1982). Purification of the pTF showed 
that its was complexed to the adenovirus polymerase (Enonioto et al, 1981) and that 
this complex was tightly bound and could only be separated in denaturing condition in 
the presence of 1.7 M urea (Lichy et al, 1981).
The teiminal protein was first identified by its ability to mediate circularization of the 
viral DNA through a non convalent interaction and a protease sensitive agent. The
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circularizing agent was shown to be a protein of Mi-55 kDa attached to the 5' end viral 
DNA (Robinson et al, 1973). However early replication assays showed that the 
terminal protein complexed to the Ad DNA polymerase was a protein with an apparent 
molecular weight of 80 kDa (Challberg 1980). In the initial step of replication, this 80 
kDa protein was covanlently cross linked to the dCMP. By studying the gene encoding 
for the pTP, Stillman found that the adenovirus 2 mutant temperature sensitive (H2tsl) 
grown at the restrictive temperature contained only the 80 kDa protein while the same 
mutant grown at the permissive temperature contained three forms of terminal proteins 
(Mr: 80, 62 and 55 kDa). The mutant virus was able to replicate and foim new virions 
(which were uninfectious) however the pTP remained at a molecular weight of 80 l(Da 
while the protein from the mature virion from wild type adenovirus had a molecular 
weight of 55 kDa. By performing peptide sequencing from each different form of the 
terminal protein, these proteins were shown to derived from the pTP by proteolytic 
cleavage of the N terminus (Smart et al, 1982). The attachment point of the DNA to the 
pTP was also mapped at a serine in position 580. Further evidence showed that the 
mutation of serine 580 of pTP to a threonine or an alanine abolished initiation of DNA 
replication (Pettit et al, 1989).
Cloning and overexpression of the protein made it possible to identify some of the 
protein’s roles in the infection (Pettit et al, 1988, Stunnenberg et al, 1988). pTP is 
synthesised as a 627 residues protein. The main role of pTP in replication involves 
protein priming. This was shown using an anti-serum raised against TP. This serum 
inhibited the labelling of pTP by dCMP using the viral genome (Rijinders et al, 1983) 
as well as linearised plasmid with the origin of replication (Van Bergen et al, 1983). 
This serum did not affect the DNA polymerase activity. Using purified pTP, this 
protein was found to bind DNA with some specificity to the origin of replication 
(Temperley and Hay 1992).
However other roles have been assigned to pTP. Transfection studies revealed that 
pTP facilitated the localisation of the Ad pol to the nucleus through a direct interaction
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(Zhao et al, 1988). Mutants of the Ad pol which lacked the Nuclear Localisation Signal 
were transported to the nucleus if cotransfected with the pTP hence showing a 
transport activity from pTP. The NLS in the pTP was mapped between residues 360 
and 412. It has also recently been reported that the complex pTP protected the viral 
genome from the nuclease activity of the DNA polymerase when complexed to the pTP 
(King etal, 1997).
Several approaches were used to define the functional domains in the protein : in vivo, 
mutant pTP was introduced into the viral genome followed by transfection of the virus. 
Mutant viruses that carried either N temiinal or C terminal deletion were not viable, 
whereas the protein seems more tolerant to deletion and insertions in between these two 
domains (Roovers et al, 1991). Mutational analysis in vitro revealed that the gradual 
deletion of the N terminal residues resulted in a decrease of initiation of DNA 
replication. Deletion of 18 residues, at the N terminus, inactivates the pTP while pTP 
retained full activity if 17 residues were deleted at the C terminus (Pettit et al, 1989). 
Lai'ger deletion at the C terminus inactivated pTP (more than 32 residues, Roovers et 
al, 1993). Most point mutation in the pTP resulted in an inactive protein (Friedman et 
al, 1991; Roovers et al, 1993).
Further results were obtained by using a combination of partial proteolysis and raising 
monoclonal antibodies. The DNA binding activity, its ability to form a complex with 
Ad pol to sustain DNA replication initiation were tested with the various proteolytic 
products. The first 175 residues are important for DNA binding, however other contact 
sites were found as monoclonal antibodies recognising the region between residues at 
position 184 to 200 and 342 to 354 inhibited DNA binding activity of pTP. Ad pol 
protected pTP from site specific proteases (such as the adenovirus protease, 
endoproteinase lys-C and endoproteinase Glu-C) the region between residues 175 and 
184, but also at the C terminus around the serine involved in the initiation of DNA 
replication. Finally the C-terminal region (between residue 608 and 671) was found to 
regulate the DNA binding activity of pTP and dissociation of the pol-pTP complex.
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Antibody binding to this region of the pTP increased the stability of the complex pTP- 
DNA and stabilised the complex pTP-pol (Webster et al, 1997a and 1997b) 
pTP is degraded during the infection into two other forms known as iTP and TP. Both 
forms have been observed in vivo. The protease responsible for the digestion is 
encoded by the viral genome. This protease is a 23 kDa protein, which can already be 
detected 24 hrs after infection but is present at higher concentration later in the infection 
(after 36 hrs). Protease is present in both the nucleus and the cytoplasm. The protease 
is synthesised in an inactive form and is activated by a disulphide linked peptide 
derived from the carboxyl terminus of the pVI virion protein (Webster et al, 1993). The 
protease is a cysteine protease and is specific for the residues (M, I, L)XGX-X. The 
cleavage sites in adenovirus 2 pTP are after the phenylalanine 175 and the aiginine 
residue 184 to produce iTP. TP is produced by cleavage after the glycine 349. iTP and 
TP were unable to bind DNA but iTP could still interact with the Ad pol. The iTP-pol 
complex was still able to sustain initiation and elongation of replication (Webster et al, 
1997b). However the role of the processing of the terminal protein by the adenovirus 
protease remains uncleai'.
Binding and initiation of replication may be regulated by phosphoiylation of pTP. In 
vivo pTP was found to be phosphorylated on several serine sites. pTP 
dephosphorylated by alkaline phosphatase was unable to initiate DNA replication and 
did not bind DNA (Kusukawa et al, 1994).
The terminal protein (TP) crosslinked to DNA should be regarded as a different 
functional entity with multiple roles . TP protects the viral genome from exonuclease 
degradation (Dunsworth-Browne etal, 1980). Shaip eta l (1976) found that TP bound 
to the genome was more infectious than deproteinised DNA. TP itself may play an 
essential role in the initiation activity since initiation of replication is stimulated twenty 
fold when using TP-DNA compared to a protein free template. After chymotrypsin 
digestion, the TP bound to DNA reduced to an approximated molecular weight of 44 
kDa is sufficient to promote replication (Pronk et al, 1992). The pTP-pol complex
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prefers binding to the TP-DNA than naked DNA. This could be a result of the 
structural changes in DNA such as those observed by DNase footprint techniques in 
this template upon binding of NFI or NFIII when compared to a naked DNA template 
(Pronk and Van der Vliet 1993). The TP-DNA could also support correct initiation and 
direct the pol-pTP to the origin.
Finally adenovirus TP plays an important role in the localisation of the viral genome in 
the cell. Adenovii-us is tightly bound to the nuclear* matrix throughout the course of 
infection due to the interaction of TP with the nuclear matrix (Schaack et al, 1990). It 
has been suggested that the processing of DNA bound pTP into mature TP frees the 
viral genome from the nuclear matrix prior to packaging (Fredman and Engler 1993). 
However this theory is in total disagreement with experimental obser*vation that, at the 
restrictive temperature, although the virus encodes for non active protease, the genome 
is packed into non-infectious virions.
III.7.3 The DNA dependent Adenovirus DNA polymerase
The existence of a viral DNA polymerase was first suggested by complementation 
experiment using temperature sensitive mutants of adenovirus type 5. These mutants 
were defective in both the initiation and the elongation of DNA replication in vivo 
(Stillman et al, 1982; Van Bergen et al, 1983). In vitro, nuclear extracts from cells 
infected with these mutant viruses could not initiate the replication. However addition 
of the wild type DNA polymerase restored the replication in these extracts. 
cDNA encoding for Ad pol has been cloned by Shu et al (1987). This has enabled 
cloning both into vaccinia virus (Stunnenberg et al, 1988) and baculovirus (Watson 
and Hay 1990). Large quantity of proteins are available and have been purified. Ad pol 
possesses 1198 residues and catalyse three different reactions: - the initiation of 
replication by transferring a dCMP onto the serine in pTP, - replicating the entire 
adenovirus genome (in fact it is able to replicate any DNA strand from a primer), - a 3 ' 
to 5' exonuclease. The nuclease function helps increasing the fidelity of replication by
53
removing mismatched nucleotides (Reha-krantz and Bessman 1977), This exonuclease 
activity is common to other viral DNA polymerases and was ten times more active on 
single stranded than on duplex DNA (Field et al, 1984).
Sequence homologies were found in DNA polymerases a  from human to yeast and 
shows the conservation of six regions. Five of these conserved regions aie also found 
in the Ad pol (their order in the protein is also conserved). The conserved region VI is 
absent in Ad pol as well as in the DNA polymerases which uses a protein priming 
mechanism for replication (Wong et al, 1988, Wang et al, 1989). Instead a region 
around this position of the conserved region VI is conserved in protein priming DNA 
polymerase such as bacteriophage \j/29 and PRDl.
In E. coli DNA polymerase I, the 3’ to 5’ exonuclease active site has been chai*acterised 
(Joyce and Steitz 1987). Based upon sequence compaiison, similar regions were found 
in bacteriophage \|/29 and showed by mutational analysis to be important for 3’ to 5’ 
nuclease activity (Bernad et al, 1989) and similar sequences are found in the Ad pol. 
Since, the crystal structure of a DNA polymerase alpha from bacteriophage RB69 has 
been solved (Wang et al, 1997). This has enabled to further understand which residues 
are important in DNA polymerase.
Mutational analysis of the Ad pol especially in these regions has failed to produce 
distinct region involved in specific function (Chen and Horwitz 1989, Roovers et al, 
1991 and 1993). An exception may be two regions containing several cysteines and 
histidines between residues 228 to 256 and 1056 to 1090. The region around residue 
250 retains a basal DNA polymerase activity but is unable to initiate replication nor to 
recognise the initiation site on the DNA although it still can interact with pTP and NFI 
(Joung and Engler 1992). Some domain mapping was achieved using limited 
proteolysis. Partial proteolysis using endoproteinase lys-C of the Ad pol produced four 
different domains (from residue 1 to 236, 237 to 539, 521 to 1019 and 879 to 1198) 
(Parker et al, 1998). Using the west-western blotting, the thiee C-terminal regions
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were shown to interact with the pTP. Several non-contiguous regions of the DNA 
polymerase are involved in interaction with the pTP.
However, enzymatic properties of the Ad pol has been investigated only to a limited 
extent. Ad pol also resembles the alpha DNA polymerase with respect to its sensitivity 
in the presence of cytosine beta D arabinose 5’ triphosphate, NaCl and N 
ethylmaleimide and furthermore, both polymerases were active on activated DNA 
(Field et al, 1984). However Ad pol was less sensitive to aphidicolin and to ddNTPs. 
Using PLP, the DNA polymerase and the exonuclease activity were shown to exist as 
different domains. PLP could inhibit the DNA polymerase activity and the initiation of 
the replication without affecting the exonuclease activity of Ad pol. This experiment 
suggest that the DNA polymerase activity and initiation are carried out by the same 
domain (Monaghan and Hay 1996).
Recent biochemical experiments have shown the effect of various inhibitors and the 
affinity of the nucleotides on both the Ad pol alone and the complex pTP-Ad pol. The 
pTP-pol complex is extremely resistant to inhibitors such as aphidicolin, ddNTP and 
(S)-HMPA. The pTP-pol complex has also a different affinity to the trinucleotides than 
the Ad pol (King et al, 1997). These experiments suggest that when Ad pol is 
complexed to the pTP and catalyses the initiation reaction, the protein complex should 
be consider as a different enzyme to Ad pol catalysing the elongation reaction in the 
replication.
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III.8 Cellular factors.
For an efficient initiation and elongation of the replication of adenovirus 2, three further 
protein were necessary in HeLa cells. Amongst them, two are DNA binding protein 
involved in regulating gene expression and one is an enzyme.
III.8.1 The role of Nuclear Factor I in adenovirus 2 replication
Nuclear Factor I was shown to stimulate the replication of adenovirus 2 and 5 in vitro 
(Nagata et al, 1982). In vivo the presence of its DNA binding site was required for 
virus replication (Hay 1985). A specific DNA binding site for NFI lies between 
nucleotide 25 and 40. The mechanism of stimulation of replication by NFI was thought 
to be complex (Mul et al, 1990). The degree of stimulation varied : it appeared to be 
strongly dependent on the concentration of the complex of pTP-pol. At low 
concentration of pTP-pol, NFI stimulates up to fifty fold. However at high 
concentration of pTP-pol, this stimulation is only two fold. This shows that the need 
for NFI, in vitro, can be overcome by high concentrations of pTP-pol. This result 
probably explains the discrepancies in stimulation level reported previously and 
strongly indicates the existence of an interaction between NFI and the pTP-pol 
complex.
NFI was shown to interact directly with Ad pol. Using an immobilised NFI for affinity 
chromatography. Ad pol and the complex pTP-pol were specifically bound to the resin. 
However pTP alone could not interact with NFI (Bosher et al, 1990). It is unclear* yet 
which residues are involved in the interaction. Interaction between the two proteins 
were analysed mainly by deletion or site directed mutants. Deletion mutants in a region 
between residues 68 and 150 could not be coimmunoprecipitated while other mutants 
did precipitate with an anti DNA polymerase antibody (Chen et al, 1990). This region 
was further defined : double mutants in the region of cysteine 79 - arginine 80 and 
isoleucine 87 - threonine 88 were able to bind DNA and formed dimers and therefore
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could be expected to fold properly. However these mutant were unable to interact with 
Ad pol and could not stimulate replication (Armentero et al, 1994).
Stimulation of replication by NFI was also enhanced in the presence of DBF. DBF 
increased the association rate of NFI for its site and decreased the rate of dissociation 
(Cleat and Hay 1989). DBF increased the initiation replication in the presence of NFI 
by increasing the affinity of NFI for its DNA binding site at non saturating amounts of 
NFI. However neither DBF nor DNA stabilised significantly the interaction between 
Ad pol and NFI.
In cells infected by adenovirus 2, immunofluorescence labelling of DBF and NFI 
showed that they co-localised into subnuclear site, the same sites as DBF which were 
in the replication areas. This was not observed in cells infected by in adenovirus 4 
(Bosher et al, 1992). So one can conclude that, in infected cells, NFI is recruited to the 
replication site.
III.8.2 Nuclear Factor III.
A second replication stimulation factor. Nuclear Factor III (NFIII), was purified from 
nuclear extract of HeLa cells, which stimulated the initiation of replication in the 
presence of NFI (Pruijn et al, 1986). Using DNase footprint and méthylation 
protection, a specific site on the DNA recognised by NFIII was mapped. This site lies 
between nucleotides at position 38 to 49 in the adenovirus 2 genome. NFIII stimulates 
the initiation of replication in vitro by three to seven fold (O'Neill and Kelly 1988). 
Although viruses whose NFIII binding site were deleted remained fully infectious 
(Hay and McDougall 1986), a later study does suggest that an intact NFIII site is 
important for efficient growth and DNA replication in vivo (Hatfield and Hearing
1993).
Purified NFIII is a protein of 92 kDa (O’Neill et al, 1988) and is in fact identical to the 
ubiquitous transcription factor Oct-1 (O'Niell et al, 1988, Pruijn et al, 1989). This 
protein binds preferentially to the octamer sequence ATGCAAAT present in many
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promoter and enhancer such as the histone 2b, the immunoglobulin light and heavy 
chain, the SV40 enhancer and also to the adenovirus type 4 inverted teiTninal repeat 
(Pruijn et al, 1987). The NFIII binding site in adenovirus 4 has a 3 fold higher affinity 
for Octl than the Ad2/5 binding site (Verrijzer et al, 1990).
NFIII belongs, in fact, to a family of transcription factors characterised by a common 
DNA binding motif, (a variant of a helix turn helix motif forming an unique recognition 
domain known as POU domain, Herr et al, 1988, Cleaiy and Herr 1995). To date 
some forty genes with POU domains have been characterised in mammals, Xenopus, 
fish. Drosophila. On the basis of similarities in the POU domains, the family members 
have been classified into six subclasses (Stein et al, 1996).
Expression of the POU domain on its own was sufficient for DNA binding and 
recognition of its specific site. The POU domain can be subdivided in two subdomains 
which aie folded independently with an linker domain connecting both subdomain. The 
linker region is variable in length and in sequence. The carboxy terminal, known as the 
POU homeodomain (POUhd) binds preferentially to the A/T AAT region of the 
specific DNA binding site. The N terminal domain recognises the nucleotides ATGC of 
the DNA binding site and is known as the POU specific domain (POUs) (Verrijzer et 
al, 1990 and 1992).
The structure of the homeodomain was determined by crystallography (Klemm et al,
1994) and by NMR (Dekker et al, 1993). The stracture revealed that both subdomains 
bind DNA in an independent fashion. Both subdomains made contact to the DNA 
through a helix turn helix motif with the third helix maldng the contact to the specific 
base in the major groove.
The role of NFIII in the initiation is similar to NFI : NFIII affected the Vmax of the 
initiation of replication but did not affect the Km of the initiation of replication reaction. 
This result suggested that, like NFI, NFIII interacted with other proteins (Mul et al, 
1993). Since the binding site of NFIII overlaps with NFI, it was suggested that both 
could act in a cooperative manner to stimulate replication, but Mul et al (1990) found
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that NFIII and NFI bound the origin of DNA replication independently, without 
cooperative effect and did not enhanced replication in synergy.
NFIII interacts directly with the pTP-pol complex as shown using a immobilised GST- 
NFIII on a glutathione column after addition the pTP-pol complex. Interestingly some 
point mutations in the NFIII resulted in a stronger affinity to the pol-pTP, (i.e.: the 
replacement of a glutamine to an alanine at position 24, Coenjaerts et al, 1992). The 
site of interaction was further mapped to the homeodomain of the POU domain. The 
POU domain was showed to be sufficient to stimulate adenovirus replication (Verrijzer 
et al, 1990) but the homeodomain on its own was not sufficient to stimulate replication. 
It can also be noted the binding of NFIII to the DNA affected the structure of the DNA 
and induced a bend (Verrijzer et al, 1991).
III.8.3 Nuclear Factor II
Although the protein described previously were sufficient to initiate replication, these 
proteins could not sustain the synthesis of the total genome. In vitro the replication 
does not proceed beyond 25 to 30 %. A third factor was purified which helped to 
synthesise the total viral genome (Nagata et al, 1983). A complex protein of 30 kDa 
was purified with contained two polypeptides of 17 and 15 kDa. This protein had 
topoisomerase activity. Replication accumulates topological stress during the 
replication fork although the genome has free ends. This could be due to the binding of 
the TP to the nuclear matrix in vivo. In vitro the TP could interact making the genome 
to circularise as shown in the electron microscope (Robinson et al, 1973) which led to 
the discovery of the terminal protein. However more evidence suggest otherwise: the 
wild type genome was digested with Xba I which produced two DNA fragments one 
of 1339 and the other of 34 596 bp. In vitro replication showed that the replication 
stops after synthesis of 25 % of the genome of the second fragment (Van der Vliet
1995) which did not occur in the presence of topoisomerase 1. Since these templates
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do contain a free end, the blockage is not due to TP-TP interaction. It is still not cleai* 
why the genome needs a topoisomerase for replication but this is the function of NFII
III.9 A model for the replication of Adenovirus DNA in vitro.
The replication could be subdivided into three main steps : first, the formation of a 
preinitiation complex and of its binding onto the template, secondly, the synthesis of a 
protein-priming complex with the pTP and a nucleotide, and in a third step elongation 
and synthesis of the complete gemone.
In the first step. The DBP is likely to bind the double stranded adenovirus template 
in vivo (figure 5). This has the effect of increasing NFI binding affinity to the origin of 
replication. By protein-protein interaction, NFI recruits the Ad pol which in vivo is 
also bound to pTP. The pTP-pol complex recognises the origin of replication between 
nucleotide 9 to 18. This interaction is further stabilised by interaction between the pTP 
and NFIII. The correct positioning of the polymerase could also be due to the various 
proteins and on the stmcture of the DNA (although this remained still unclear). Further 
stabilisation could come through a direct interaction between the bound TP and other 
proteins (such as pTP).
In the second stage, the DNA must unwind which takes place within the core of the 
viral origin of DNA replication and the complex pTP-pol repositions itself so that the 
protein start synthesising the first three nucleotides (CAT) at position 4 to 6.
This synthesis which is probably carried out by Ad pol is very different in nature from 
the DNA polymerase activity. The affinity of each nucleotide is different in the 
initiation step (or synthesis of the CAT) and is much more resistant to inhibitors such 
as ddNTP, aphidicolin and (S)-HPMPApp. The affinity for the first nucleotide (dCTP)
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is much higher than the affinity of Ad pol during elongation. Furthermore this step is 
carried out by Ad pol complexed to pTP. After synthesis of CAT, the complex 
dissociates (King et al, 1997). The start of synthesis also affect NFI DNA binding 
which dissociates at this stage (Coenjaerts et al, 1994). This was shown using 
immobilised GST-NFI on a glutathione column and adding the various components of 
the initiation complex.
Before synthesis, Ad pol must jump back to the start of the genome so that the newly 
synthesised CAT complement with the first three nucleotides. The event of the jumping 
back and of the dissociation of the complex pTP-pol is not know how they relate in 
time. It was clearly showed that both are not linked by using a mutant of the first three 
nucleotides. The dissociated polymerase is more efficient once dissociated.
In the third step, Ad pol synthesises a new strand of DNA. The synthesis is helped 
by unwinding of the DNA by DBP and by a topoisomerase. NFIII is dissociated 
during the elongating phase of the replication.
After synthesis, the replication leaves a single stranded molecule and a double stranded 
molecule. The non template strand is displaced during this reaction and DBP bound to 
this molecule. Although the inverted terminal repeats could annealed to form a 
panhandle structure, DBP is known to inhibit intramolecular interaction but favour 
intermoleculai" interaction. The ssDNA molecule has been demonstrated in vitro 
replication can be initiated from single stranded template.
To summarise, the main role of NFI during the replication of adenovirus is to recruit 
the pTP-pol complex to the origin of replication. The pTP-pol complex is brought to 
the origin by direct interaction between NFI and the polymerase. The role of NFI is 
limited to the first steps of the replication process. NFI quickly dissociates from the 
DNA as soon as the initiation of replication proceeds (Coenjaert et al, 1994).
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IV. Aim of the project
The aim of this project was to determine the DNA binding domain of NFI. Such a 
project required large quantity of pure and active protein. Therefore the production and 
purification of lai'ge amounts of active protein was first investigated. Although NFI 
could be purified using recombinant baculovirus technology, bacterial systems were 
also studied and used. NFI produced in bacteria formed inclusion bodies, but these 
could be easily purified and could be renaturated into an active protein . Folding in 
vitro of NFI was further investigated and found to be a convenient method to obtain 
large quantity of protein.
In most transcription factors, the DNA binding region is localised to one specific 
region of the protein. To map the minimal region in NFI required to bind DNA, NFI 
was subjected to limited proteolysis in the presence and absence of DNA. The 180 N 
terminal residues was found to contain the DNA binding activity. A further region 
around residues 160 to 180 was also discovered to be critical for the DNA binding 
activity.
As the DNA binding domain remains quite large and it is expected that only a few 
residues will obviously be involved in making specific contact with the DNA, we used 
the differential labelling technique to identify these residues. Using iodoacetate, 
cysteine residues in NFI involved in close contact with DNA, were radioactively 
labelled and then identified.
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Materials and Methods
I. Composition of commonly used buffers
IxTBE : 90 mM Tris-Borate, 2 niM EDTA
TEN300 : lOmM Tris pH8, ImM EDTA, 300mM NaCl.
PBS (phosphate-buffered saline) : 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HP04,
1.8 mM KH2P04, pH 7.4
Buffer A : 25 mM Hepes NaOH pH7.5, 0.25 mM NaCl
II. Cloning of Nuclear Factor I
II.1 Oligonucleotides
Oligonucleotides used for the construction of the various plasmids for protein 
expression were obtained either in house (synthesis on an Applied Biosystems 
oligonucleotide synthesiser, followed by ethanol precipitation), or ordered from 
Oswell's DNA service (University of Southampton)
Oligonucleotides used in the cloning of pET 22b were
FOR : 5' - AGA GCC ATG GAT GAG TTC CAC CCG TTC A - 3'
BACK : 5' - AGA GGA ATT GAG AGC TCA GTG ACG CTG AA - 3’ 
Oligonucleotides used in the cloning of NFI in pGEX 2T cPk were :
FOR : 5' - GTG GAT CCA TGT TCC AGG CGG CCG AGG ATG AGT TCC ACC 
CGT TC - 3'
BACK : 5' - TAG AAT TCC GAG CTC AGT GAC GCT GA - 3’.
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Oligonucleotides used for insertion of NFI cDNAs into transfer plasmids used for 
obtaining recombinant baculovirus were :
FOR : 5' - GTG GAT CCA TGT TCC AGG CGG CCG AGG ATG AGT TCC ACC 
CGT TC - 3'
BACK : 5' - TTG GAT CCT CAG GTG GAG TCC AAT CC - 3\
The digestion sites of the restriction enzyme used in cloning are in bold.
11.2 Plasmids
The plasmid used for the bacterial expression system were : pET 22b(+) purchased 
from Novagen and plasmid pGEX 2T cPk which was a gift from Dr R. E. Randall 
(Hanke et al, 1994).
The plasmid for the construction of recombinant baculovirus were pVL1393 (gift from 
Dr A. Dawson) and pAcG2T (gift from Dr I. M. Jones (Davies et al, 1993)).
11.3 Agarose gel electrophoresis
DNA samples were analysed using a horizontal agarose gel apparatus (10 cm x 10 cm). 
The concentration of the gel ranged between 0.8 and 2%. DNA samples were mixed 
1/6 with loading buffer (6x : 0.25% bromophenol blue, 30% glycerol) and loaded into 
the wells of the gel. Electrophoresis was cairied out in IxTBE at 80 V till the dye 
migrated two thirds of the way down the gel. The DNA was stained by ethidium 
bromide (1 mg/1) and visualised on a UV transilluminator.
To recover DNA fragments from the agai'ose gel, the desired band was sliced and 
enclosed in a dialysis bag with a molecular cut off of 3 500 Da (Pierce) with 200 to 400 
jll of IxTBE. The dialysis bag was placed in a electric field of 80 V in IxTBE till the 
DNA migrated out of the agarose (usually 20 minutes). The liquid in the dialysis bag 
was recovered and the DNA fragment was concentration by butanol 2, precipitated by 
ethanol and the DNA pellet was dried. The DNA was resuspended in water and a 
fraction of it was used to estimate the level of DNA recovery by gel electrophoresis.
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11.4 Amplification of cDNA encoding NFI by Polymerase Chain Reaction (PCR).
The cDNA encoding for the N tenninal 222 residues of NFI was obtained by PCR. 
100 jil reaction mixtures consisted of PCR buffer (lOmM Tris HCl pH 8.8, 50mM 
KCl, 1.5 mM MgCl2, 0.1% (v/v) Triton X 100), 0.2mM of each nucleotides (dATP, 
dCTP, dGTP, dTTP), 0.25mM of each primer and 1 unit of Vent DNA polymerase 
(New England Biolab). The amount of template varied from 1 to 10 ng. When 
possible, the template used was the original CTFl clone obtained from Dr R. Tijan 
(Santoro et al, 1989). The conditions for PCR were : A first step incubation for 5 
minutes at 94°C then 30 cycles of : 94°C for 2 minutes, 55°C for 1.5 minutes and 72°C 
for 1.5 minutes. The PCR ended with a final step of 72°C for 9 minutes. The PCR 
product was checked by agarose gel electrophoresis and purified using a Qiagen PCR 
purification kit following the manufacturer instructions.
11.5 Enzymatic reactions with DNA
Restriction digest of DNA : PCR products were digested using the appropriate 
restriction enzyme (usually Eco RI, Bam HI or Nco I) for 3 hours at 37°C following 
the manufacturer’s instructions.
Dephosphorylation of the 5' ends : after endonuclease digestion, plasmid 5' end 
termini were dephosphorylated by further incubating the digestion product in 10 units 
of alkaline phosphatase (Boehringer Mannheim) in 50 jil for 1 hour at 37°C.
DNA Ligation : a 3 to 1 molar ratio of insert to vector was combined in a total of 10 p.l 
of ligation buffer (Ix : 50mM Tris HCl pH 7.8, lOmM MgCl2, lOmM DTT, ImM 
ATP and 25 pg/ml BSA), 200 units of T4 DNA ligase (New England Biolab) were 
then added and the ligation proceeded at 16°C for a minimum of 12 hours. The ligation 
mixture was used directly for the transformation of E. coli competent cells.
Removal of protruding ends in DNA : the DNA was digested by the mung bean 
nuclease with 20 units of nuclease for 5 pg of DNA in 20 pi digestion buffer (30mM
66
sodium acetate pH 4.6, 50mM NaCI, ImM ZnCl2 and 5% glycerol) at 37°C for 5 
minutes.
II.6 Preparation and transformation of competent E. coli cells
E, coli XL-1 blue strain (in house supply) was used for transformation. Cells were 
made chemically competent following the method of Kushner. A 50 ml bacterial culture 
was grown to an OD of 0.15 to 0.2 at 650 nm. 30 ml of the culture was centrifuged at 
1000 g for 10 minutes at 4°C. The bacterial pellet was resuspended in 10 ml of ice cold 
MOPS buffer I (lOmM MOPS NaOH pH 7, lOmM RbCl) and again collected by 
centrifugation. The cells were gently resuspended in 10 ml ice cold MOPS buffer II 
(lOOmM MOPS NaOH pH 6.5, lOOmM CaCl2, lOmM RbCl) and kept on ice for a 
further 1 hour before use.
For each transformation, cells from 0.5 ml of suspension were collected by 
centrifugation as above, resuspended in 0.2 ml ice cold MOPS buffer II and incubated 
with plasmid DNA or ligation mix for 30 minutes on ice. Bacteria were heat shocked at 
42°C for 90 seconds, then left to recover in LB broth supplemented with 20mM 
glucose at 37°C for 1 hour. Each transformed bacterial aliquot was spread on LB plates 
with the appropriate antibiotic (usually 100 pg/1 of ampicillin). Two controls were
transformed in the same way by using either 1 ng of pUC19 (positive control) or no 
DNA at all (negati 
per |xg of pUC19.
ve control). Efficiency of tiansformation was at least 10^ colonies
II.7 Preparation of plasmid DNA
The alkaline-lysis method of Birnboim and Doly (1979) was chosen for small scale 
preparation of DNA (minipreps). Large scale prepai'ation were obtained using a 
Quiagen DNA maxi-prep ion exchange column according to the manufacturer 
instmctions. Quality and quantity of DNA were analysed by spectrophotometry at 260 
and 280 nm and through visualisation by agarose gel electrophoresis.
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IL8 DNA sequencing
Recombinant plasmids were sequenced using a ABI Prism 377 DNA sequencer 
(Perkin Elmer).
III. Construction of a recombinant baculovirus expressing  
NFI and isolation of the virus
111.1 Preparation of the baculovirus DNA
The DNA of a recombinant virus (AcRAK6) expressing (3-galactosidase under the 
control of the polyhedrin promoter was co transfected with the transfer vector for the 
construction of a NFI expressing recombinant baculovirus. This viral DNA contains 
two Bsu36 I endonuclease sites one situated in the p-galactosidase gene and one in the 
ORF1629, a gene necessary for baculovirus infection. The DNA was obtained from 
Prof. R. T. Hay.
10 (ig of the viral DNA was subjected to a digestion with 10 units of the endonuclease 
Bsu36 I (New England Biolab) in 50mM Tris HCl pH 7.9, lOOmM NaCl, lOmM 
MgCl, ImM DTT and 0.1 mg/ml BSA in a final volume of 50 pi at 37°C overnight. 
The mixture was heat treated at 70°C for 20 minutes after the addition of EDTA to a 
final concentration of lOmM.
111.2 Transfection of Sf9 cell
Recombinant baculovirus expressing NFI cPk and GST-NFI cPk were generated by co 
transfecting the viral genome of AcRAK6 digested with Bsu36I and the transfer vector 
pVL1393 NFI cPk or pAcG2T NFI cPk into Spodopterafmgiperda cells (Sf9 or Sf21) 
using lipofectin. 10^ cells were left to attach in a 25 cm^ flask in TClOO medium for 2 
hours. Prior to transfection, the monolayer was washed twice with 5 ml of OPTIMEM 
medium (BRL-GIBCO) and incubated with 3 ml of the same medium.
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1 pg of Bsu36 I digested AcRAK6 was mixed to 4 pg of transfer vector in 50 pi of 
water and combined with an equal volume of lipofectin (BRL). This mixture was 
incubated at 20°C for 15 minutes. The 100 pi lipofectin/DNA solution was added 
drop wise directly on the cell layer and incubated for 4 hours at 28 °C. The medium was 
then replaced with TClOO supplemented with 10% FCS (Foetal Calf Serum) and 
incubated 4 days at 28°C. The supernatant of these cells was harvested and used to 
isolate NFI or GST-NFI expressing baculovirus.
111,3 Purification of a recombinant baculovirus expressing NFI or GST- NFI
Recombinant vims was purified by plaque assay as described by O’Reilly et al (1992). 
The media from the transfected cells was serially diluted a hundred to a million in 
TClOO. 150 pi of each dilution was used to infect Sf9 cell monolayer in a 60mm dish 
with the cell monolayer being 60-70% confluent. After 1 hour, the monolayer was 
overlaid with 4 ml of TClOO supplemented with 5% FCS, 1.5% low melting point 
agar at 40°C and 0.120 mg/ml of 5-Bromo-4-Chloro-3-Indoly 1 p-D-Galactopyranoside 
(Sigma). The plates were incubated in a humid compartment at 28°C. When blue 
plaques appeared (usually 6 days post infection), the cells were stained with 4 ml of 
TClOO containing 0.5% neutral red for 2 hours. Ten colonies were picked and the 
viruses of each plaque assayed for expression of NFI and of P-galactosidase. Vims 
stocks were gradually built up by infection of fresh Sf9 cells.
IV. Expression and purification of Nuclear Factor I 
IV. 1 Expression of NFI and of GST-NFI in E. coli
The E, coli BL21 (DE3) strain was used for the expression of NFI using the pET 22b 
plasmids. Expression of the fusion protein GST-NFI was achieved in E. coli strain 
XL 1-blue. A single bacterial colony from a LB agar plate containing 100 mg/1 of
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ampicillin was picked and used to inoculate 50 ml of LB broth supplemented with 100 
mg/1 of ampicillin. The culture was left overnight at 37°C under agitation. The 
overnight culture was scaled up to 1 litre in LB-broth with 100 mg/1 of ampicillin and 
grown till the OD of the culture reached 0.6 at 600nm. The bacterial colony was 
induced by ImM IPTG, for 3 to 4 hours at 20°C for the production of GST-NFI or at 
37®C for NFI. Cells were harvested by centrifugation at 6 000 g for 10 minutes at 4°. 
Pellets were washed once with PBS and stored at -70°C until needed.
IV.2 Expression of NFI and GST-NFI in insect cells 
IV.2.1 Cell culture
Spodopterafmgiperda cells were maintained in exponential growth in TClOO medium 
(Gibco) supplemented with 7% foetal calf serum (Sera Lab Ltd).
IV.2.2 Virus stock
Recombinant baculovirus {Autographa californica) expressing the DNA binding 
domain of NFI was obtained from R. T. Hay (Bosher et al, 1991). Titres of virus 
stocks were determined by plaque assay as described above.
IV.2.3 Optimisation of expression of protein from a stock solution of baculovirus
To determine the optimal expression of NFI and GST-NFI from a particular virus 
stock, the following method was used. 5x10^ Sf9 cells were added to each well in a 24 
well plate. In each individual well, cells were infected with various volumes of the 
virus stock and made up to 150 pi with TClOO and left to infect for 1 hour. 1ml of 
TClOO supplemented with 7% FCS was added in each well. Infected cells were 
harvested after 48 to 72 hour post infection and the expression of the protein in each 
well was analysed by SDS PAGE followed by western blotting.
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IV.2.4 Infection of Sf9 with recombinant baculovirus
500 ml (10^ cell per ml) of SF9 in a spinner culture were collected by centrifugation at 
400 g for 5 minutes and resuspended in the presence of the virus stock. Cells were 
incubated 1 to 3 hours at 28°C with the virus before adding TClOO with 7% FCS to 
500 ml and incubated in a spinner culture at 28°C for 48 to 72 hours.
IV.3 Purification of GST-NFI fusion protein
IV.3.1 Purification of GST-NFI expressed in E. coli
Induced cells were resuspended in 5 ml (per litre of culture) of 50mM Hepes-NaOH 
pH 7.5, 0.5 M NaCl, ImM PMSF, 5mM DTT. Triton X-100 was added to a 
concentration of 1% and the extract was ultrasound sonicated with 6 burst for 30 
seconds. The extract was centrifuged for 30 minutes at 30 000 g. The supernatant was 
then used to purify GST-NFI on a immobilised glutathione column.
IV.3.2 Purification of GST-NFI expressed in Sf9
500 ml of a spinner culture of Sf9 cells infected for 48 hours at 28°C, were harvested 
by centrifugation at 400 g for 5 minutes. From then on all steps were caixied out either 
on ice or in the cold room. Buffers and centrifuges were cooled to 4°C. The cells were 
washed once with PBS and resuspended in 5 ml of 25mM Hepes-NaOH pH 7.5, 5mM 
DTT, 0.5 M NaCl, ImM sodium metabisulfate, ImM PMSF and 10 pg/ml pepstatin 
and incubated for 20 minutes. This cellulai' extract was centrifuged at 45 000 g for 30 
minutes on a Beckman TLIOO ultracentrifuge. The supernatant was used to purify 
GST-NFI by immobilised glutathione affinity chromatography.
IV.3.3 Glutathione affinity chromatography
The column was equilibrated in 25 to 50mM Hepes-NaOH pH 7.5, ImM DTT and 0.5 
M NaCl. The protein extract was loaded and unbound proteins were removed by 
washing with 5 to 10 column volume of the equilibrating buffer. Bound protein was
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eluted in 50mM Hepes-NaOH pH 7.5, 0.2 M NaCl, 10 % glycerol and lOmM 
glutathione (pH 7 with NaOH). An aliquot of each fraction was run on a 10% SDS 
PAGE.
IV.4 Purification of Nuclear Factor I
IV.4.1 Purification of Nuclear Factor I  as inclusion bodies and large scale folding in vitro
The pellet from each litre of bacterial culture was resuspended in 10 ml of 50mM 
Hepes-NaOH pH 7.5, 0.5 M NaCl, ImM PMSF, 5mM DTT and 0.35 mg/ml 
lysozyme and incubated 30 minutes at 20°C. Triton X-100 was added to a 
concentration of 1% (v/v) followed by ultrasound sonication of small burst of 30 
seconds till the solution became homogeneous. The extract was then treated by 20 mg/1 
of DNase I for 1 hour at 37°C. The soluble fraction was separated from the inclusion 
bodies by centrifugation for 30 minutes at 30 000 g at 4°C. The pellet was washed 
twice with PBS, 1% Triton X-100.
Pellets were dissolved in 50mM Hepes-NaOH pH 7.5, 6 M guanidine, 25mM DTP 
and incubated for 2 hours. Insoluble material was precipitated by centrifugation at 300 
OOOg for 10 minutes at 20°C. The soluble material was diluted very rapidly to a final 
protein concentration of 0.1 mg/ml using a syringe and a needle into 50niM Hepes- 
NaOH pH 7.5, 1 M NaCl, ImM DTT, 1 M NDSB additive under vigorous agitation at 
4°C in a glass beaker. Agitation was stopped 2 minutes later and the folding mixture 
left overnight on ice.
The solution was then diluted to a NaCl concentration of 0.3 M using 50mM Hepes- 
NaOH pH 7.5, ImM DTT and 0.1 mg/ml BSA and NFI was finally purified by ion 
exchange and/or by DNA affinity chromatography. The purity was estimated by SDS 
PAGE.
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IV.4.2 Purification of NFI from Spodoptera friigiperda cells infected with recombinant baculovirus
500 ml of SF9 cell culture was infected with recombinant baculovirus for 72 hours at 
28°C and harvested by centrifugation at 400 g for 5 minutes. From then on all step 
were carried out either on ice or in the cold room. Buffers and centrifuges were cooled 
to 4°C. The cells were washed once with PBS and resuspended in 5 ml of 25mM 
Hepes-NaOH pH 7.5, 5mM KCl, 0.5mM MgCl2 , ImM benzamidine, ImM sodium 
metabisulfite, ImM PMSF, 10 pg/ml antipain, 10 pg/ml pepstatin and 10 pg/ml 
leupeptin. The cells were disrupted with 20 strokes in a Dounce homogeniser using a 
type B pestle. Nuclei were collected by centrifugation at 2 000 g for 5 minutes. The 
nuclei were resuspended in 5ml of 25mM Hepes-NaOH pH 7.5, 5mM DTT, 0.4 M 
NaCl, ImM PMSF, 10 pg/ml antipain, 10 pg/ml pepstatin and 10 pg/ml leupeptin 
and incubated for 20 minutes. The nuclear extract was diluted two fold in 25mM 
Hepes-NaOH pH 7.5 before centrifuging the extract at 45 000 g for 30 minutes at 4°C. 
The supernatant was used to purify NFI by ion exchange chromatography and by 
affinity chromatography.
IV.4.3 Ion Exchange Chromatography
Two types of ion exchange resin were used : either Biogel 70 which is a weak anion 
exchange column (BioRad) or a fast flow strong anion exchange column (Fast flow SP 
Sepharose Pharmacia). Biogel was prepared as follow : 2 ml of resin powder was 
resuspended in 8ml of 250mM Hepes NaOH pH 8, 1 M NaCl, lOmM EDTA for 1 
hour. The suspension was left to settle and the resin was then washed twice in 
deionised water.
The resin was preequilibrated in 25 mM Hepes NaOH pH7.5, 0.2 M NaCl, 1 mM 
DTT. The protein extiact was loaded onto the column, unbound protein washed by 
Buffer A, 1 mM DTT and bound protein eluted by 25 mM Hepes NaOH pH 7.5, 0.7 
M NaCl and 1 mM DTT. An aliquot of each fraction was used for SDS PAGE.
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IV.4.4 DNA Affinity Chromatography 
Preparation of an DNA affinity resin
The scheme for preparing the oligonucleotide affinity resin was based on Kadonaga 
and Tijan (1986). To generate a NFI affinity column, 4 mg of a single stranded amino 
linked to the 5’ end oligonucleotide (5’ -GAT CTT ATT TGG ATT GAA GGC CAA 
TAT G) was annealed to a complementary oligonucleotide (5’ - GAT CCA TAT TGG 
CCT TCA ATC CAA ATA A), precipitated twice in ethanol and resuspended in 
deionised water.
For the cross linking reaction, 3 g of cyanogen bromide activated (CNBr) Sepharose 
4B (Sigma) was swollen in 15 ml of ImM HCl for 1 hour. Beads were washed on a 
stintered glass funnel with 400ml of ImM HCl, then by 500 ml of ultrapure water, 
followed by 400 ml of lOmM sodium phosphate pH 8. The resin was then left to react 
with 8 mg of double stianded oligonucleotide overnight at 20°C under gentle rotation. 
The resin was collected by centrifugation at 150 g for 1 minute. The supernatant 
discarded, and the resin was washed once with 5 ml of lOmM sodium phosphate 
pH 8. Unreacted CNBr sites were blocked by incubating the resin in 100 ml of IM 
ethanolamine pH 8 under mild rotation for 4 hours. The resin was then washed with 
100 ml of lOmM sodium phosphate pH 8, 0.1 M NaCl, followed by 100ml of 2M 
NaCl and finally using 100ml of TEN300 with 0.02% sodium azide. The NFI affinity 
resin was stored at 4°C in TEN300, 0.02% NaN3.
Purification of NFI by affinity chromatography
Prior to loading with a protein extract, the DNA-Sephaiose was washed with 10 
column volumes with 25mM Hepes-NaOH pH7.5, ImM EDTA, ImM DTT and 0.2 M 
NaCl. The protein extract was diluted so that the NaCl concentration was brought 
down to 0.25 - 0.3 M with 25mM Hepes-NaOH pH7.5, lOmM DTT. 6 |ig of poly 
(dl-dC) or non specific double stranded oligonucleotide was added per mg total 
protein. The extract was then loaded onto the column. Unbound protein were eluted by 
25mM Hepes-NaOH pH 7.5, ImM EDTA, ImM DTT and 0.2 M NaCl. Bound NFI
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was eluted in 25mM Hepes-NaOH pH 7.5, 1 M NaCl, ImM DTT, 10 % glycerol. 
Fraction were analysed by SDS PAGE.
V. Analysis of NFI protein
V .l Determination of protein concentration
The protein concentration was determined using the method of Bradford (1976). A kit 
was purchased from Bio-rad and used following the manufacturer’s instructions. 
Protein samples (5 to 50 pi) were mixed with 990 pi of Bradford's reagent and 
incubated for 5 minutes at room temperature before measuring the absorbance of the 
solution at 595 nm. Protein concentration of the sample was determined from a 
standard curve obtained using BSA as standard.
V.2 Polyacrylamide gel electrophoresis in denaturing condition and Western blot analysis.
10 to 15% polyacrylamide gels were cast using a Bio-Rad Mini Protean apparatus from 
a 30% (w/v) stock polyacrylamide solution (29% acrylamide : 1% bisaciylamide) in 
0.375 M Tris pH 8.9 and polymerised by the addition of 0.1 % (w/v) ammonium 
persuphate and 1/1000 volume of TEMED (BDH). The stacking gel contained 5% 
aciylamide in 0.125 M Bis-Tris HCl pH 6.5. Protein sample were diluted in 4x 
denaturing buffer (Ix ; 1% SDS, 0.175 M p-mercaptoethanol, 8% v/v glycerol and 
0.06% w/v bromophenol blue) and boiled for 5 minutes at 100°C before loading. The 
electrophoresis buffer was 0.025 M Tris, 0.19 M glycine and 0.1% SDS. Once the 
migration front reached the bottom of the gel, electrophoresis was stopped and the gel 
apparatus dismantled. The gels were either fixed in 10% acetic acid, stained in 0.1% 
Coomassie blue G250, 10% acetic acid and 20% ethanol and destained in 10% acetic 
acid and 20% ethanol, or transferred onto a PVDF membrane for immunodetection as 
described as follow.
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Separated polypeptides were transferred unto a PVDF membrane (Millipore) in a semi 
dry blotter in 48mM Tris, 190mM glycine, 20% ethanol for 1 hour at 1 mA/mm^ of 
gel. After transfer, the membrane was blocked with PBS containing 5% (w/v) 
skimmed milk powder and 0.1% Tween 20, then incubated with the appropriated 
antibody at a dilution ranging from 1/1000 to 1/5000 in the same buffer. The 
membrane was washed twice before adding an HRP antibody raised against the 
previous antibody in blocking buffer for 30 minutes at a dilution of 1/5000. The 
membrane was washed then developed by the enhanced chemiluminiscence (ECL; 
Amersham International) protocol according to the manufacturers recommendations. 
When protein separated by SDS PAGE were to be sequenced, the proteins were 
transferred to a PVDF membrane as described above with the following variations : 
i) the separating and stacking gel were degassed prior to polymerisation, ii) The 
separating gel was prepared the day before its use and stored in 0.375 M Tris pH 8.8 
overnight, iii) The gel was prerun with electrophoresis buffer at the anode and a buffer 
of 0.125 M Tris, 0.1% SDS, 60jLiM glutathione at the cathode, iv) The gel was run 
with electrophoresis buffer supplemented with lOOpM p-mercaptoacetic acid at the 
cathode, v) Transfer was carried out in a wet blotter (Bio-Rad) for 1 hours at 300 mA 
in lOmM CAPS pH 11, 10% ethanol on a PVDF membrane (Perkin Elmer), vi) The 
membrane was stained with 0.1% Coomassie blue R250, 40% ethanol and 1% acetic 
acid for 1 to 2 minutes and destined in 40% ethanol, 1% acetic acid. Bands were cut 
out and stored in an eppendorf tube at -20 C.
V.3 Preparation of a radioactively labelled double stranded 
oligonucleotide
Two complementary oligonucleotides (GAT CTT ATT TTGGCT TCA AGC CAA 
TAT G and GAT CCA TAT TGG CTT CAA GCC AAA ATA A) which contained a 
NFI DNA binding site were synthesised and annealed.
The récessives ends of the double stranded oligonucleotide were labelled with 
^^ P dCMP using the E. coli DNA polymerase (Klenow fragment) (NEB). 500 ng of
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double stranded oligonucleotide was mixed with 33 jiM of dATP, dGTP, dTTP and 
20 jiCi [a-^^P] dCTP (3000 Ci/mmol) with 1 to 5 units of DNA polymerase in lOmM 
Tris HCl pH 7.5, 5mM MgCl2, 7.5mM dithiothreitol. The reaction was incubated at 
25°C for 15 minutes. 33 pM of dCTP was added and the reaction left for a further 5 
minutes before stopping the reaction by the addition at a final concentration of 20mM 
EDTA and 10% glycerol.
The radioactively labelled DNA was purified by running on a 12% polyacrylamide gel 
(29 acrylamide : 1 bisacrylamide) in 1 x TBE. An X-ray film was exposed to the gel 
for 5 minutes in order to detect the position of the probe. The appropriate band was cut 
out and eluted overnight in 300 pi of TEN300 at room temperature. The buffer 
containing the probe was decanted and stored at 4°C
V.4 Gel Electrophoresis DNA binding assay
Prior to the gel retention assay, NFI was incubated with 20mM freshly prepared DTT. 
1 to 100 ng of purified NFI or 1 to 6 pg of nuclear or cellular extract was incubated 
with 50mM Hepes-NaOH pH 7.5, 200mM NaCl, 5mM MgCl2 and 10 ng to 1 pg of a 
non specific double stranded oligonucleotide (the amount depended on the purity of 
NFI). After 20 minutes, 1 to 5 ng of labelled double stranded DNA was added and 
incubated a further 30 minutes at 4°C. The NFI-DNA complex was sepaiated from free 
DNA on a 8% polyaciylamide gel (55 acrylamide : 1 bisacrylamide). The gel was 
prerun at 150 V for 30 minutes prior to loading. Electrophoresis was carried out in 
O.SxTBE for 90 minutes at 150 V. The gel was fixed in 10% acetic acid for 10 
minutes, dried and exposed either to X-Ray film or to a phosphoimager screen.
V.5 Limited proteolysis of Nuclear Factor I
NFI was dialysed to 25mM Hepes-NaOH pH 7.5, 0.25 M NaCl, ImM DTT. Prior to 
digestion, NFI was incubated 20 minutes on ice with 20mM DTT. Trypsin, 
chymotrypsin, V8 and proteinase K were added at ratio ranging from 1/1 to 1/1000 
(w/w) of protease to NFI. The digestion reaction was incubated at 25°C for 1 hour.
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ImM PMSF was then added to quench the proteolysis reaction and incubated on ice for 
20 minutes. The digestion products obtained were analysed by SDS PAGE and the 
various digest product were N terminally sequence (Perkin Elmer procise protein 
sequencer, University of St. Andrews) and their moleculai* weight determined by laser 
desorption mass spectrometry (University of Aberdeen).
To analyse the susceptibility of DNA bound NFI to proteolytic attach was studied by 
adding a 2 fold molar excess of a double stranded DNA containing a NFI binding and 
incubating for 30 minutes on ice.
V.6 lodoacetic labelling of Nuclear Factor I
100 to 200 pg of NFI was dialysed in 25mM Hepes-NaOH pH 7.5, 0.2 M NaCl, 
ImM DTT and ImM EDTA. NFI was incubated at 4°C with 200pl of NFI affinity 
resin for 1 hour. The resin was collected in a eppendorf by a brief centrifugation at 200 
g and the supernatant removed. The resin was then washed twice with 1 ml of buffer 
A. NFIDBD bound to the column was treated with lOmM lodoacetic acid (Sigma) in 
buffer A for 30 minutes at 20°C (the lodoacetic acid was equilibrated to pH7 with 
NaOH). The affinity resin was then washed twice with 1 ml of buffer A and 2mM 
DTT. NFI was eluted in 25mM Hepes-NaOH pH 7.5, 1 M NaCl and 2mM DTT. NFI 
was then dialysed for 4 hours buffer A and ImM DTT before concentration in a 
microconcentrater (Centricon-30) with a membrane with a molecular cut off of 30 kDa
14by centrifugation for 1 hour. NFI was then treated with a neutral solution of C 
lodoacetic acid (ICN) for 30 minutes at 20°C. The reaction was quenched by the 
addition of 50mM DTT and left on ice for 15 minutes.
V.7 Isolation, identification of radiolabelled cysteine containing peptide
NFI labelled by C was precipitated by the adding to a final concentration 10% 
trichoroacetic acid and left on ice for 1 hour prior to centrifugation at 100 000 g at 4°C 
for 20 minutes. The supernatant was discaided and the pellet washed twice with ice
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cold acetone before being dried in air. The pellet was resuspended in 8 M deionised 
urea, lOOmM Tris HCl pH 8 and the urea concentration lowered to 2 M by addition of 
water. NFI was digested by trypsin at a ratio of 1/50 (w/w) for 20 hours at 37°C. The 
peptides were sepaiated by reverse phase chromatography using a Waters HPLC 
system with a Delta C18 column. The peptides were eluted in a gradient of 0 to 80% 
acetonitrile in 0.06% (v/v) trifluoroacetic acid at a flow rate of 0.5 ml/min. 0.5 ml 
fractions were collected and a 10 pi aliquot of each fraction was added to 5 ml Ecoscint 
A and scintillation counted. Peak radioactivity fractions were sent for N terminal amino 
acid sequencing (University of St. Andrews).
V.8 Small Scale folding of Nuclear Factor I
Folding in vitro of NFI was performed by quick dilution. Purified inclusion body was 
resuspended in 6 M guanidine, 50mM Hepes NaOH pH 7.5, 25mM DTT (or |3- 
mercaptoethanol) for 1 hour at 20°C. Insoluble material was precipitated by 
centrifugation at 100 OOOg for 10 minutes at 20°C. Unless stated, the folding was 
performed in 50mM Hepes-NaOH pH 7.5, 1 M guanidine, 5mM DTT and 1 M NDSB 
256t (synthesised by Dr Vuillaid) in a final volume of 0.5 ml. The folding buffer and 
the denatured NFI were added into the same eppendorf tube talcing cai'e not to mix 
them. The amount of stock NFI was chosen to achieve a final concentration of 0.1 
mg/ml. Mixing was carried out by vigorous vortexing for 10 seconds at 20°C. The 
folding reaction was left overnight at 4°C before testing the activity of NFI by gel 
retention assay.
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Chapter 1 : Cloning, expression and purification of Nuclear Factor 
I DNA Binding Domain (NFIdbd)
Understanding the precise details of the interaction between protein and DNA requires 
lai'ge amounts of pure and active protein. In mammalian cells, several isoforms of 
Nuclear Factor I are produced in small amounts due to vaiiable splicing and post 
translational modification. Various means of overexpressing the protein were 
investigated in order to obtain large amounts of an active fragment of NFI sufficient for 
DNA binding (NFIdbd). Although a recombinant baculovirus expressing NFIDBD 
already existed, this protein had a higher moleculai' weight than expected (determined 
by mass spectrometry. University of Aberdeen). Furthermore NFIDBD migrated as a 
doublet and contained a blocked amino terminal, making the study of the regions 
involved in DNA binding difficult. One of my first objectives was to obtained a 
NFIdbd with the proper moleculai' weight and with a free amino terminus. Therefore 
in this chapter, two different protein expression systems (bacteria and baculovirus) 
were investigated.
I. Cloning and expression in bacteria
Two different E. coli expression vectors were chosen for the expression of NFIDBD: 
the pET22b+ and the pGEX2T cPk (figure 1.1). Both vectors contain a bacterial 
origin of replication, an ampicillin resistance gene (p lactamase) and a gene encoding 
for the lactose repressor protein (Lac U).
In pET 22b+, the recombinant protein is expressed at the C terminus of a periplasmic 
localisation signal (pelB) under the control of a T7 promoter and a lactose operator. 
Recombinant proteins should then be exported to the periplasmic region of the bacteria.
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Figure 1.1 Schem atic representation of the vectors pET22b+ and 
pGEX2T cPk used for the expression o f Nuclear Factor I in bacteria.
The cDNA encoding for the 222 amino terminal of Nuclear Factor I was inserted in the 
restriction sites Ncol and EcoRI in the vector pET22b+ and BamHI and EcoRI in the 
pGEX2TcPk. The green arrow represents the promoter involved in the expression of 
the inserted gene. Red and orange boxes represent the protein expressed after induction 
with IPTG and the blue boxes represent other proteins expressed by the vector in the 
bacteria.
81
During the process of export of the protein, the localisation signal is cleaved off from 
the protein by a specific peptidase.
The vector pGEX2T cPk was derived from the vector pGEX2T (Smith and Johnson 
1988). This vector had the coding region of a portion of the P protein of the Simian 
Virus (SV5) for which a monoclonal antibody is available (Pk). The coding region of 
the antibody binding site was inserted at the 3’ end of the multiple cloning site. In this 
vector, Nuclear Factor I is expressed as a fusion protein with the glutathione-S- 
Transferase at the N terminus which allows purification by affinity chromatography on 
immobilised glutathione and the Pk site at the C terminus. Protein expression is under 
the control of the lactose promoter which is inducible by IPTG.
I .l Construction of the bacterial expression vectors.
The coding region for NFIDBD was amplified using the polymerase chain reaction 
(PCR). The template was the original CTFl plasmid obtained from Dr. R. Tjian 
(Santoro et al, 1988). Primers used in the PCR for the cloning into the pET22 system 
had an Ncol site at the 5' end of the gene which kept the coding sequence of NFlDBD 
in the same reading frame as the localisation signal. The reverse primer had a stop 
codon followed by a Eco RI restriction site.
Primers used in the PCR for the cloning of NFIDBD into pGEX2T contained a BamHI 
site at the 5' end and the coding sequences of the first six residues of IkBa inserted 
after the thrombin coding sequence. The expressed GST-lKBa was found to be 
efficiently cleaved by thrombin. It was expected that by adding these six residues from 
the N terminal region of iKBa between NFIDBD and the thrombin cleavage site, the 
fusion protein GST-NFIDBD would be more sensitive to proteolysis by thrombin. The 
reverse primer possessed an EcoRI site and the reading frame for the Pk antibody 
recognition site was not altered. Therefore a codon encoding for a glycine residue was 
added between the NFIDBD coding region and the EcoRI restriction site.
Analysis of the PCR products revealed a single band of DNA migrating with the 
expected mobility in an agarose gel. Vectors and PCR products were digested using
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appropriate restriction enzymes: Ncol and EcoRI for cloning into pET22b+, BamHI 
and EcoRI for cloning into pGEX2T. Ligation products were used to transform 
competent E. coli XLl Blue strain (chemically prepared competent E. coli). Colonies 
resistant to ampicillin were individually picked and grown to obtain a small scale 
preparation of plasmid DNA. The presence of the cDNA encoding for NFIDBD in the 
vector was checked in each plasmid.
1.2 Protein expression and purification in bacteria
1.2.1 Expression and purification of NFIdbd
For protein expression using the pET22b-t- vector, the plasmid had to be transformed 
into a special strain of bacteria which expressed the T7 RNA polymerase. The bacterial 
strain BL21 (DE3) is an&  coli strain in which the T7 RNA polymerase, inserted into 
the chromosomal DNA, is under the control of an inducible lactose promoter. By 
adding IPTG to the media, the T7 RNA polymerase is expressed which then 
specifically transcribes genes which are under the control of a T7 promoter.
NFIDBD expression was obtained by the addition of 1 mM IPTG into the media of the 
transformed bacterial culture when the culture reached an OD of 0.6 at 600 nm. The 
culture was incubated for a further 4 hours at 37°C. Total bacterial lysates were 
analysed by SDS PAGE followed by staining with Coomassie Brilliant Blue (figure
1.2). In the presence of IPTG, a polypeptide was detected with an apparent molecular 
weight of about 30 kDa.
To lyse the cells, bacteria were treated by lysozyme (0.7 mg/ml) and their membranes 
disrupted by Triton X-100 and sonication. The lysate was then centrifuged to separate 
insoluble and soluble material. The insoluble fraction was resuspended in a buffer 
containing a strong detergent (1% SDS in PBS). Each fraction was analysed by SDS 
PAGE.
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Figure 1.2 Induction and purification of NFiDBD expressed from the vector pET22b+.
Transformed BL21DE3 with pET22b+ NFIDBD was grown and induced for 4 hours at 37°C 
with 1 mM IPTG. Proteins in an aliquot of the non induced (NI) and of the induced (I) bacterial 
culture were separated on a 12 % SDS PAGE and the proteins stained with Coomassie blue. The 
bacterial culture was harvested and bacteria lysed in gentle condition. The bacterial extract was 
centrifuged to separate the soluble material (SN) and the insoluble material (IB) which was 
resuspended in PBS suplemented with 1% SDS. An aliquot of the soluble (SN) and insoluble 
material (IB) was also loaded in the gel. M are the protein markers and the molecular weight of 
each marker is indicated in kDa.
Almost all of NFIDBD was detected in the insoluble fraction. Furthermore the protein 
migrated with an apparent moleculai* weight of 30 kDa while NFIDBD alone migrated 
with an apparent molecular weight of 27 kDa, suggesting that the pelB export signal 
was not cleaved and that NFIdbd was not exported to the periplasmic region of the 
bacteria.
In other experiments, NFIDBD could not be detected in a periplasmic fraction (data not 
shown). Induction of protein expression at lower temperature (20°C) or with lower 
amounts of IPTG did not affect significantly the solubility of the protein.
1.2.2 Expression and purification of GST-NFIdbd
Protein expression of GST-NFlDBD was induced in E. coli XLl Blue strain at 20°C 
with 0.4mM IPTG. Analysis by SDS PAGE, a lysate from IPTG induced bacteria 
showed the appearance of a polypeptide with an apparent molecular weight of 55 kDa 
(figure 1.3 A).
In a similar fashion as described above, proteins in the soluble and insoluble fraction 
were separated on a SDS PAGE (figure 1.3A). Although most of the GST-NFlDBD 
was detected in the insoluble fraction, some protein was also present in the soluble 
fraction. Therefore the soluble GST-NFlDBD was purified by affinity chromatography 
on immobilised glutathione. Specifically bound protein was eluted by competing by 
free glutathione (lOmM). An aliquot of each fraction was analysed by SDS PAGE 
(figure 1.3B).
The protein GST-NFlDBD could be detected in all the various fractions but the amounts 
of protein varied. Most of the fusion protein was unable to bind glutathione and was 
found in the flow through fraction (lane FT). DNA binding activity of NFlDBD could 
also be detected in this fraction. A very small fraction of the GST-NFIDBD bound to 
the column.
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Figure 1.3 Expression and purification of GSTNFIDBD expressed in E.coli.
Expression of GST-NFTDBD was induced with 1 mM IPTG and incubated for 4 hours before 
harvesting the cells. An aliquot of the bacteria were lysed with 1%SDS in PBS from an extract 
before (NI) and after 4 hours induction (I) and proteins were separated on a 12% SDS PAGE 
which were stained using Coomassie blue. Bacteria were harvested and lysed. Insoluble (IB) 
and soluble (SN) material were separated by centrifugation (figure A).
The GST-NFIdbd in the soluble fraction was purified onto a glutathione agarose column (figu­
re B, LO and FT), the column was washed (W) and the bound protein eluted by adding 10 mM 
glutathione in the buffer (E l). The eluted GST-NFlDBD was treated for 2 hours with thrombin 
(E2). M are the protein markers and the molecular weight of each marker is indicated in kDa.
The DNA binding activity of the fusion protein GST-NFIDBD in the elution fraction 
was measured by a gel retardation assay (figure 1.4). Various amounts of protein were 
incubated with a dsDNA containing a specific DNA binding site for NFI. Free DNA 
and GST-NFIdbd - DNA complex were separated in a native polyacrylamide gel. 
Between 2 |ig and 200 ng of GST-NFIdbd , the DNA was fully saturated by GST- 
NFlDBD. At 20 ng most of the probe was migrating as the free DNA. However several 
bands could be detected but they did not correspond to any band found at higher 
concentrations, suggesting these were due to non specific binding. 10 ng of active 
NFIdbd is sufficient to saturate the probe. Therefore the amount of DNA binding 
activity of GST-NFlDBD was estimated between 1 and 5 % of the total protein.
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Figure 1.4 DNA binding activity of the GST-NFlDBD.
The DNA binding activity of the GST-NFlDBD bound to the glutathione agarose column, was 
measured by gel retardation assay. The protein concentration was estimated by Bradford and the 
equivalent of 2pg to 0.2ng of protein was used per gel retardation assay. DNA protein complex 
and freeDNA were separated in a 8% polyacrylamide gel with 0.5xTBE for 90 minutes at 150V. 
The gel was dried and exposed on a phosphoimager plate. The amount of protein used in each 
assay is indicated on top of the gel in nanograms.
II. Cloning, Expression and purification of N F Id b d  in  
baculovirus infected cells.
Unlike bacterial expression, previous studies showed that expression of NFIDBD using 
recombinant baculovirus (Bosher et al, 1990) or vaccinia virus (Gounari et al, 1989) 
produced an active and soluble protein. As the DNA binding activity of NFlDBD did 
not seem to be affected by GST in the bacterial expression system (figure 1.4), we 
used therefore the baculovirus system to try to obtain soluble and active GST-NFIDBD.
11.1 Cloning of NFlDBD in pAcG2T and pVL1393.
NFIdbd was cloned into the transfer vectors pAcG2T and pVL1393 in order to obtain 
recombinant baculovirus (figure 1.5). Both vectors contained a bacterial origin of 
replication, an ampicillin resistant gene and a multiple cloning site to insert the requh'ed 
gene under the control of the polyhedrin promoter flanked by baculovirus sequences 
required for homologous recombination. In the vector pAcG2T, the cDNA of NFlDBD 
is inserted at the 3’end of the GST gene.
The coding region of NFIdbd was amplified by PCR using the pGEX2T NFIDBD cPk 
as template constructed in section “ 1.1”. The same 5' end oligonucleotide was used but 
the 3’ end primer recognised the Pk region and contained a BamHI restriction site and 
the sequence encoding a stop codon. Vectors and PCR were digested with BamHI and 
ligated into one another. Ligation mix was transformed into E. coli XLl Blue strain. 
The presence of inserts in the plasmid was checked by digestion using the restriction 
enzyme BamHI and its orientation using EcoRI.
11.2 Production of recombinant baculovirus
The resulting plasmids pAcG2T NFlDBDcPk and pVL1393 NFlDBDcPk were 
co transfected into SF9 cells as described by Kitts et al (1990) with linearised viial 
DNA purified from the recombinant baculovirus AcRK6 (obtained from Prof. Hay).
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Figure 1.5 Schem atic representation o f the vectors pVL1393 and 
pAcG2T used for the production o f recom binant baculovirus
The cDNA encoding for the 222 amino terminal of Nuclear Factor I was inserted in the 
restriction site BamHI of the vectors pVL1393 and pAcG2T. The restriction sites 
EcoRI are also represented which were used for checking the orientation of the insert 
in the vector. In yellow is represented the region of the baculovirus genome required 
for recombination. The green arrow represents the polyhedrin promoter involved in the 
expressionof the inserted gene. Red and orange boxes represent the protein expressed 
and the blue boxes represent the bacterial selection marker.
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This recombinant virus contained the gene encoding for the p gaiactosidase under the 
control of a polyhedrin promoter. Furthermore a Bsu36I restriction site was engineered 
in the ORF 1629 which is an essential gene for viral infectivity. Therefore by 
subjecting the DNA purified from this recombinant virus to digestion using the 
endonuclease Bsu36I, the viral DNA was cleaved twice: once in the ORF1629 and 
once in the p gaiactosidase gene. By cotransfection, two main recombinant viruses 
were produced: either a AcRK6 type virus which would produce blue plaques in the 
presence of X-gal or the required recombinant baculovirus (white plaques). The virus 
was isolated from the supernatant of these cotransfections by plaque assay in the 
presence of X-gal, Clearly separated white plaques on a SF9 monolayer were selected 
and the recombinant virus was used for subsequent infections,
II.3 Purification of NFIDBD
The purification of NFlDBD from recombinant baculovirus infected cells has already 
been described by Bosher et al (1990), NFIDBD was purified from a Sf9 cells culture 
infected for 72 hours using a three steps strategy: in the first step, a nuclear extract of 
these Sf9 cells was prepared. In the second step, NFIDBD was purified by ion 
exchange chromatography and then, by affinity chromatography on DNA immobilised 
in the final step,
NFIDBD cPk was also purified in this fashion. An aliquot of each fraction was 
analysed by western blotting using the Pk antibody (figure 1.6), This revealed that 
NFIDBD bound efficiently to the ion exchange column and to the DNA affinity column, 
A very limited amount of protein was either found in the flow through fractions or in 
the wash fraction of each column. The purification resulted in a pure fraction of 
NFIDBD (figure 1,8C), The addition of these 21 residues from the IlcBa at the N 
terminus and the Pk at the C terminus did not affect the DNA binding activity, 
suggesting that NFlDBD cPk was folded in a similai* way than in the original NFIDBD 
recombinant baculovirus.
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Figure 1.6 Purification of NFIDBD cPk from infected Sf9 cells infected with a 
recombinant baculovirus expressing NFIDBD cPk.
A nuclear extract (NE) was obtained from infected insect cells with a recombinant baculovirus 
expressing NFlDBD. NFlDBD was purified on an anion exchange column and by affinity chro­
matography using a DNA immobilised Sepharose column. Proteins of the loaded (LO), the 
flow through (FT), the wash (W) and the elution (E) fractions were separated on a 12% SDS 
PAGE and blotted onto a PVDF membrane. Proteins on the membrane were probed using the 
Pk antibody and bands were revealed using the enhanced chemiluminescence procedure.
II.4 Purification of the GST-NFlDBD
II.4.1 Purification by glutathione affinity chromatography
For large scale protein purification, Sf9 cells were infected for 48 to 60 hours with the 
recombinant virus expressing GST-NFIDBD. Each stock of virus was tested 
individually for optimal protein expression (see material and methods). An infected cell 
extract was clarified by centrifugation prior to purification of the fusion protein by 
affinity chi'omatography on glutathione agarose. The column was washed and 
specifically bound protein eluted by competition with free glutathione (10 mM) added 
to the buffer. An aliquot of each fraction was analysed on a 10% SDS PAGE stained 
with Coomassie Brilliant Blue (figure 1.7A). A 55 kDa polypeptide corresponding to 
GST-NFIdbd was not detected in the glutathione elution. However examination of the 
stained gel revealed two polypeptide species with appaient molecular weights of 26 
kDa., suggesting that they could represent GST protein.
To identify full length GST-NFlDBD and follow its purification, western blotting was 
performed on each fraction using tlie Pk antibody which recognises the Tag at the C- 
terminus of the protein. The western blot revealed the existence of a polypeptide 
species specifically recognised by the antibody at an apparent molecular weight similar 
to GST-NFIdbd produced in bacteria (figure 1.7B), which did not appear to bind to 
the column, but was present in the flow through of the glutathione affinity column. A 
small amount of immunoreactive material was however detected in the fraction eluted 
with glutathione which was below the level of detection in the Coomassie stained gel.
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Figure 1.7 Purification of GST-NFlDBD expressed in infected Sf9 cells using a
recombinant baculovirus.
The GST-NFlDBD fusion protein was purified by affinity chromatography on a glutathione 
immobilised column. The GST-NFlDBD content in every fraction during purification was fol­
lowed by separating proteins on a 12% SDS PAGE and analysing the various fractions either 
by Coomassie blue staining (A) or by western blot using the Pk antibody (B). GST-NFlDBD 
was also loaded on an ion exchange column. The GST-NFlDBD content of the various frac­
tions were analysed by western blot using the Pk antibody. LO is the load on to the column 
fraction, FT the flow through. NI and I are fractions of non induced and induced E.coli trans­
formed with pGEX2T NFlDBD. W is the wash fraction. 1 and 2 are elution fractions of the 
glutathione immobilised column while 0.4 M and 0.7M represent the salt concentration used 
in the fraction to elute the ion exchange column. M are the protein markers and the molecular 
weight of each is indicated in kDa.
It seems that GST was active but most of the fusion protein was unable to bind 
glutathione. The same purification was performed in the presence of either additives 
(1% Triton X I00, 8 mM CHAPS, 1 M NDSB 201) or in vai'iable NaCl concentration 
(0.2, 0.4 and 1 M). None of these conditions enabled the purification of GST- 
NFIDBD by glutathione immobilised affinity chromatography. Thus GST-NFlDBD 
could not be purified by affinity chromatography on immobilised glutathione.
IL4.2 Purification by anion exchange chromatography
An alternative strategy employing anion exchange chromatography was used. The 
infected cell extract was loaded onto an ion exchange column at 0.2 M NaCl. The resin 
was washed and bound proteins were eluted by raising the NaCl concentration first to 
0.4 M NaCl followed by 0.7 M. An aliquot of each fraction was analysed by Western 
blotting using the Pk tag monoclonal antibody (Figure 1.7C). The vast majority of the 
fusion protein did not bind to the column and was present in both the flow through and 
the wash fraction. A small fraction of protein eluted at 0.4 M NaCl and also some in 
0.7 M NaCl.
II.4.3 Purification of NFlDBD after treatment of thrombin
NFlDBD could be purified only after treatment of the fusion protein with thrombin. The 
GST-NFIdbd was dialysed to remove any protease inhibitors and to lower the salt 
concentration to 0.2M. The GST-NFlDBD was treated with thrombin for 3 hours. 
NFIDBD could then be purified as described earlier on in section 2.3 (figure 1.8). A 
deal* band eluted from the anion exchange column. On the affinity column, about half 
of the protein did not bind to the column and was detected either in the flow through 
fraction or the wash fraction. Although other proteins were also present, NFlDBD 
represented a large proportion. NFlDBD migrated as a single band with an apparent 
moleculai* weight of 30 kDa while NFlDBD purified directly from the insect cells 
migrated as a doublet with an apparent molecular weight between 30 to 32 kDa.
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200 — Figure 1.8 Purification of NFlDBD after thrombin cleavage by 
ion exchange chromatography and hy affinity chromatogra­
phy on immobilised DNA.
GST-NFIdbd was incubated with thrombin for 4 hours at 20°C. 
NFlDBDwas then purified on an anion exchange column (A) and by 
affinity chromatography as described in section II. Proteins in each 
fraction were separated by SDS PAGE ( 12%) and the gel was stained 
with Coomassie blue.
In (C), the molecular weight of NFlDBD expressed as a fusion pro­
tein with GST and purified as above (lane 2), was directly com­
pared on a SDS PAGE to NFlDBD expressed alone in infected in­
sect cells and purified in figure 1.6 (lane 1).
M are the protein markers and the molecular weight of each marker 
is indicated in kDa.
III. Summary and conclusion
In an attempt to obtain active protein, we tried two expression systems. In bacteria the 
protein was either insoluble or the amount of active NFIDBD was very low. Using 
baculovirus we could purify active NFIDBD. However the NFlDBD produced as a 
fusion protein was difficult to purify and involved the removing of the GST. If 
produced alone, NFlDBD produced a variety of polypeptides with different molecular 
weights (mainly a doublet). The apparent molecular weight was slightly higher than 
expected. The reason for heterogeneity in the protein preparation is still unknown. No 
post translational modification has yet been found for the DNA binding region of NFI. 
It was suspected that the doublet was due to proteolysis. However this method remains 
the only available and convenient source of pure and active NFlDBD.
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Chapter 2 : The folding in vitro ofNuclear Factor I DNA Binding Domain expressed in bacteria
Expression of proteins in bacteria is inexpensive and convenient compared to using the 
baculovirus expression system. As previously shown, NFlDBD produced in bacteria 
produced homogenous protein which could be easily purified. Therefore, we 
investigated if this protein could be folded into an active protein. Earlier research did 
show that CTF 1 could be renatured from bacterial inclusion bodies by dialysis 
however this work only described the production of very limited amount of protein (at 
most micrograms, Amemiya et al, 1994). Similarly NFlDBD was renatured by dialysis 
but this was carried out using a fusion protein with GST (Coenjaert et al, 1994). The 
work presented in this chapter is an investigation of the expression and the optimal 
condition for renaturation of NFlDBD.
I. Construction of a vector for the expression of NFIDBD.
The pET LS NFlDBD expression vector described in chapter 1, expresses a fusion 
protein of NFlDBD fused to a periplasmic localisation signal at its N terminus. To 
obtain a vector expressing only NFIDBD, the periplasmic coding sequence was 
digested out of the vector by using the restriction enzymes Nco I and Nde I (figure 
2.1). The cohesive ends were filled in using the DNA polymerase (Klenow fragment). 
This construct was religated with T4 ligase which enabled us to express NFIDBD 
proteins (pET NFlDBD).
The pET 22b+ vector also contains a sequence coding for a six histidines residues at 
the C terminus of a protein. Adding these residues could allow protein purification 
under native and denaturing condition, in addition to providing an epitope tag. There
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were two major problems in the construction of a vector expressing NFlDBD fused to 
the C terminus of 6 histidines (pET NFlDBD Tag) : first the nucleotides GA in the Eco 
RI restriction site was part of the stop codon of the NFlDBD gene and had to be 
removed, secondly the sequence coding for the 6 histidines had to be fused to NFlDBD 
in the same reading frame.
Nde I Nco I
p elB
pET LS N H  DBD
N F ID B D
Eco RI Xho I
6 Histidine
1. Nde I / Nco I
2. DNA polymerase (Klenow)
3. T4 ligase
pET N H  DBD
N F ID B D
Eco RI Xho I
6  Histidine
1. Eco RI / Xho I
2. Mung Bean Nuclease
3. T4 ligase
t
pET N H  DBD Tag
N F ID B D 6  Histidine
Figure 2.1 Construction o f expression vector pET NFI DBD and pET
NFI DBD Tag.
The coding sequences are represented by color boxes, the localisation signal (pelB) in 
pink, the NFI D B D  in green and the 6 histidines in blue. The first cloning step was to 
construct pET NFI D B D  to express NFI D B D . The second cloning step was to construct 
pET NFI D B D  cTag which expresses NFI D B D  fused to 6 histidines residues at the C terminus of the protein.
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Hence the easiest way to obtain the new construct was to digest the pET NFlDBD using 
Eco RI and Xho I restriction enzymes and the cohesive ends digested using mung bean 
nuclease to produce a blunt ended vector. This procedure changed the stop codon 
(TGA) into a TGG sequence coding for a tryptophan while putting in frame the six 
histidines sequence. The vector was religated with T4 ligase.
To identify positive clones expressing NFIDBD - 6 histidines, competent BL 21 (DE3) 
were transformed. Bacteria from individual colonies were screened by western blotting 
using a monoclonal antibody recognising the 6 histidine sequence at the C terminus of 
the protein (Invitrogen).
II. Expression and purification of NFIDBD (and NFIDBD  
Tag)
NFIDBD was expressed in E. coli BL21 (DE3) strain. The expression was induced by 
ImM IPTG as described in chapter 1. Growth of bacteria and induction of protein 
production were performed at 37°C. When total cellulai* proteins were analysed by 
Coomassie blue staining of SDS PAGE, an induced species with an estimated 
molecular mass of 26 kDa was detected. As previously shown, the protein was found 
in the insoluble fraction. To purify the inclusion bodies, bacteria were treated with 
lysozyme and their membrane disrupted by Triton X-100 and sonication. DNA was 
digested by the addition of DNase and MgCl2. Soluble material and inclusion bodies 
were separated by centrifugation and the pellet washed with PBS supplemented with 
1% Triton X-100 (v/v). To solubilize the inclusion bodies, various concentrations of 
urea and guanidine were tried (2, 4, 6 and 8M). Soluble and insoluble fractions were 
separated by centrifugation at 50 000 g.
NFIDBD remained insoluble in urea even when using a 8 M concentration (figure 2.2). 
Instead in 6 M guanidine, NFIDBD was soluble, while most contaminant proteins 
remained insoluble. At this stage, NFlDBD was thus the major protein in this fraction.
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Figure 2.2 Expression and purification of Nuclear Factor I from BL21 (DE3).
NFlDBD was expressed in E.coli transformed with pET22b NFlDBD. NFlDBD was expressed by 
adding 1 mM IPTG to the bacterial culture. Total protein content in an aliquot of the bacterial 
culture before (NI) and after 3 hours addition of IPTG (I), was analysed on a 12%SDS PAGE. 
The bacterial culture was harvested by centrifugation and resuspended in extraction buffer. 
Soluble(SF) and insoluble proteins were separated by centrifugation. As NFlDBD was in the 
insoluble fraction, solubility in the presence of 6M guanidine or 8M urea was tested. The inclu­
sion bodies were resupended in the dénaturant for 2 hours, and insoluble (IM) and soluble mate­
rial (SM) were separated by centrifugation. Each fraction was analysed by SDS PAGE. Proteins 
were stained with Coomassie blue. As NFI was not soluble in urea, the pellet was washed (W) 
with water and the pellet solubilised with 6M guanidine. Insoluble proteins were separated 
from the soluble proteins (SP) by centrifugation. The proteins in this pellet were resuspended by 
PBS supplemented with 1% SDS (IP). Lane M are the protein markers and the molecular weight 
of each marker is indicated in kDa.
III. Renaturation assay and interpretation of results.
This section describes the renaturation assay used in this study and the method to 
quantify yield of folded NFlDBD.
Figure 2.3 shows the main steps of the renaturation procedure. The renaturation 
solution was added to the bottom of an eppendorf tube. A small volume of NFlDBD 
solution in denaturing buffer was laid carefully on the side of a tube. It was then mixed 
to the renaturation solution by vortexing vigorously for 10 seconds. The folding mix 
was then left overnight at 4 °C without stirring.
A gel retention assay was performed to determine the proportion of functional NFI in 
each renaturation test. NFlDBD was incubated with a radioactively labelled 
oligonucleotide which contained a specific binding site for NFI. (To quench any non 
specific DNA binding which may occur with improperly folded NFI, an excess of non 
specific oligonucleotide was present).
NFI-DNA complex was separated from free DNA in a native polyacrylamide gel. Gels 
were analysed quantitatively using a phosphoimager. The more slowly migrating 
species represented the DNA-protein complex while the free DNA migrated close to the 
dye front. The yield of correctly folded, and hence active, NFI in each renaturation 
assay was detennined by estimating the radioactivity present in the DNA - protein 
complex compared to the total radioactivity in each assay.
Our preliminaiy results showed that the folding yield was critically dependent on 
experimental parameters. We therefore decided to investigate these parameters in order 
to optimise the folding yield.
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1i
,NF I BDB in denaturing buffer
(6M guanidine, 50mM Hepes pH 7.5, 25 mM DTT)
Renaturing solution
(50 mM Hepes pH 7.5, 1 M guanidine, 5 mM DTT, I M NDSB)
The protein and the renaturing solution 
are stirred vigorously 10 seconds
The mix is then incubated overnight at 4°C
Renaturation solution with NF I DBD  at a concentration o f 0.1 mg/ml
Figure 2.3 Schematic representation of the renaturation assay.
The folding of NFI DBD was performed by rapid dilution. In step 1, both solutions 
were added to an eppendorf tube but not mixed. In step 2, the protein was mixed to the 
renaturation buffer by vigorous vortexing. The protein was left to incubate overnight in 
in the renaturation buffer (step 3).
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IV. Renaturation of NFIDBD using non detergent 
sulphobetaine
A new family of chemicals was found to increase folding yield of protein (Vuillard et 
al, 1998, Goldberg et al, 1996). These chemicals known as non detergent 
sulphobetaines (NDSB), were made by reacting propane sultone to an amine which 
produced different types of NDSB depending on the amine used. However all NDSB 
share similar properties which aie : i) water soluble (up to 60 %), ii) improve yield in 
protein renaturation and purification by increasing protein solubility and by reducing 
aggregation, iii) zwitterionic molecule that could be used at pH between 3 and 12, and 
iv) compared to detergent, they are non denaturing and easily removed by dialysis.
The chemical structure of the various NDSB family members (figure 2.4) shows two 
distinct regions :
A hydrophilic region similar in all NDSB containing a sulphonate group separated by a 
thiee carbon arm from a quaternary ammonium. In solution, it is supposed that the 
negatively charged oxygen from the sulphonic group might interact with the positive 
ammonium thus forming a six membered ring. The other region is hydrophobic and is 
variable between NDSB. A whole range of NDSB exists with a small hydrophobic 
region such as in NDSB 195 to a larger one such as seen in NDSB 256.
The effect of five different NDSB were tested in NFlDBD renaturation : with NFIDBD, 
NDSB 195 decreased the amount of renatured NFlDBD by 50% while NDSB 201 and 
223 did not improve the folding yield. Both forms of NDSB 256 increase renaturation 
up to 300% compared to the control (Figure 2.5).
With NFIDBD Tag, the effect was different. NDSB 195 had no effect, while 201 and 
223 increase renaturation 200% and both forms of NDSB 256 by 400%. However the 
yield in the control experiment was 2 times lower using NFlDBD Tag compared to 
NFIDBD.
NDSB 256 increased significantly the folding yield of NFlDBD and NFlDBD Tag. In 
further experiments, NDSB 256 tertio butyl was chosen to do the renaturation assay.
104
NDSB 195
N " SO3'
NDSB 201
SO]'
NDSB 223 /  \  
° \_____ SO]-
NDSB 256 teitio butyl (NDSB 256t)
SO]
NDSB 256 phenyl (NDSB 256p)
Figure 2.4 Schematic representation of the chemical structure of the 
various Non Detergent Sulphobetaine used in this study.
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Figure 2.5 E ffect o f various Non D etergent Sulphobetaines on the 
fo ld in g  y ie ld  o f NFI DBD  and NFI DBD Tag.
The folding yields were determined by gel retention assay of the renaturation assay in 
the presence of different NDSB (195, 201, 223, 256t, 256p) at a concentration of IM 
as described in the text. Blue columns represent the renaturation of NFI DBD while red 
columns represent NFI DBD Tag. The yield was an average of three independent 
renaturation assays. P/Po is the fraction of bound DNA to the total amount of DNA added in each assay
V. Determination o f the optim al condition for NFIDBD  
renaturation.
Various parameters in the renaturation assay were tested in order to determine which 
condition allowed an optimal folding yield. Substitution of NDSB by related chemical 
was also investigated.
V .l  Ionic strength
Ionic strength is critical for NFlDBD stability. Purified NFlDBD precipitates at an ionic 
strength of 0.1 M. To determine the effect of guanidine on refolding in vitro, NFlDBD 
was renatured in concentration ranging from 2 to 0.25 M guanidine.
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At 1 M guanidine, the renaturation of NFlDBD was optimal but remained high at 
concentration of 0.75 M guanidine (figure 2.6). When folding was performed in 0.25 
M guanidine, there was a sharp decrease in yield (up to 3 times) compared to 1 M. As 
expected, increasing the guanidine concentration was also detrimental for the folding of 
NFlDBD. The guanidine affects both the ionic strength but is also a dénaturant and 
probably affects the structure of NFlDBD at higher concentration.
An experiment was also performed where the guanidine was replaced by NaCl. Similar 
results were obtained, however the folding reached a plateau (instead of a peak) at 
concentration of NaCl between 0.75 and 2 M.
Although no difference in refolding yield was observed using NaCl instead of 
guanidine, one has to bear in mind that guanidine is a chaotropic salt and affects the 
solution.
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F igure 2.6 Effect o f the guanidine concentration on the folding of NFI 
DBD and NFI DBD Tag (A) and com parison o f NaCl and guanidine 
concen tration  on fold ing o f NFI DBD cTag (B).
(A) The renaturation was done in concentration of guanidine varying between 2M and 
0.15M. Blue column represent the renaturation of NFlDBD while red column 
represents NFlDBD Tag (previous page). This experiment was repeated twice.
(B) The folding yield of NFlDBD Tag was compared using either NaCl or guanidine in 
the renaturation buffer used at concentration between 2 and 0.25 M. The black line 
represents the renaturation in the presence of NaCl and in red, in the presence of 
guanidine. This experiment was done only once.
V .2  E ffect o f  the protein concentration in the renaturation assay
It must be pointed out that protein concentration was determined using the 
“Bradford’s method” with BSA as standard. This is valid for comparison purpose but 
may not reflect on the real protein concentration.
The final protein concentration was varied between 0.5 and 0.01 mg/ml in the 
renaturation assay. Both NFlDBD and NFlDBD Tag gave similar results (figure 2.7). 
The yield of renatured protein peaked at a concentration of 0.1 mg/ml. At a 
concentration of 0.25 mg/ml, the folding yield decreased to a half and by 4 fold at a 
concentration of 0.5 mg/ml.
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In more diluted assay, the renaturation also decreased although not as dramatically. 
However if the protein was very dilute (0.01 mg/ml), virtually no refolded protein was 
detected.
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Figure 2.7 E ffect o f the protein concentration on the folding yields o f
N F I DB D and N FI DBD Tag.
NFI DBD and NFI DBD Tag were folded at a final protein concentration ranging from 
0.5 to 0.01 mg/ml in the renaturation solution. The folding yield was determined by 
using 100 ng of protein per gel retention assay. Blue column represents the folding 
yield of NFI DBD and in red the folding yield of NFI DBD Tag. The results are from one experiment.
V .3  E ffect o f  pH in NFlDBD fo ld ing
The pH mainly affects the charges of acidic and basic residues in the protein. 
Renaturation assays were performed in pH ranging from 4.7 to 10.4. Our choice of 
buffer used for this experiment dictated the pH studied. The pH was set at the pKa of 
the buffer to ensure maximum buffering capacity and that the amount of acid or base 
added did not vary between buffers (and the ionic strength). There was however one 
exception : at pH 7, Bis Tris propane was used (pKa2 @ pH 6.8). Maximum
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renaturation was observed at pH 7 (figure 2.8), but remained high at pH 7.5, 8.1 and 
9. There was a four fold decrease in renaturation yield if the pH was lowered from 7 to
6.1 and even stronger between pH 9 and 10.4.
P/PO (%) 
80 
70 
60 
50 
40 
30 
20  
10 I k
4.7 6.1
jHrnïïïïi
7.5 8.1 9.1 10.4
pH
Figure 2.8 E ffect o f pH on NFI DBD and NFI DBD cTag folding
The renaturation were performed at the stated pH on the graph as described in the text. 
Each renaturation assay were performed using the following buffer at the concentration 
of 50 mM :
pH 4.7 with acetic acid/NaOH
pH 6.1 with MES/NaOH
pH 7 with Bis Tris Propane/HCl
pH 7.5 with Hepes/NaOH
pH 8.1 with Tris/HCl
pH 9.1 with Bis Tris Propane/HClpH 10.4 with CAPS/NaOH
The gel retention assay was performed in 50 mM Hepes pH 7.5 as described in 
material and methods. Blue column represent the folding of NFI DBD and in red, the 
folding of NFI DBD Tag. The results are from one experiment.
To ensure that an effect of pH was not masked by the high ionic strength in the 
renaturation buffer, the same experiment was performed by substituting IM guanidine 
by 0.25 M NaCl. The folding yield in 0.25M NaCl was three times lower than in IM 
guanidine. Except for pH 7.5, the same pH dependence (figure 2.9) was observed.
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However at each pH, the refolding yield was still 3 times lower for each pH tested 
compared to the refolding done in the presence of 1 M guanidine. This is unfortunate 
as it means that the protein solution would need to be diluted significantly before the 
next step in the purification of NFlDBD.
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Figure 2.9 E ffect o f pH on NFI DBD folding at 0.25M  NaCl.
NFI DBD folding was performed in the presence of 0.25M NaCl instead of IM 
guanidine. Renaturation was performed as described in figure 2.8. Folding yields were 
determined by gel retention assay as described earlier. Each assay was performed in only once.
V .4  Influence o f  Temperature
Two slightly different approaches were chosen to study the influence of temperature on 
the renaturation. In both experiments the renaturation buffer was incubated at the stated 
temperature. Following mixing, in the first experiment, the protein was immediately 
incubated at 4°C. In the second experiment the renaturation assay was incubated for a 
further 1 hour at the stated temperature.
i l l
The folding of the protein by quick dilution can schematically be divided in two stages. 
Initially the protein is unfolded as a strand and collapses forming a molten globule by 
mixing NFlDBD in the renaturation solution. In a second stage, the protein rearranges 
itself to form active protein, the first event occurs in milliseconds while the next step 
can take up a few minutes to several hours. The first experiment is to study the 
influence of temperature on the collapse. In the second experiment the influence of 
temperature is tested in the rearrangement process.
The temperature studied were -10, 0, 10, 20 and 37°C. Temperature did not influence 
significantly the renaturation yield of NFlDBD (figure 2.10). Folding yield remained 
the same thought out the temperatures tested except when the renaturation assay was 
further incubated at 37°C, which resulted in a three fold decrease in yield (figure 2.10).
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Figure 2.10 Influence o f tem perature on NF I DBD Folding
Renaturation was performed at the stated temperature under standard conditions. The 
renaturation solution was either left overnight at 4°C (green columns) or incubated for a 
further hour at the stated temperature (red columns).The results are from only one assay.
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V .5 E ffect o f  reducing agent
NFlDBD is very sensitive to red-ox conditions and requires the presence of a reducing 
agent in order to be active. The effect of the type of reducing agent and its optimal 
concentration in the folding procedure were investigated.
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Figure 2.11 E ffect o f reducing agent in the fold ing o f NFI DBD.
Inclusion bodies were resuspended with 25 mM of the studied reducing agent for 2 
hour prior to renaturation. Renaturation were performed as described before
supplemented with DTT (green columns) or p- Mercaptoethanol (purple column) at a 
concentration ranging between 0.5 to 10.5 mM. The results are from one assays at 
each concentration.
In this experiment, NFlDBD Tag was used as it may be used for purification purpose 
on a Nickel column. NFlDBD Tag was dissolved in denaturing condition with either 25 
mM DTT or 25 mM (3-mercaptoethanol. The protein was then renatured in the presence 
of varying concentration of reducing agent. The final concentration of the reducing 
agent ranged between 0.5 and 10.5 mM. Figure 2.11 shows that the optimal 
concentration of DTT was 1.5 mM and did not fluctuate significantly between the 
different concentrations used. With p -  mercaptoethanol, the yield of folding was
113
concentration dependent. The yield increased with higher concentration of (3— 
mercapoethanol to reach a peak at 5.5 mM. Nevertheless, in |3-mercaptoethanol, 
folding was not as effective as in DTT.
V.6 Dilution versus dialysis
Dialysis is often suggested as a way to renature protein but the intermediate form of the 
protein tends to aggregate with long residence times in renaturation buffer. Dialysis has 
successfully been used with NDSB 201 to fold the protein complex HDH/Ku (Ochem 
et al, 1998). The principle of this method is that guanidine, being a significantly 
smaller molecule than NDSB, would diffuse faster in the dialysis buffer and the protein 
is left without guanidine but with NDSB.
NFIDBD was diluted before dialysis to 4 M guanidine, 1 M NDSB 201, 50 mM Hepes 
pH 7.5 and 25 mM DTT. Dialysis was tried at 0.5 mg/ml and 0.25 mg/ml NFlDBD, 
The dialysis buffer was the same as the renaturation buffer. At the same time, a quick 
dilution renaturation assay was performed using the same protein concentration to 
compare both methods.
As shown in figure 2.12, both methods gave very different results. The yield achieved 
by dialysis at both protein concentrations tested was 4 times lower than when using the 
quick dilution procedure (folding yields were 16 % by dialysis and 64 % by quick 
dilution).
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Figure 2.12
R enaturation by quick dilution versus dialysis
NFI DBD was renatured either by quick dilution (blue columns) or by dialysis (orange 
columns) at a final concentration of 0.5 mg/ml or 0.25 mg/ml. The folding yields were 
determined by using 1 microliter of each renaturation into a gel retention assay and 
analysed as described previously. This experiment was performed twice with very 
similar results
V I. Renaturation using detergent
Two different types of detergent were studied for their ability to influence the folding 
yield of NFlDBD. CHAPS is a zwitterionic detergent, chemically similar to NDSB, but 
with a much larger hydrophobic region. A non ionic detergent was also tested, n- 
octylglucoside (OPG), which is a pyranose with a 8 carbon chain on Cl of the sugar. 
The concentration of each detergent used in the renaturation buffer was dictated by the 
critical micelle concentration (CMC). CMC is the concentration at which detergent 
forms micelles. CHAPS has a CMC of 4 to 8 mM and therefore was tested at 8 and 80
115
mM, whereas OPG having a CMC of 14.5 was tried at 15 and 150 mM. The 
renaturation assay was done in parallel with NDSB, so folding yield could be 
compared.
In the presence of CHAPS, folding yields were respectively 77 % and 63 % (figure 
2.13). These figures were very similar to the yield obtained with NDSB 256 which 
gave a folding yield of 75 %. In the presence of OPG in the renaturation buffer, the 
yields were much lower (2 and 19%) even compared to the control which had no 
additive (20%).
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Figure 2.13 Folding yield using detergents CHAPS and OPG
Renaturations were performed as in figure 2.5 except that NDSB was replaced by 
either CHAPS (8 and 80 mM) or OPG (15 and 150 mM). For comparison purpose, 
renaturation in the presence of no additive and 1 M NDSB 256 were also performed. 
The yields are an average of three renaturation assays.
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VII. In vitro folding of NFI ; an overview
The optimal conditions did not vary significantly between NFlDBD and NFIDBD Tag. 
However with the latter form of the protein, the yields were never as good. The 
optimal conditions for folding NFIdbd were very sensitive to specific conditions. 
These were the ionic strength which should be kept at about 1 M guanidine or NaCl, a 
final protein concentration of 0.1 mg/ml, a pH of 7, DTT at 1 mM and either 1 M 
NDSB 256 or 8mM CHAPS. Folding should be performed using the quick dilution 
procedure.
VIII. Renaturation and purification of large amount o f 
NFIDBD
Large scale folding and purification scheme of NFlDBD is shown in figure 2.14. 
Purified inclusion bodies from induced bacteria were resolubilised in dénaturation 
conditions and NFIDBD was folded in the buffer described. Before purification, the 
guanidine concentration had to be lowered to 0.3M guanidine so that the protein could 
either be purified by affinity or by ion exchange chromatography. The renaturation 
buffer was diluted by stirring the renatured protein solution and pouring in a buffer 
without salt. More gentle methods were investigated to reduce the salt concentration : 
dialysis, concentration of protein by ultra centrifugation before dilution and purification 
on a nickel column. None of these methods improved the yield (data not shown). 
These other methods had major inconveniences (volume, slow and presence of DTT) 
and were left out.
To purify NFlDBD, the protein was loaded onto an affinity chromatography column as 
described in chapter 1 at a flow rate of 1 ml per min. The column was washed and 
NFIdbd was eluted in IM NaCl. Most of the NFIDBD was in the flow through fraction 
(compare LO and FT in the SDS PAGE). The wash removed all of the contaminant 
protein remaining and a homogenous fraction of NFIDBD was recovered in the
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fractions eluting with IM NaCl. All of the NFlDBD with DNA binding activity bound 
to the column as no NFlDBD was detected in the flow through or the wash fraction 
(figure 2.15). The DNA binding site on the column was therefore not saturated. It is 
important to note that as low as 0.5 ng per microliter can be detected by a gel retention 
assay. Thus the DNA affinity column is an excellent step to separate active and inactive 
NFIdbd .
Using the affinity chromatography is in fact time-consuming as the renaturation is 
diluted and lar'ge volumes are being handled. Therefore other means of purification 
were investigated. The most obvious one was to use ion exchange chromatography. A 
strong anion exchange resin was chosen which can withstand fast loading capacity 
(750 cm/hr) (Pharmacia SP Sepharose Fast Flow). The column (1.5 cm2) was loaded 
at 10 ml/mrn at 0.3M NaCl. The column was washed and eluted fractions were 
analysed both by SDS PAGE and gel retention assay. The majority of the protein did 
not bind on the resin (figure 2.16A and B). On the gel retention assay, the active 
protein bound to the column (> 95%) and eluted in the IM NaCl buffer.
NFIdbd was further purified by affinity chromatography. Suprisingly all of NFIDBD 
bound to the affinity column, suggesting that only properly folded NFlDBD bound to 
the ion exchange resin. Although the fraction is not as pure as in the previous 
purification, the protein extract was in this case not perfect. This problem could be 
solved by using a more homogenous extract of NFIDBD.
From 150 mg of protein extract, 1.9 mg of pure protein was obtained in renaturation of 
NFIdbd Tag in the presence of NDSB 201. It is expected that the final folding yield in 
IM guanidine with no added additive should about 2 % while in the presence of NDSB 
256 it reached at least 5 % for NFlDBD.
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Figure 2.14 procedure used to purify rn vitro folded NFI with DNA binding activity after renaturation
RENATURATION Renaturation Buffer ;
50 mM Hepes pH 7.5 
0.7 M NaCI 
I mM DTT 
I M NDSB 256c
NFI DBD added to a 0.1 mg/ml 
Stirred for 5 mins. Stop stirring. 
Incubate ovemishc at 4°C
I
DILUTION Renaturation assay diluted to [NaCl] = 0 3  M 
in 50 mM Hepes pH 75, 1 mM DTT
Affinity chromatography
Equilibration buffer : 50 mM Hepes pH
7 5 ,0 3  M NaCl 1 mM DTT
Loading at 1 mi/min
Wash buffer : 50 mM Hepes pH 7.5, 
0 3 M N aC lIm M D T T
Elution buffer : 50 mM Hepes pH 7.5, 
IM N aQ , IraM DTT
PU RIFICATIO N
Ion Exchange chromatography
Equilibration buffer : 50 mM Hepes 
pH 7 5 ,0 3  M NaQ, 1 mM DTT
Loading at 10 mi/min
Wash buffer : 50 mM Hepes pH 7.5, 
0 3 M N aC llm M D T T
Elution buffer : 50 mM Hepes pH 75 , 
lM N a a ,lm M D T T
Affinity chromatography
SDS PAGE 
Gel Retention Assay
Analysis of the fractions
Equilibration buffer : 50 mM Hepes pH i
7 .5 ,03  M NaQ, I mM D ÎT  |
I
Loading, at 1 mi/min |
Loading buffer : 50 mM Hepes pH 7.5, 
0.25 M NaCl, 1 mM DTT
Wash buffer : 50 mM Hepes pH 7.5,
03  M NaCl, 1 mM DTT
Elution buffer : 50 mM Hepes pH 7.5,
1 M NaQ, 1 mM DTT
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Figure 2.15 ;Purification of in vitro folded NFI DBD by affinity chromatography.
NFI DBD was renatured and diluted to a salt eoncentration of 0.3M. The protein was 
then loaded (fraction LO) onto a DNA affinity column containing a double stranded 
oligonueleotide with an NFI DBD site. The column was washed (fraction W) and 
fractions (fraction 1 to 6) were eluted in IM NaCl. 10 microliters aliquots of each 
fraction were analysed on a 12% SDS PAGE stained with Coomassie blue (A) and 1 
microliter by gel retention assay (B). FT is the flow through fraction of the column 
during loading of the affinity chromatography. M is the protein standards (MW are 
from top to bottom 175, 83, 62, 47.5, 32.5 25, 16.5, 6.5 kDa)
120
8 MLO FT W
LO FT
lAv; . j  -• ',» MX.    (
M LO FT w  1175 —
wgua#
" M f16.5—
a#NM #Ë0i#NgASM
Figure 2.16 :
Purification of in vitro folded NFI DBD by ion exchange (A and B) and affinity
chromatography (C)
NFI DBD was renatured and diluted to 0.3 M salt coneentration. The protein was loaded 
on an ion exchange column, wash and eluted in 1 M NaCl. The protein was rediluted to 
0.3 M NaCl before purifying it on a affinity column as described in figure 2.15. Fraction 
LO is the fraction loaded on the column, FT is the flow through of the column, W is the 
wash fraction and eluted fraction are numbed. M are protein markers. Gels A and C are 
Coomassie stained 12 % SDS PAGE and B is a gel retention assay.
IX. Comparison of the activity and structure of renatured 
NFIDBD with baculovirus purified NFIDBD.
In this section, the DNA binding affinity and the structure of the renatured NFIDBD 
was compared to baculoviras expressed NFIDBD purified as described in chapter 1.
IX, 1 Comparison of the dissociation rates
To compai'e the affinity for both NFlDBD, a DNA competition assay was performed. 
Both proteins bound to DNA in a gel retention, however, this did not give an idea of 
the protein affinity for DNA. This could only be tested by determining the equilibrium 
constant from the association rate and the dissociation rate. We chose just to determine 
the dissociation rate. This is experimentally more straight forward and gave a better 
idea of the stability of the DNA-Protein complex.
NFIdbd was incubated first with a molai' excess of radioactively labelled DNA 
containing an NFI binding site. Once equilibrium was reached, the preformed DNA - 
NFIdbd was challenged with a 100 fold molai* excess of the same oligonucleotide but 
unlabelled. At different time points, an 20 microliter aliquot was taken and loaded 
immediately onto a mnning non denaturing polyacrylamide gel where bound and free 
DNA were sepaiated. All experiments were performed at 20°C.
As it is difficult to estimate the time for the DNA-protein complex to be effectively 
separated from the free oligonucleotide, the radioactivity in the band corresponding to 
the complex DNA-NFI was compared at different time points with the first time point 
loaded after the addition of the eold oligonucleotide. The percentage of the remaining 
complex DNA-NFIdbd was plotted versus time. The dissociation of the complex 
followed an exponential decay which was very similai' for baculovirus purified and 
refolded protein (figure 2.17B).
To determine the dissociation rate, the time points between 1 and 30 minutes were 
used, as at 60 minutes, the reaction had reached an equilibrium with the competitor 
DNA.
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Figure 2.17
Comparison of the dissociation rate of renatured NFI DBD(Al) and 
baculovirus NFI DBD (A2)
(Al) and (A2) are the gel of the competition assay run. At various time points (0,1, 2, 5, 10, 20, 
30, 60 minutes) an aliquot of the competition assay was loaded on a 8%polyacrylamide gel. The 
gel was dried and analysed by a phosphoimager.
(B) is the percentage of the remaining complex DNA-NFI at various times compared to the 
complex at time 1 minute.
(C) is the plot to determine the dissociation rate
The logarithm of the remaining probe at time x compared to time 1 minute was plotted 
versus time. The slope showed a dissociation rate of 1.2 10’^  per second for the 
baculovirus purified NFlDBD and 7.6 per second for E. coli NFIDBD, which is 
rather similar given the very different expression and purification of the two proteins.
IX.2 Comparison of their structure studied by limited proteolysis
An alternative approach was used to examine the stmcture by studying the digestion 
pattern of NFIDBD subjected to limited proteolysis in native conditions. NFIDBD cPk 
purified from baculovirus infected cells and renatured NFIDBD were incubated with 
chymotrypsin at a ratio from 1:10 to 1 .TOGO (w/w) chymotrypsin to NFIDBD for 1 
hour at 20 °C. Each digest was performed on the free protein and also complexed to the 
DNA. Digestion products were analysed on a SDS PAGE.
Figure 2.18 shows the digestion of each NFIDBD. Both proteins are very resistant to 
the degradation effect of chymotrypsin especially when the protein is bound to a 
specific recognition site on the DNA. The renatured NFIDBD and baculovirus purified 
NFIdbd gave similar patterns in the digestion. A first digestion product was observed 
at about 19 kDa. This digest product was protected from cleavage by DNA. A further 
digest product, which was not protected by DNA was observed around 15 kD at a ratio 
of 1:10 NFIdbd to chymotrypsin. The digest product was not only similar for 
renatured NFIDBD but no other bands were identified than those already mentioned. 
This signifies that the purified NFlDBD from the renaturation was homogenous 
concerning its structure.
Both methods suggest that the renatured NFlDBD has a structure that is 
indistinguishable from that of the baculovirus purified NFIDBD. Furthermore renatured 
NFIdbd binds DNA with an affinity comparable to that of the baculovirus NFlDBD.
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Figure 2.18 comparison of the structure of folded in vitro NFIDBD and NFIDBD puri­
fied from baculovirus by limited proteolysis.
Prior to proteolysis, NFlDBD was incubated with DTT and in (B) with DNA for 30 minutes at 
20°C. Chymotrypsin was added in varying ratio from 1/100 (w/w) of protease to NFIDBD (lane 
1), 1/50 (lane 2), 1/10 (lane 3) to 1/5 (lane 4). The proteolytic reaction was incubated for 1 hour 
at 20°C. The digestion was stopped by the addition at a final concentration of ImM PMSF. In 
the top gel (Al and B 1), the reaction was done on NFlDBD purified from infected insect cells 
using a recombinant baculovirus and in (A2) and (B2), in vitro folded NFlDBD was used. The 
various proteolytic digest products were separated in a 12% SDS PAGE and proteins stained by 
Coomassie blue. Lane C represent NFI incubated with no protease. Lane M 1 are the proteins 
markers (200, 97.5,66,43,29, 18.4, 14.7 kDa.) while M2 are (175, 83, 62, 47.5, 32.5, 25, 16.5,
6.5 kDa)
Chapter 3 : Characterisation of the NFI DNA binding domain by limited proteolysis
In the absence of any high resolution stmctural data on the DNA binding domain of 
NFI, alternative methods have been used to define the functional domains of this 
protein. Site directed mutagenesis experiments did not yield a great deal of information. 
Most mutants produced inactive monomeric proteins even when expressed in HeLa 
cells using recombinant vaccinia viruses (Armentero et al, 1994).
For these reasons, limited proteolysis was used to study the domain organisation of 
NFI. The active protein was subjected to limited proteolysis using various proteases, 
so that the distinct structural domains of NFI could be defined. The protease is thought 
to preferentially recognise residues available in the protein sequence that are in 
unstmctured region of the protein such as flexible loops. By performing the proteolysis 
in the absence or the presence of DNA, residues protected by DNA may be identified. 
The protease digestion products were analysed by SDS PAGE and the various 
fragment obtained were characterised by N-terminal sequencing and mass 
spectrometry. By combining both sets of data, it was possible to precisely detennine 
the position of the cleavage sites.
Digests were initially performed on NFlDBD purified from insect cells infected by 
recombinant baculovirus. However the identification of the digestion sites was difficult 
as the protein had a higher molecular weight than expected and the amino terminus of 
the protein was modified. None of the digestion products identified could be 
sequenced.
As seen in chapter 2, both NFIDBD purified from infected insect cells and NFlDBD 
folded in vitro following expression in E. coli, had a similar chymotrypsin digestion 
pattern. The digestion patterns obtained with trypsin, endoproteinase Glu-C or
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proteinase K were also similai*. Therefore the in vitro folded NFIdbd was used in this 
work as its N terminal group was not blocked.
In this chapter, we used the following conventions: ratios are indicated as weight to 
weight of protease to NFlDBD. Fragments V, T, C and K are proteolytic products of 
the Endoproteinase Glu-C, Trypsin, Chymotiypsin and proteinase K respectively (Mi­
ls the relative molecular weight).
I. Limited proteolysis of NFIDBD using endoproteinase 
G in C
Endoproteinase Glu-C or protease V8, cleaves either after glutamic acid residues in 
ammonium bicarbonate buffer or after acidic residues (aspartic acid and glutamic acid) 
in other buffer conditions. As the digestions were performed in Hepes, it was expected 
that any accessible acidic residues would be susceptible to cleavage.
In the presence of endoproteinase Glu-C, NFlDBD is degraded into fragments of 
moleculai* weight of 19.3 and 19.5 kDa at a V8 to NFIDBD ratio of 1/100 (VI, 
figure 3.1 A). At a ratio of 1/10, the initial product (VO) was completely degraded into 
the VI product. However at higher ratios, a band was detected with the same Mi* as 
VO. This was real as the amount of protease increased from lane 4 to 7 (figure 3.1 A). 
This band does not appear* to be a by product of the protease as it is not seen in the 
digestion of NFlDBD done in the presence of DNA (figure 3. IB lanes 6 and 7). The 
band is probably NFId b d  which is difficult to explain as the NFlDBD was totally 
degraded at a lower amount of protease.
When NFId bd  is complexed to DNA, the degradation into the product VI is protected 
from the protease V8 at ratio (w/w) of 1/100 and 1/50 (a weak band of similar appai*ent 
molecular* weight could be detected from a ratio of 1/10 to 1/1). Instead following a 
similar* cleavage pattern, NFlDBD was degraded into a V2 protein fragment of a
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Figure 3.1; Partial proteolysis with endoproteinase Glu-N of NFI DNA Binding 
Domain(A) and when complexed to a double stranded oligonucleotides with a specific
DNA binding site for NFI(B).
Prior to proteolysis NFI was incubated with 5mM DTT and in (B) with DNA for 30 minutes at 
20°C. Endoproteinase Glu-N was added in varying ratio from 1/1000 (w/w) protease to NFI 
(lane 1), 1/500 (lane 2), 1/100 (lane 3), 1/50 (lane 4), 1/10 (lane 5), 1/5 (lane 6) to 1/1 (lane 7). 
The protease reaction was incubated for 1 hour at 20°C. The protease was inactivated by incuba­
tion for 15 mins on ice with 1 mM PMSF. An aliquot (2 pg) of protein was separated on a 12% 
SDS PAGE and proteins bands revealed by staining with Coomassie blue. The molecular weight 
of each band was determined by mass spectrometry. The mass spectrum is shown to the right of 
each gel. Lane C represent NFI non treated with protease and lane V8 represent the protease 
alone. Lane M are the protein markers and the molecular weight of each marker is indicated in 
kDa. (C) is a schematic representation of the different cleavage sites of V8 in NFIDBD.
molecular weight of 24.2 kDa, (although the signal was poor in the mass spectrometry, 
no other peak could be detected between 20 and 25 kDa.).
Protein sequencing of the band V 1 and V2 yielded the original N terminal sequence of 
NFIdbd and thus the V8 protease digested at the C terminus of NFlDBD (figure 
3.1C). The digestion site was after the Glu 166 and after the Asp in position 168 in the 
absence of DNA, and after the Glu in position 209 in the presence of DNA. 
Interestingly in the absence of DNA, no V2 product was observed in the gel, 
suggesting that the cleaving rate of the V8 protease for the acidic residues in position 
166 and 168 was higher than the one in position 209.
In both assays, the protein products (VI and V2) were optimal at a V8 to NFlDBD ratio 
of 1/10 (w/w). Increasing V8 proportion, the intensity of the band representing the VI 
and V2 protein fragment decreased suggesting further proteolysis on other acidic 
residues in NFlDBD. Some of these products were detected in the SDS PAGE. 
However the amount of protein was insufficient to determine their amino terminal 
sequence and hence to determine the cleavage site.
II. Limited proteolysis using chymotrypsin
Chymotrypsin cleaves protein preferentially after aromatic, leucine, methionine and 
alanine residues. The digestion of NFlDBD using chymotrypsin followed a simple 
pattern. NFIDBD was degraded from a ratio of 1/100 of chymotrypsin to NFIdbd in to 
a single band (figure 3.2A). However the laser desorption mass spectrometiy showed 
that the protein is in fact cleaved at several sites producing several fragments of a 
moleculai’ weight ranging from 19.8 to 20.4 kDa (Cl) while N terminal sequencing 
revealed that the fragments had common N-termini. Chymotrypsin cleaves after several 
different residues between the tyrosine residue in position 170 to the valine residue in 
position 175. In fact this region contains an alanine, a leucine, another tyrosine and a 
phenylalanine, all residues susceptible to cleavage. As the concentration of 
chymotrypsin increases. C l appears to be of a slightly smaller moleculai’ weight. It is
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most likely that the chymotrypsin cleaves after the valine 175 first and then down to the 
tyrosine in position 170. Several bands of different molecular weight were observed in 
valions mass spectrophotometry charts.
At a ratio of 1/1, two further proteolytic products were detected in the presence and the 
absence of DNA. Sequencing of each band showed that the lower band (C3) contained 
the N teiminal sequence of NFlDBD (MW = 4 and 4.15kDa). The upper band (C2) 
was the cleavage product of C l at the tyrosine and at the phenylalanine residue in 
position 32 and 33 respectively. However from the gel, the molecular weight of the C2 
product cleaiiy indicated that this fragment migrated between the 6 and the 16.5 kDa 
protein marker. If the C2 and C3 were digestion products simply at position 32 and 33 
from the Cl fragment, the molecular weight of the C2 product would be 15.5 kDa. No 
peak at this molecular weight was observed on the mass spectrometry charts. Instead 
peaks in the mass spectrometry chart were seen at 10 to 10.3 kDa. Therefore the C2 
product contained the NFIDBD sequence from the Y32/F33 to either a leucine or to a 
tryptophane residue at position 119. However other peaks were observed in the mass 
spectrometry (i.e. a peak at 12 kDa.) but their molecular weight determination was not 
as accurate as for the 10.3 kDa fragment. The apparent molecular weight was 
calculated and was 11 kDa.
When complexed to DNA, the digestion of NFIdbd by chymotrypsin produced a 
complex patterns of products. The digestion of the protein to residues 170 and 173 (to 
produce C l) was barely detectable at ratio of 1/10 to 1/1. Both sites were protected 
from cleavage in the presence of DNA (figure 3.2B). However the C2 and C3 
proteolytic product appeared with the same pattern, although the intensity of the bands 
was slightly lower. At a ratio of 1/100 an unchai'acterised proteolytic product of 
NFIdbd was detected with an apparent moleculai* mass of 25 kDa (C4) and a further 
product at a chymotrypsin to NFlDBD ratio from 1/10 with an apparent moleculai* 
weight of 24.5 kDa (C5).
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Figure 3.2: Partial proteolysis with chymotrypsin of NFI DNA Binding Domain (A) and 
when complexed to a double stranded oligonucleotides with a specific DNA binding site
forNFI(B).
Prior to proteolysis NFI was incubated with 5mM DTT and in (B) with DNA for 30 minutes at 
20°C. Chymotrypsin was added in varying ratio from 1/1000 (w/w) protease to NFI (lane 1), 1/ 
500 (lane 2), 1/100 (lane 3), 1/50 (lane 4), 1/10 (lane 5), 1/5 (lane 6) to 1/1 (lane 7). The protease 
reaction was incubated for 1 hour at 20°C. The protease was inactivated by incubation for 15 
mins on ice with 1 mM PMSF. An aliquot (2 fxg) of protein was separated on a 15% SDS PAGE 
and proteins bands revealed by staining with Coomassie blue. The molecular weight of bands 
C l, C2 and C3 were determined by mass spectrometry. The mass spectrum is shown to the right 
of the gel (A). Lane C represent NFI non treated with protease. Lane M are the protein markers 
and the molecular weight of some markers are indicated in kDa. In (C) is a schematic represen­
tation of the different cleavage sites of Chymotrypsin in NFIDBD.
N teiminal sequencing of the C4/C5 protein fragment showed that the cleavage took 
place at the C terminal end of the protein but as no precise moleculai* weight was 
obtained, the digestion site could only be mapped approximately, after the 
phenylalanine 217 and valine 212. Further bands could be detected just under the C5 
protein fragment such as C6. Unfortunately there were not enough materials for 
sequencing and no molecular weight of the C6 fragment was obtained. A band was 
detected just under the C5 product but a similar band was also seen in the digest 
performed on free NFlDBD (Mr= 24 kDa). This band was probably a fragment of the 
chymotiypsin protein.
III. Limited proteolysis using Trypsin
Ti*ypsin cleaves protein specifically after positively charged residues (lysine and 
arginine). As shown in figure 3.3, NFlDBD is very sensitive to trypsin.
The various digestion products obtained are shown in figure 3.3. NFlDBD is cleaved in 
three products of molecular weight 21.6 (Tl) 20.5 and 20.6 kDa (T2) (figure 3.3A and 
B). At a ratio of 1/100, NFIDBD is degraded into the Tl and T2 product. The amount 
of T l and T2 were similar at that ratio. At higher ratio, NFlDBD was degraded into T2 
to be totally degraded and could not be detected at a ratio of 1/5 of trypsin to NFIDBD 
(w/w). These digestions take place at the C terminus of NFIDBD as the N termini of 
the product was identical to the original NFlDBD. The T2 protein product is composed 
of 2 different proteolytic products. As the concentiation of trypsin is increased, 
NFIdbd seems to first be degraded at the arginine residue in position 178 followed by 
the arginine in position 176 as suggested by mass spectrometry analysis.
When complexed to DNA, NFlDBD was cleaved into the same products. However in 
the presence of DNA, the proteolytic pattern of NFI was different. At a ratio of 1/100 
the main product was the T l protein fragment and the degradation from T l to T2 
proceeded at a reduced speed. Proteolysis did not mn to completion as T2 could still be 
detected at a trypsin to NFIDBD ratio of 1/1.
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Figure 3.3: Partial proteolysis using trypsin of NFI DNA Binding Domain (A) and when 
complexed of a double stranded oligonucleotides with a specific DNA binding site for
NFI(B).
Prior to proteolysis NFI was incubated with 5mM DTT and in (B) with DNA for 30 minutes at 
20°C. Trypsin was added in varying ratio from 1/1000 (w/w) protease to NFI (lane 1), 1/500 
(lane 2), 1/100 (lane 3), 1/50 (lane 4), 1/10 (lane 5), 1/5 (lane 6) to 1/1 (lane 7). The protease 
reaction was incubated for 1 hour at 20°C. The protease was inactivated by incubation for 15 
mins on ice with 1 mM PMSF. An aliquot (2pg) of protein was separated by migration in a 12% 
SDS PAGE and proteins bands revealed by staining with Coomassie blue. The molecular weight 
of each band was determined by mass spectrometry. The mass spectrum is shown on the right of 
the gel. Lane C represent NFI non treated with protease and lane T represent the protease alone. 
Lane M are the protein markers and the molecular weight of each marker is indicated in kDa.
(C) is a schematic representation of the different cleavage sites of trypsin in NFIDBD.
In a further experiment performed at a higher temperature, NFlDBD was totally 
degraded by trypsin even in the presence of DNA. At a trypsin to NFIDBD ratio of 1/1, 
other forms of the protein migrating faster in the gel were detected: these protein 
products migrated between the protein markers of 16.5 kDa and 6 kDa. None of these 
polypeptides species were identified.
IV. Limited proteolysis using proteinase K.
Proteinase K is a non specific protease and was therefore expected to cleave after any 
residue. From a proteinase K to NFIdbd ratio of 1/100, free NFIDBD is cleaved into a 
major product K l. In the presence of DNA, this K1 product was protected from 
cleavage, and instead two major protein fragment K2 and K3 were obtained, they had a 
higher molecular weight than Kl.
The N terminal sequencing showed that K l and K2 were cleaved at their C terminal 
end. Although K3 was not sequenced, it was expected to have the same N terminal 
sequence as it is an intermediate proteolytic product of degradation to the K2 fragment. 
This product was also appaient in the digestion of free NFIDBD (albeit weaker). The 
molecular weight of these protein fragments were not obtained by mass spectrometry, 
but by calculating their apparent moleculai* weight in SDS PAGE using the VI and T l 
and T2 as moleculai* weight markers (figure 3.4C). The Kl fragment migrated just 
between the T2 and VI while the K2 fragment migrated between T l and T2. The 
apparent molecular weight for K l was estimated at 19.6 kDa while K2 and K3 were
21.1 kDa and 24 kDa respectively. This meant that Kl was cleaved after the leucine in 
position 169, K2 after the glutamic acid 181 and K3 after the glutamine in position 
208 .
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Figure 3.4; Partial proteolysis using proteinase K of NFI DNA Binding Domain (A) and 
when complexed of a double stranded oligonucleotides with a specific DNA binding site
forNFI(B).
Prior to proteolysis NFI was incubated with 5mM DTT and in (B) with DNA for 30 minutes at 
20°C. Proteinase K was added in varying ratio from 1/1000 (w/w) protease to NFI (lane 1), 1/ 
500 (lane 2), 1/100 (lane 3), 1/50 (lane 4), 1/10 (lane 5), 1/5 (lane 6) to 1/1 (lane 7). The protease 
reaction was incubated for 1 hour at 20°C. The protease was inactivated by incubation for 15 
mins on ice with 1 mM PMSF. An aliquot (2pg) of protein was separated by migration in a 15% 
SDS PAGE and proteins bands revealed by staining with Coomassie blue. The apparent molecu­
lar weight of K l, K2 and K3 was determined by comparing on a SDS PAGE with other NFIDBD 
proteolytic products of known mass (T l, T2 and VI). Lane C represent NFI non treated with 
protease and lane K represents the protease. Lane M are the protein markers and the molecular 
weight of some of the markers are indicated in kDa. In (C), the cleavage site are schematicaly 
represented.
V. Summary
By performing these paitial proteolysis experiment on NFlDBD in the presence and 
absence of DNA, different patterns of digestion were obtained. The susceptibility to 
degradation by proteases of the residues in NFIDBD enabled us to determined thiee 
different groups of residues (figure 3.5): i) those which were degraded in the presence 
DNA (R187, Y32 and F33, Q208, E181), ii) those whose degradation was slowed 
down in the presence of DNA (R176, R178) and iii) those which were protected from 
degradation by DNA (E l66, Y170 to V175 and LI69). Other cleavage sites are likely 
since some of them were detected by SDS PAGE but the cleavage site has not yet been 
determined.
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Figure 3.5 R epresentation o f the various dom ains susceptible  
to proteolytic degradation.
The various cleavages site identified in the partial proteolysis experiments are 
represented. Cleavage sites identified in the absence of DNA, are represented over the 
diagram, while those which were detected in the presence of DNA are shown under it. 
The domain sensitive to cleavage by proteases, is shown in a green box while the 
domain not required for DNA binding is in a red box. The others region previously 
identified as being involved in DNA binding are the lysine-arginine rich domain (yellow 
box). The conserved region between residues 100 to 175 is also shown by a blue box.
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Chapter 4 : Identification of the cysteines residues of Nuclear Factor I involved in the DNA binding activity.
In vivo, NFI DNA binding activity seems to be regulated through a red ox mechanism 
involving cysteine residues which are required for DNA binding (Bandyopadhyay et 
al, 1998). However, which of the four conserved cysteine residues is involved in DNA 
binding is still unknown. Site directed mutagenesis showed that all of them, except 
cysteine 111 (positioning in human), were sensitive to mutations which led to an 
inactive protein (probably due to misfolding of the protein, Novak et al, 1992, 
Armentero etal, 1994, Bandyopadhyay et al, 1994). To identify the cysteine residues 
involved in the DNA binding activity, a direct labelling method with iodoacetic acid 
was used (prior to use, iodoacetic acid was neutralised by titration with NaOH to form 
iodoacetate). Unlike site directed mutagenesis, this method has the advantage that 
iodoacetate labelled all the different cysteine residues involved in the active site of a 
native protein and ensures that the overall fold is conserved. Iodoacetate labelling is a 
method that was already successfully used to label cysteine residue in position 62 
involved in the DNA binding of the p50 subunit of NFkB (Matthews et al, 1992).
At a pH lower than 8, iodoacetate specifically reacts with the SH group of cysteine via 
a direct nucleophilic subtitution releasing a proton and a negatively charged iodine and 
resulting in the addition of a caitoxyl group on the S. This new carboxyl function is a 
negatively charged group at physiological pH.
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I, Effect of iodoacetate on DNA binding activity of NFI
It had been shown on cellulai' extract fractions, that the DNA binding activity of NFI 
was abolished by treatment with a number of cysteine modifying chemicals (such as N 
ethylmaleinede, diamide, Novak et al, 1992, Bandyopadhyay et al, 1994). 
Furthermore it was noticed that the addition of fresh DTT to fractions containing 
purified NFIDBD enhanced the DNA binding activity of this protein. This suggested 
that cysteine residues in NFlDBD were directly involved in the DNA binding activity. 
This was investigated further in the following manner: cysteine residues were first fully 
reduced by incubation in 20 mM DTT for 30 minutes (this step ensured that the 
chemical modification could take place on all available sulphydryl groups). NFlDBD 
was then diluted into the gel retaliation buffer and treated with iodoacetate at a 
concentration varying from 2 to 15 mM for 30 minutes at 20°C. The iodoacetate 
modification reaction was stopped by the addition of 50 mM DTT for 15 minutes. The 
remaining DNA binding activity of NFI in each assay was deteraiined by a gel 
retention assay in the presence of an excess of probe. This enabled to detect any 
inhibitory effect of iodoacetate on the DNA binding activity of NFI. Quantification of 
the amount of radioactivity in each NFI band (Figure 4.1 A) was done by scanning the 
film followed by analysis with Biorad analyser software. The intensity of each band in 
the presence of iodoacetate was compared to the control (incubated without any 
iodoacetate). The percentage of the radioactivity remaining was plotted versus the 
concentration of iodoacetate. In all samples containing iodoacetate, the DNA binding 
activity of free NFlDBD was inhibited and the remaining radioactivity varied between 5 
and 10%. Addition of 2 mM iodoacetate was sufficient to inhibit the DNA binding 
activity of NFI (Figure 4.1 A). However some DNA binding activity still remained 
even after treatment at higher concentration of iodoacetate (10 or 15 mM) which can not 
be explained by the residual DTT present in the assay buffer (less than 0.5mM).
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Figure 4.1 Effect of various concentration of iodoacetic acid on the DNA binding activity 
of NFI. Iodoacetic acid was added either to NFI (A) or NFI complexed to DNA (B) and 
incubated for 30 minutes at 20°C. The reaction was quenched by addition of DTT to a final 
concentration of 50mM. The complex DNA-NFI was separated from the free probe on a 8% 
native polyacrylamide gel at 150 V for 90 minutes. The gel was dried and exposed with a film 
overnight. The positioning of the complex NFI-DNA and of the free DNA are indicated. The 
concentration of the iodoacetic acid used in each assay is also indicated on top of each lane in 
mM. In (C) is a representation of the percentage of DNA binding activity of NFIDBD remain­
ing after treatment with iodoacetic acid either free (red) or complexed to DNA (blue).
As opposed to what has been described above where DNA was added after 
modification, NFIDBD was also treated with the same chemical but when complexed to 
a radioactively labelled oligonucleotide containing an NFI binding site (figure 4. IB). 
This was performed as described above except for the fact that the probe (1.6 ng) was 
added before treating NFlDBD with iodoacetate. NFlDBD, when complexed to the 
DNA, was resistant to inactivation by iodoacetate at concentration of 2 to 15 mM. 
However at concentration of 15 mM of iodoactetic acid, the modifying agent had an 
inhibitory effect on the DNA binding activity of NFI as the quantity of complex probe- 
NFI decreased. When NFlDBD was complexed to DNA, the percentage of remaining 
DNA binding activity of NFlDBD followed a sigmoid curve. At concentration under 
4mM of iodoacetate, the DNA binding activity of NFlDBD was over 90% of the 
control. Above 4mM of iodoacetate, the DNA binding activity of NFlDBD decrease 
dramatically falling to 15% at 15mM iodoacetate.
These experiments clearly demonstrated the involvement of cysteines residues in the 
DNA binding activity of NFI.
II, Labelling of cysteines using '"C iodoacetate.
To identify the cysteine residue(s) modified by iodoacetate in DNA binding 
experiments, the differential labelling procedure develop by Koshland was used 
(1959). This two step procedure involved the treatment of NFI when complexed to 
DNA with “cold” iodoacetate in order to modify exposed and sensitive residues to 
iodoacetate but which are not involved in the DNA binding activity. Elution from the 
DNA column then exposed any cysteines residues, in intimate association with DNA,
14which can then be labelled with C iodoacetate. To avoid any alteration to the protein 
state, C iodoacetate labelling was performed under identical conditions to the initial 
cold iodoacetate treatment.
The procedure used is described in figure 4.2. NFI was first complexed to DNA using 
an NFI binding site immobilised on Sepharose beads. Bound NFlDBD was extensively
141
washed and then exposed to unlabelled 10 luM iodoacetate (in the same buffer) for 30 
minutes at 20°C. The concentration of iodoacetate used was kept to lOmM to ensure 
that the reaction ran to completion. Beads were then washed by the equilibration buffer 
supplemented by 2mM DTT (to quench any residual iodoacetate) followed by elution 
of NFI from the beads by raising the salt concentration to IM.
NFI was then dialysed to reduce the NaCl concentration to 0.25M and the protein was 
concentrated by centrifugation using a Centricon membrane with a molecular weight
14cut off of 30 kDa. NFI was labelled with lOmM C iodoacetate (ICN) under the same 
conditions as described above. The labelling reaction was terminated by the addition of 
50 mM DTT and incubation continued for a further 15 minutes.
III. Fractionation of the peptides from the tryptic digestion  
and identification of the labelled peptides.
14C labelled Nucleai' Factor I was precipitated by addition of 10% (w/v) tiichloroacetic 
acid and the pellet washed twice with acetone. This step separated the unincorporated 
iodoacetate from the protein. The NFlDBD precipitate was resuspended in 8 M 
deionised urea, 100 mM Tris pH 7.5 and boiled for 10 minutes. The urea concentration 
was lowered to 2 M by addition of water, and NFI was then digested using trypsin at a 
ratio of 1/25 (w/w) for 16 hours at 37°C.
The various peptides were purified by reverse phase HPLC using a Waters HPLC 
system and a "delta pak" C l8 column. Elution was achieved using a gradient of 0 to 
98% acetonitrile in water in the presence of 0.06% trifluoroacetic acid. Fractions were 
collected and their radioactivity was determined by liquid scintillation counting. The 
elution profile of the HPLC column at 210 nm and scintillation counting aie 
represented in figure 4.3. Six main radioactive peaks were obtained. Fraction 7 
corresponded to unreacted iodoacetate. Fraction 49, 58, 60, 61 and 73 were dried and 
peptides sequenced by automated Edman degradation.
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NFI Is bind to immobilised 
DNA on sepharose beads
DNA
The DNA NFI complex Is treated 
with 10 mM Iodoacetate
12-COO-
The DNA-NFI complex Is 
dissociated and separated 
from one another
NFI Is treated with 10 mM 
radioactively latielled Iodoacetate
0
NFI Is denatured and digested Into 
peptides using trypsin. Peptides 
are separated by HPLC
o  -
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Figure 4.2 Procedure used for the differential labelling with iodoacetate 
of cysteine residues in Nuclear Factor I
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Figure 4.3 Fractionation of the various peptides obtained from 
the trypsin digestion of NFI.
The elution profile of the reverse phase HPLC is represented in (A). Identification of C14 la­
belled peptides (B) was done by scintillation counting for 5 minutes and plotted. The scintilla­
tion counting of each fraction is represented in counts per minute (cpm).
IV. Sequencing of the various fractions and identification o f  
the residues labelled with "C iodoacetate.
Each fraction was sequenced for eight cycles. 80% of the material released at each 
cleavage step was loaded onto a HPLC in order to identify the amino acid residue. The 
remaining 20% was used to determine the radioactivity of the cycle by liquid 
scintillation counting. Figure 4.4 shows both sequences and the scintillation counting 
profile of each fraction.
No clear sequence could be determined for fraction 49 nor were any radioactive peaks 
detected. An aliquot of the resuspended fraction was also monitored by scintillation 
counting. No radioactivity was found in this fraction (data not shown). It seems that 
the peptide was either lost during the drying procedure or remained bound to the tube. 
With fraction 73, a sequence could barely be determined, the scintillation counting also 
revealed a small peak coinciding with a cysteine residue in position 148 in the human 
NFI.
Using the three other fractions (58, 60 and 61), the sequences could be easily be 
determined. In fraction 58, the peptide which was sequenced, corresponded to the 
sequence between isoleucine 93 and arginine 97 in the human NFI. Furthermore 
another sequence was also obtained which span from the lysine 107 to leucine 113. 
The radioactivity associated with the third sequencing cycle increased dramatically 
coinciding with a residue which eluted from the HPLC as a cai'boxymethyl cysteine 
residue (cysteine residues are broken down in the Edman reaction). This corresponds 
to the labelling of the cysteine residue in position 95. In the other sequence, a cysteine 
residue was expected in the fifth cycle. However, the slight increased in the 
radioactivity could not account for the precise labelling of this cysteine residue.
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Fraction 49 cpm  200
150
100
50
0
Fraction 58 cpm  200
150
100
50
Sequence 1 : 
Sequence 2 :
I D Cmc L R 
K A P G Cmc V L
0
Fraction 60 cpm  500
400
300
200
100
Sequence 1 : K A P G Cmc V L S 0
Sequence 2 : R I D  Cmc L R
Fraction 61 cp m  5 0 0
4 0 0
3 0 0
2 0 0
1 0 0
Sequence 1 : 
Sequence 2 :
R I D  Cmc L R 
K A P G Cmc V L
Fraction 73 cpm  2 0 0
1 5 0
1 00
5 0
Sequence 1 : A A Q C G H P
Figure 4.4 Sequence of the peptides in fraction 49, 58, 60, 61 and 73 purified by reverse
phase HPLC.
The fractions were sequenced and each flow through of each sequencing cycle was recovered. 
The radioactivity of each cycle was determined by scintillation counting for 5 minutes and 
plotted as above. The result of the sequencing is represented under the plot. The sequence (Se­
quence 1) is the major sequence whereas the sequence 2 is the minor sequence obtained. 0 
represents the background of the scintillation counter
Sequencing of fractions 60 and 61 also revealed in both of them the existence of two 
different peptides: from lysine 97 to a serine 114 and from an arginine 92 to 
arginine 97. The first peptide was predominant in fraction 60 while the second one
14was the main peptide of fraction 61. In fraction 60, two peptides labelled by C were 
detected by scintillation counting: the cysteine modified residue in the minor sequence 
eluted in the fourth cycle which coincided with an increase of radioactivity. In the fifth 
cycle, the radioactive signal was further increased due to the presence of a labelled 
cysteine residue present at that stage in the major sequence. In fraction 61, the 
radioactivity peaks in each fraction also coincided with carboxymethyl cysteine 
residues. The cysteine residue in position 95 was cleaiiy labelled. The radioactive 
labelling of the cysteine residue in position 111 is less obvious as the radioactive peak 
could be also inteipreted as the cany over from the previous fraction. However 
comparing the fifth and sixth cycle of fraction 60 and 61 does suggest that the cysteine
14residue in the fifth cycle of fraction 61 is C labelled.
Surprisingly this method shows the existence not of one but of two cysteine residues 
protected from modification by iodoacetate by DNA: cysteine residue in position 95 
and 111. The cysteine residue in position 95 did not seem to be labelled more 
preferentially than the cysteine residue in position 111. These labelled residues 
accounted for two thirds of the radioactivity present in the modified NFlDBD. Although 
other cysteine residues seemed to be labelled such as cysteine in position 148, these 
could only account for about 10% of the total incorporation of radioactivity, hence 
showing the reactivity of cysteine residues 95 and 111.
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Discussion
I. Nuclear factor I: a family of proteins with two distinct 
functional domains.
Nuclear Factor I is divided into two distinct functional domains: a DNA binding region 
between residue 1 and 222 and a region at the C terminus involved in the regulation of 
transcription. This N terminal region alone can bind DNA and stimulate DNA 
replication of the genome of adenovirus 2 and 5. This is achieved by enhancing the 
formation of a nucleoprotein preinitiation complex at the origin of replication through a 
direct interaction with the Ad pol. Although the role of NFI in this replication process 
is now well established, stmctural information about the protein is still scarce. Using 
deletion analysis, Chen et al, (1990) found the interaction site between the Adenovirus 
polymerase and NFI lies between residues 68 and 150. Aimentero and co workers 
(1994) used site directed mutagenesis, to pinpoint the residues: two double mutants at 
residues cysteine 79/ai'ginine 80 and isoleucine 87/threonine 88 were unable to interact 
with the Ad pol. However as most mutants did not form active protein, it is possible 
that other regions are also important for the interaction of NFI with Ad pol.
Two subdomains in the NFI DNA Binding Domain possess different DNA binding 
activity. A region between residues 1 to 78 binds DNA non specifically. Another 
region between residues 78 to 222 recognises specifically the NFI DNA biding site 
(Dekker et al, 1996). Further site directed mutagenesis showed that cysteines are 
involved in the DNA binding (Novak et al, 1992). In this work, we attempted to define 
these regions more precisely and in particular find out which cysteines are important. 
This was achieved using two techniques: limited proteolysis and differential labelling. 
However to study NFlDBD by limited proteolysis, it is important to have a protein with 
a correct molecular weight and a free N terminus.
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II. Expression and purification of Nuclear Factor I DNA  
Binding Domain.
II.1 Expression of Nuclear Factor I
Both expression systems (bacterial and baculovirus) produced very different results. 
Production of Nuclear Factor I in bacteria enabled us to obtain large quantity of protein 
(20 mg/1 of induced cells) but here NFlDBD formed insoluble and inactive material. The 
reason why protein forms inclusion bodies is still not understood. It has been found 
that the tendency of inclusion bodies formation does not correlate with the size or the 
hydrophobicity of the expressed recombinant protein (Wilkinson et al, 1989). 
Overexpression of a naturally occurring bacterial protein can even lead to aggregates 
(Gribskov et al, 1983). A kinetic model has been proposed where the formation of 
inclusion bodies would depend on the rate of protein synthesis, the rate of aggregation 
and the rate of protein folding of the protein being expressed (Kiefhaber et al, 1991). 
This interpretation correlates with the experimental finding that induction carried out 
under reduced growth condition (extreme pH values, low temperature) and limited 
level of induction resulted in an increased recovery of soluble material. The solubility 
of the protein GST-NFlDBD was increased by inducing protein production at a lower 
temperature, but the effect was not reproducible for NFlDBD. NFlDBD solubility was 
increased by inducing protein production at low cell density in the media (Deklcer et al, 
1996). Maybe a way to interpret the formation of NFlDBD inclusion bodies in bacteria 
would be to relate them with results obtained during folding in vitro. We showed that 
low salt concentration, high temperature and high protein concentiation are the worst 
conditions for NFlDBD folding in vitro. These conditions are precisely those which 
prevail in the bacterial cells when protein production is induced. Another possibility 
which may explain the insolubility of NFlDBD expressed in bacteria is that this protein 
might be toxic for bacteria. NFlDBD binds tightly to DNA and may cause a problem for
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the bacteria to grow or even survive. Therefore only bacteria producing insoluble 
protein survived after induction by IPTG. However using NFlDBD fused to a 
periplasmic localisation signal should have solved this problem. The protein with the 
localisation signal was still insoluble and not exported to the periplasmic region. 
NFlDBD is probably insoluble as soon as it is synthesised.
Baculovirus system allowed the overproduction of NFlDBD in an active form. The 
construct which was described in chapter 1, contained added sequences which were 
not related to NFlDBD sequence; at the N terminus 5 residues from IkB and at the 
C terminus a sequence from the viral protein P of SV5 were added. This modified 
NFlDBD (named NFlDBD cPk) construct was soluble, imported to the nucleus of 
infected insect cells and could be purified in a similai* fashion as NFlDBD from other 
recombinant virus construct (Bosher et al, 1990). Therefore we could expect this 
protein to fold like the native one. Using this system of expression, the yields obtained 
were generally low (1 to 1.5 mg of purified protein per litre of infected cell). This was 
much lower than the 10 mg of protein typically expected.
II.2 Expression of Nuclear Factor I as a fusion protein with GST.
The NFlDBD was produced in baculovirus as a fusion protein for a main reason: to 
avoid post translational modification of the N terminus. NFlDBD cPk was then 
produced as a fusion protein with GST at its N terminus in infected insect cells. The 
main difficulty was that the GST-NFIDBD cPk could not be purified by affinity or ion 
exchange chromatography, despite the fact that several different conditions were used 
to attempt to destabilise the putative interaction between GST and NFlDBD. 
Purifications were tried in the presence of various additives (Triton, CHAPS, NDSB) 
or various NaCl concentration (0.2, 0.4 and 1.5 M). None of these conditions enabled 
the purification of GST-NFIDBD cPk by affinity chromatography on immobilised 
glutathione. This suggests that no weak hydrophobic or ionic interaction occurred
151
152
between both proteins. Dialysis of the cellular extract also ensured that GST binding to |
glutathione - agaiose was not hindered by the presence of free glutathione present in 
the insect cell. We can also rule out that GST (and NFlDBD) were mutated as both 
proteins could be easily purified once separated. This further supported the hypothesis f
that no strong interaction existed between the two proteins but steric hindrance. Also 
no frame shift occurred as a monoclonal recognition site at the C terminus was still 
recognised by the antibody Pk.
The methods set up for purification of NFlDBD were awkward and hard to reproduce.
The critical step was the cleavage of the GST-NFIDBD with thrombin in a crude cellular "f
extract. Although the cellular extract was dialysed to remove protease inhibitors, the 
proteolysis reaction using thrombin was not always successful. One of the critical 
conditions which was identified, was the salt concentration in the extract. This needed 
to be at 0.2 M NaCl (data not shown). Other unidentified factors also could affect this 
step.
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II.3 Comparison of NFlDBD proteins produced under different 
conditions
NFlDBD purified from baculovirus, migrated as a doublet in a SDS PAGE and had an 
apparent higher moleculai' weight than NFlDBD purified when fused to GST (figure 
1.8). The nature of the post translational modification of this protein is still unclear.
However this doublet disappears after tieatment with protease (figure 2.18) which 
suggests that the modification took place at the extieme C terminus. As 
phosphorylation and glycosylation seem to occur outside the DNA binding domain I
(Bosher, personal data), this doublet is most likely due to proteolytic degradation. The 
high apparent moleculai" weight of this protein compared to the other protein is unclear.
It may be just a result of the modification of the N terminus which affects binding of 
the SDS to the protein. The exact molecular weight would need to be deteimined by 
other methods such as mass spectrometry. #
III. In vitro folding of Nuclear Factor I
111.1 Advantages
Besides the high quantity of protein produced, the formation of inclusion bodies has 
several advantages: this enabled the production of a potentially toxic protein, protected 
the protein from proteolytic degradation and made the protein easy to purify. By 
disrupting the bacterial membrane using lysozyme, Triton and sonication, and after 
digestion of the DNA, inclusion bodies are easily separated by simple centrifugation 
from the rest of the cellulai* proteins. This produces an extiact with 4 major proteins. 
None of the other proteins found in the inclusion bodies were solubilised in 6M 
guanidine (figure 2.2) except for NFlDBD. No attempts were made to purify further the 
protein. NFlDBD could have been further purified by gel filtration or for the six 
histidine Tag protein, by metal immobilised affinity chromatography.
111.2 Optimal conditions for folding
Refolding experiments have described several stages in the folding process. In 
denatured condition, the protein can be considered as a long flexible chain, however 
some structural element may still exist. During the folding process, the protein first 
adopts a loose tertiary structure known as the molten globule. Then secondary structure 
is acquired. In the final stage the protein compacts and rearranges to obtain the final 
structure.
As the primary stiucture of proteins dictates their tertiary structure, the folding pathway 
may differ between proteins. In chapter 2, we attempted to detemiine the optimal 
conditions for NFI folding in vitro. These depended on the additive used, the 
concentration of salt, the concentration of protein and the choice of method used for the 
renaturing. Other factors were also investigated such as the effect of temperature, pH
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and the redox state. The yields obtained were rather low and varied between 2% for 
folding in the presence of guanidine alone to 8% in the presence of NDSB 256.
III.3 Role of hydrophobic residues
The driving force in protein folding are the hydrophobic interactions. To modulate 
these interactions, additives were devised. How Non Detergent Sulfobetaine (NDSB) 
acts in the folding process was studied (Vuillaid et al, 1998). These molecules have a 
small hydrophobic region with a hydrophilic tail which prevents NDSB remaining in 
the hydrophobic core of the folded protein and avoids protein-protein aggregation. The 
effect of NDSB is to bind to hydrophobic regions transiently thus allowing the protein 
to fold correctly and avoid the formation of aggregates.
The effect of the various NDSB (of vaiiable hydrophobicity) in folding could be 
classified into three groups: i) NDSB 195 had a negative influence in the folding yield, 
ii) NDSB 201 and 223 did not affect the folding yields while iii) NDSB 256 improved 
the folding yield by 3 to 4 fold. The more hydrophobic NDSB were the most effective. 
The folding yield increased up to concentration of 0.8 M NDSB.
In vitro folding experiments suggest that influencing the hydrophobic interaction alone 
could not result in a folding yield over 10%. Using detergents such as CHAPS and 
dimethyl octyl ammonium propane sulfonate (SB 3-8) at concentrations above and 
below the CMC (critical micelle concentration) instead of NDSB, the yield could not be 
increased over 8%. The structure of these additives ai"e similai* to NDSB. Their 
hydrophobic region is much laiger causing this compound to form micelles. At the 
concentration used, these detergents did not affect significantly the folding yield of 
NFI. Using other detergents which contain a similar hydrophobic region but lack this 
zwitterionic region such as N-laurylsarcosine, the folding yields were close to zero.
In the optimal conditions set up, the folding yield did not exceed 8%. This suggests 
that to increase the folding yield further, the formation of the native structure is 
dependent on interactions other than hydrophobic. This was further supported by the
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observation in these optimal conditions, that the unfolded protein remained in solution 
and did not form any obvious aggregates as generally observed for proteins where 
hydrophobic patches are exposed.
III.4 The role of charged residues in folding
The chaiged residues have a significant effect in NFlDBD folding. NFlDBD contains at 
least 30% of charged residues (38 basic residues and 34 acidic residues). Some 
observations showed the role of the charged residues in the folding of NFIDBD.
The folding was successful with only protonated basic residues (compare folding 
yields at pH 9.1 and 10.4). However we did not study the effect of deprotonated acidic 
residues on the folding yields. Furthermore the folding yields were increased by a high 
ionic strength which seemed to indicate that the ions in the solution should screen the 
interaction between charged residues bearing opposite chai'ges. Folding yields in the 
presence of a non ionic detergent were poor.
The folding is pH dependent hence depends on ionic interaction. A striking fact is that 
at pH 7.5, NFlDBD can bind to an anion exchange column at a high salt concentration 
(0.3M NaCl) although the pi is 8.6. The incorrectly folded NFIDBD does not bind the 
resin at this ionic strength (figure 2.16). The positively charged residues aie clustered 
in a region at the N terminus of NFlDBD and it is most likely that this region interacts 
with DNA with no sequence preference(Dekker et al, 1996). To improve folding 
yields, one should examine ways to get this region to fold properly as it seems that this 
region is needed to bind to the ion exchange column. A factor which may help and was 
shown to increase yield in the folding of a family of DNA binding factor, the AiaC 
(Egan et al, 1994), is DNA. DNA would screen and lock in position positive charge 
residues which salt or guanidine cannot do. Furthermore it may help dimérisation.
155
111.5 The role of protein concentration in folding of NFlDBD in vitro
The final concentration of protein was a major factor in obtaining the optimal folding 
yield. In our studies the optimal yield was obtained between 0.25 and 0.05 mg/ml. In 
other proteins, optimal folding yield is obtained at a lower concentration usually 
between 10 to 50 mg/1 (Clark, 1998). For NFIDBD, the effect of the protein 
concentration on folding seems to be a consequence of two competing reactions. On 
the one hand, folding at high protein concentration increases the chance of protein 
aggregation either via hydrophobic or ionic interactions. This effect will be minimised 
at low protein concentration. On the other hand, it is clear that NFlDBD is only active as 
a dimer (data not shown, Kruse et al, 1994, Aimentero et al, 1994) and as this is a 
bimolecular reaction, it will be favoured at high concentration.
111.6 The effect of the methodology, of pH and temperature
Another critical step in the folding in vitro of NFlDBD is the way in which guanidine is 
removed from the solution. Two conventional methods were tried (dialysis and rapid 
dilution). For some proteins, precipitation is observed when the denatured form is 
placed in native solvent conditions and therefore gradual removal of the dénaturant may 
be the best way to obtain high yields (Clark, 1998). However by dialysis, the protein 
is exposed to intermediate dénaturant concentration for an extended period of time. At 
these intermediate concentrations, the protein is likely to exist as a folding intermediate 
in which exposed hydrophobic regions lead to aggregation. In the case of NFlDBD, 
folding yields were much higher by rapid dilution than using dialysis (figure 2.12).
The optimal pH and temperature required for the folding in vitro of NFlDBD are broad 
(pH between 7 and 9 when folding was performed at a temperature below 20°C, 
figures 2.8 and 2.10).
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111.7 the role of cysteine residues in the folding
Reduced cysteine residues ai'e important for the DNA binding activity of NFlDBD. Two 
different reducing agents yielded rather different results. Using (3 mercaptoethanol, the
optimal concentration was lO.SmM while the optimum for DTT was 1.5 mM. The 
difference in concentration is probably due to the difference in reducing capacity of 
these two chemicals.
Disulphide bridges and thus a proper oxidative state are important for protein folding 
i.e. for a secretoiy protein. Although the cell is in a reducing environment, some 
protein in cells may contain disulphides bonds important for their activity (such as the 
Adenovirus protease). Although folding yield of NFI is improved by the presence of a 
reducing agent, the mutation of any of 3 (out of the 4 conserved cysteine) residues 
affects proper folding of NFlDBD, suggesting that these residues are important for 
folding (Novak et al, 1992). It would therefore be of interest to attempt folding in an 
oxidised environment and to test the activity of NFlDBD after reduction of cysteine 
residues.
111.8 Role of the histidine residues in the folding of NFlDBD
Some evidence suggest that histidines residues are important in the folding of NFIDBD. 
When NFIDBD contains six histidines at the C terminus, folding yields in guanidine 
are half those obtained using NFlDBD (figure 2.). Furthermore, the folding yield of 
NFIDBD at pH 7 was increased 400% compared to pH 6.1 (figure 2.). The pKa of a 
histidine residue is around 6.1 but may vary depending on the environment indicating 
that successful refolding requires deprotonated histidine residues. A metal ion could 
also be involved in the structure of NFlDBD. A putative zinc motif could be determined 
in the NFlDBD sequence between residues cysteine 148 and histidine 166. Folding in 
the presence of various metals did not improve the folding yield, however the solutions 
did not contain EDTA.
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III.9 Folding of GST-NFIDBD
Attempts have been made by us and other groups to renature the fusion protein as the 
interaction of GST with glutathione can be carried out at up to 1.5 M NaCl. The 
folding yields using GST-NFI were much lower than using NFlDBD. This could paitly 
be due to the fact that the yield were estimated by gel retardation and that GST-NFlDBD 
from baculovirus binds poorly to DNA.
IV. Analysis of the DNA binding domain of NFI
Direct methods exist which may be employed to define the mechanism by which 
NFIDBD recognises DNA. This can be done by solving the structure of the DNA 
protein complex by X-ray crystallography (Nuclear Magnetic resonance is impractical 
due to the high moleculai* weight of NFIDBD). However crystallography requires a 
large amount of pure and homogenous protein (at least 10 mg). Expression of NFI in 
baculovirus produced several isoforms and it is only by using homogenous in vitro 
folded NFI that we may generate NFI of sufficient purity and quantity to crystallise the 
protein.
The DNA binding domain of NFI has mainly been studied using site directed 
mutagenesis. However the problem with introducing mutations in NFI is that 
mutations could alter the overall structure of the protein. As this seems to happen with 
most mutants of NFI, a different approach using correctly folded NFI was employed. 
Experiments were performed in vitro, on purified and active NFlDBD to determine 
which region and residues were important for DNA binding activity.
The first objective was to identify cysteines residues involved in DNA binding, as 
initial experiments indicated that one, or several cysteine residues were involved. DNA 
binding of NFI was stimulated in the presence of reducing agents and inhibited by
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cysteine modifying reagents. To identify the residues responsible for this effect, we 
chose iodoacetate labelling. Iodoacetate inhibited DNA binding activity of NFI at a low 
concentiation and was specific for cysteines residues at pH under 8. Furthermore 
radioactively labelled iodoacetic acid was commercially available.
Using the differential labelling procedure, two cysteine residues were identified 
(cysteines 95 and 111) in which bound DNA blocks modification by iodoacetate. In 
other DNA binding proteins, cysteine residues have been shown to play multiple roles 
in DNA protein interactions: in interacting directly with the DNA structure (with the 
backbone as seen in the crystal structure of p50 (Ghosh et al, 1995), or interacting with 
the nucleoside as seen in the crystal structure of the transcription factor API (Glover 
and Harisson, 1995)). Alternatively cysteine residues can paiticipate in the formation 
of a structural motif such as the zinc finger or the zinc ribbon. In the zinc finger, four 
residues (histidines or cysteines) residues coordinate an atom of zinc (King and 
Rhodes, 1987).
In NFI, site directed mutagenesis demonstrated that cysteine 111 did not perturb its 
DNA binding activity but mutation of this residue resulted in the loss of the redox 
regulation of NFIDBD. Thus it appears that cysteine 111 is important for the redox 
regulation of NFI DNA binding activity.
This result is very similai* to what was observed with the transcription factor API 
(Abate et al 1990). The subunits of API contain a cysteine in the region involved in 
DNA binding activity. When mutated, API could still bind DNA but could not be 
regulated by changes in the redox state. In fact the extreme sensitivity of this residue to 
oxidation necessitated the use of a cysteine to serine mutant in the crystallographic 
analysis (Glover et al, 1995). The serine residue makes a direct contact with the base in 
the major groove of DNA. In a similar fashion, cysteine 111 in NFI may be susceptible 
to redox regulation and make direct contact with DNA. Interestingly, mutation of the 
residues immediately following this cysteine (leucine 112 and arginine 113) generated a 
protein that could form dimers but could not bind DNA (Armentero et al 1994). These 
experiments suggest that cysteine 111 is involved in direct contact with DNA.
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Another means to regulate the DNA binding activity of these transcriptions factor could 
be by direct regulation with NO. NO generating compounds such as sodium 
nitroprusside inactivate the DNA binding activity of transcription factors such as API 
(Tabuchi et al, 1994) and NF kB (Matthews et al, 1996). The C62S mutant of p50 was 
more resistant to inactivation indicating that this cysteine residue was the principal site 
of NO modification. In preliminai'y experiments, these NO compounds were also 
shown to inactivate the DNA binding activity of NFI.
Although the cysteine residue in position 95 is not in any known DNA binding motif of 
NFI, it is not uncommon to have additional residues making contact with the DNA. 
This was cleaiiy seen in the crystal structure of NFkB. However this residue is 
important in the correct folding of the protein as the mutation of this residue results in a 
misfolded protein.
Dekker et al (1996) identified two domains involved in the interaction of NFIDBD with 
DNA: a region binding DNA without specificity (residues 1 to 78) and a region which 
specifically recognised the DNA binding site of NFI (residues 78 to 236). To 
investigate further the role of these different functional domains, the method of paitial 
proteolysis was employed.
These experiments were performed on functionally active NFIDBD, in the absence or 
the presence of DNA. By compaiing the various proteolytic products, residues which 
were protected by the presence of DNA could be identified.
The digest products obtained were clearly different due to the addition of DNA. This 
suggested that the region whose residues were cleaved in the absence of DNA, but not 
the site of interaction with DNA, were either directly involved in DNA binding or close 
to the DNA binding site. Following determination of the cleavage sites for most 
proteolytic fragments, two regions of different proteolytic susceptibility were 
identified. A region between residues 166 and 175 was degraded in the absence of 
DNA but protected in the presence of DNA, a region between 181 and 222 was cleaved
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in the presence, but not the absence of DNA (figure 3.5), A few other cleavages site 
were mapped in NFI using chymotrypsin but the protein remained largely resistant to 
further degradation even when using substantial amounts of protease.
Our results may cast light on previously unexplained obseiwations and may explain the 
role of this region in DNA binding. Most of the DNA binding region, from residue 2 to 
178, is encoded from a single exon. It was thought that this exon encoded for the 
whole active DNA binding domain. However experimental data from us and other 
groups showed that overexpression of only the 178 residues of the N terminal of CTFl 
produced a protein with a dramatically reduced DNA binding activity compared to the 
full length NFIDBD (222 residues) or CTFl (499 residues). One could interpret this 
result as an incorrectly folded protein.
However, in vivo, the protein NFI B3 was identified which contains only the 
N terminal region. NFI B3 is the result of an alternative splicing of the intron between 
exon 2 and 3. For the production of CTFl, this intron is normally spliced (figure 5.1), 
but for the production of NFI B3, this intron remains in the mRNA. The first codon of 
this intron encodes for a stop codon. Therefore NFI B3 has the equivalent DNA 
binding region of the construct presented before, that is the 177 residues of exon 2 and 
an additional 9 residues at the N terminus. The key point about NFI B3 is that this 
isoform of NFI can not bind DNA while a fragment of NFIDBD cut after residue 181 
still retains DNA binding activity.
Co expression of NFI B3 with CTFl produced two types of DNA binding proteins: 
the CTFl homodimer and the heterodimer CTFl-NFI B3. However CTFl homodimer 
had a higher DNA binding affinity than the heterodimer CTFl-NFI B3. Therefore NFI 
B3 seems to contain all the required elements for proper folding and dimérisation but 
lacks an essential element for DNA binding. This was surprising as the ai'ginine and 
lysine rich region and the specific DNA recognition region were both present in this 
protein. Our result therefore showed that this region between residue 166 and 181 is 
critical for DNA binding.
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mRNA
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exon 1 NFIB3
Figure 5.1 Schematic representation of the alternative splicing events 
occuring in the production of NFI B3 and CTFl at the 5 end of the pre 
mRNA encoding for NFI proteins.
The stop codon in the intron between exon 2 and 3 is represented by a red box. Due to the 
non splicing of the intron between the exon 2 and 3, the mRNA producing for NFI B3, 
encodes for a protein with the N terminal 186 residues (red box) and does not contain any 
transcription activation domain. The protein produced can not bind DNA. The removal of this 
intron in the pre mRNA encodes for a protein such as CTFl with a transcription activation 
domain (green box) with DNA binding activity.
This region is very sensitive to proteolytic degradation. This observation suggests that 
this domain is very exposed in the molecule and is less compact than the rest of the 
protein. The amino acid sequence also showed that it was composed of two regions: a 
highly conserved region between residue 166 to 175. Closer to the C terminus, only an 
acidic residue (usually an aspartic acid residue) in position 179 was conserved among 
NFI species. The digest pattern also suggests that this region probably exists into two 
subdomains: a region very well protected by DNA which may interact directly with 
DNA and a region between 176 and 181 required for the DNA binding but nevertheless 
sensitive to the protease (i.e. the ai'ginine residues in position 176 and 178). Cleavage 
of these arginine residues in position 176 and 178 did inactivate the DNA binding of 
NFI.
In an attempt to determine the role of this region in DNA binding, the amino acid 
sequence of this region (166 to 181) was tested for homologies with other proteins in 
the “genbank” database. NFI was the only DNA binding protein possessing this type 
of sequence. Therefore it is difficult to establish the exact role of this region in DNA 
binding until structural data is obtained.
One could suggest that the difference of the digestion pattern of NFI in the presence or 
absence of DNA could be due to a conformational change in the protein. If NFI 
displayed large confonnational changes when binding to DNA all digestion patterns 
would differ significantly in the presence or absence of DNA. This is obviously not the 
case, as the digest pattern using trypsin in the presence or absence of DNA, is the same 
at the C terminus. Furthermore, the digest products C2 and C3 are also present in both 
sets of condition suggesting that no N terminal conformational change could be 
detected. Therefore no lai'ge scale change of confonnation was evident either at the C 
or at the N terminus of the protein. To explain the difference in the digest pattern with 
V8 in the presence or absence of DNA (the V2 product is not observed in the digest 
without DNA), the protease reactivity for both cleavage sites may vary. Once exposed, 
the glutamic acid in position 166 might be more reactive than the residue in position 
209.
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V. Conclusion
By using new refolding techniques, we were able to set up a method for obtaining 
homogenous functional NFI. This was helpful to understand which residues ai*e 
involved in DNA binding. How Nuclear Factor I binds to DNA and how the domains 
bind still remains unclear. However our results from the purification, labelling with 
iodoacetate and partial proteolysis shows that NFI uses several regions to bind DNA. 
A region rich in positively charged residues was previously shown to interact with 
DNA, most likely via the phosphate backbone. We showed that another region, located 
between residue 166 and 181, is cracial in DNA binding. Labelling with iodoacetic 
acid showed that cysteines 95 and 111 are in close contact with the DNA. This 
confirms results from site directed mutagenesis showing that the region close to 111 is 
involved in recognition of the DNA binding site and that the role of cysteine 111 is 
crucial for redox regulation. It is now becoming apparent the DNA binding activity is 
located in the whole length of the DNA binding domain of the protein. However 
without any spatial structure, it is as yet impossible to have any understanding of how 
this protein folds and therefore the relation between these various regions in DNA 
binding.
VI. Future Work
To characterise further the residues of NFI involved in DNA binding activity, several 
footprinting methods have been recently developed which employ the use of an 
irreversible and reversible modifying chemical. This has the advantage that the protein 
has to be functional only for the time of the first modifying reaction. Also a hydroxyl
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radical cleavage reaction has been developed. These may help to better characterise the 
various regions involved in the DNA binding.
Obviously the next step would be to solve the stmcture of NFI. Although this has 
already been attempted, the production of NFI has mainly relied on using infected cell 
with a recombinant virus. However the protein in these cells is often modified and 
results in a heterogeneous population. Therefore the folding in vitro is a very attiactive 
method as the protein is most unlikely to contain post translational modification. Still 
the folding yield remains low. This seems to be either due to the lack of a factor 
required for the correct folding such as DNA or a metal. Further research should 
therefore focus on optimising further the folding yield.
Another method would to refold with the addition of a cytoplasmic extract from HeLa 
cells. These may contain a factor (such as a chaperonine) required for optimal folding 
of NFI. If successful, one could therefore attempt to purify this factor and characterise 
it.
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